var title_f41_55_42864="Amsler grid PI";
var content_f41_55_42864=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F74919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F74919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 525px\">",
"   <div class=\"ttl\">",
"    Amsler grid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 505px; height: 573px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    When people with wet age-related macular degeneration (AMD) look at straight lines, the lines actually look bent or wavy. Doctors often test people's vision by asking them to look at a grid of straight lines like this one.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Age-Related Macular Degeneration: What You Should Know. U.S. Department of Health and Human Services. Available at: file://www.nei.nih.gov/health/maculardegen/nei_wysk_amd.PDF.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42864=[""].join("\n");
var outline_f41_55_42864=null;
var title_f41_55_42865="Holoprosencephaly development";
var content_f41_55_42865=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F51494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F51494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Holoprosencephaly",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 369px; height: 326px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kawamoto, HK Jr, Pravin-Kumar, KP, Atypical facial clefts. In: Pediatric Plastic Surgery, Bentz, M (Ed), Appleton Lange, Stamford, CT 1998. p.184, Copyright &copy;1998 The McGraw-Hill Companies, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42865=[""].join("\n");
var outline_f41_55_42865=null;
var title_f41_55_42866="Stevens-Johnson syndrome - oral";
var content_f41_55_42866=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Stevens-Johnson syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erosions and crusts are present on the lips of this patient with Stevens-Johnson syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42866=[""].join("\n");
var outline_f41_55_42866=null;
var title_f41_55_42867="Amyl nitrite: Patient drug information";
var content_f41_55_42867=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Amyl nitrite: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/1/33813?source=see_link\">",
"     see \"Amyl nitrite: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/25/405?source=see_link\">",
"     see \"Amyl nitrite: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10492713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024839\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691802",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cyanide poisoning.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3573630",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used with a test for the heart.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024838\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701520",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to amyl nitrite or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703229",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Bleeding in the brain, glaucoma, or head injury.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024844\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698088",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flushing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024842\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696579",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is used on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699262",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from heat.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11464 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-41.78.124.10-207A0925F2-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42867=[""].join("\n");
var outline_f41_55_42867=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10492713\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024839\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024838\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024843\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024844\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024846\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024842\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024847\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024848\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?33/1/33813?source=related_link\">",
"      Amyl nitrite: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/25/405?source=related_link\">",
"      Amyl nitrite: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_55_42868="Insulin NPH: Patient drug information";
var content_f41_55_42868=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Insulin NPH: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/7/10359?source=see_link\">",
"     see \"Insulin NPH: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?3/23/3446?source=see_link\">",
"     see \"Insulin NPH: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F2135494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      HumuLIN&reg; N;",
"     </li>",
"     <li>",
"      NovoLIN&reg; N",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F2136088\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Humulin&reg; N;",
"     </li>",
"     <li>",
"      Novolin&reg; ge NPH",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10018623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691404",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower blood sugar in patients with high blood sugar (diabetes).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10018622\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702304",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to insulin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10018627\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697009",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are 80 or older, use this drug with care. You could be more sensitive to low blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696750",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not drive if your blood sugar has been low. There is a greater chance of you having a crash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698422",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check your blood sugar as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698495",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have an eye exam and visit the foot doctor every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696704",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep workouts the same. More workouts may lower your insulin needs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10018628\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698210",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low blood sugar may occur. Signs may be dizziness, headache, feeling sleepy, feeling weak, shaking, a fast heartbeat, confusion, hunger, or sweating. Keep hard candies, glucose tablets, liquid glucose, or juice on hand for low blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10018630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very low blood sugar or very high blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10018625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699163",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use out dated insulin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10018626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3629482",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Give a missed shot as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3629483",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next shot, skip the missed shot and go back to your normal time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10018631\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699566",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store unopened containers in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3528085",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may store opened vials at room temperature or in a refrigerator. If stored at room temperature, throw away any part not used after 4 or 6 weeks as you have been told.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699510",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store opened cartridges and pens at room temperature. Throw away any part not used after 2 weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699284",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect opened containers from heat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699285",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect opened containers from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10018632\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11550 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-23B01FB2C7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42868=[""].join("\n");
var outline_f41_55_42868=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2135494\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2136088\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018623\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018622\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018627\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018628\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018630\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018625\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018626\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018631\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018632\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?10/7/10359?source=related_link\">",
"      Insulin NPH: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?3/23/3446?source=related_link\">",
"      Insulin NPH: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_55_42869="Lipoma terminal ileum CT";
var content_f41_55_42869=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F68559%7EGAST%2F80114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F68559%7EGAST%2F80114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lipoma of terminal ileum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 321px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan of the lower abdomen demonstrates a soft tissue mass of fat density in the lumen of the terminal ileum (arrow). These characteristics are diagnostic for a lipoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Norman Joffe, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lipoma of the terminal ileum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 321px; height: 288px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEgAUEDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3BdF0vPOl6WSOQfsUQwf++PYVIdG01iWbStNLA5ybOLOfX7lXY+AATtyMHHI4qRSEPBYtkgZPWgCkNF0wNxpWmbhwD9kiH1/g9arXGhabJIW/sjSmdsKXayhJx/d+50rZjJ4HU4+bPXNOUZBJO0FcnHWgDB/4R7SON2h6T5i8BjYwfkPk7U1fD2iuSZNE0c7iNzHT4Tux/wAA9q6DblR82VPPX8KiZMLwBuPcdR/SgCgfDGiyli2iaQXJ3ENYwHn3O2lPhfQDGyPoOjeWx5U2MJGfpt5rbTBAj746HqKFA3fe+XlScdfagDGfwtoB2n+wtI4wB/oEPyn0+7ULeFtA3k/2DpGMEZ/s+D8R93Nb64yRgEbcY55FMcgkEnn/AGe/saAML/hGNC3Kw0LSdwOFxp8JOcdjt9Kgl8NaCjMF0PRwpXZj+zYBwM/7PTn9TXQdixABxnAPT2phQNubkAnuOpx0+lAHOP4a0MjadC0cgcHOmwHn0+5UaeGdDwQNC0bgHJGmW/T/AL4xW9Io5I5BHPbIFQyHceOMH1NAGDJ4V8PsuxvD2hEBtwB0q3Iyf4vudfelPhvw+A4/4R3Q8FsgNptuAx/7461tMp4HKhR6DmoHwRgjjjqBj8PagDKbwz4ekQF/D+iOuMfNpduQV9vk/OnDwz4f3ZHh7Q8bgdw0y3HP/fH6+1aSE7guc7eRz1HvUhyW4JJOPoM/4/zoAxl8NaAOR4e0NHP/AFDLcZP12fjSjw5omAz+H9DY+h06349h8la5IZWGMgjI5oOAULD5QuTlv5UAY0nhrw+c/wDEg0Ejqf8AiV25x/45WXd+H9GQsDoGgAdsaVbnr7eXXVF1wzFs46k9ax9TIwzNuBAB4B9e3t0oA5afRdG3bRoWhqM8f8Sq25J47pVN9I0ZCV/sXQjnls6Xb4J6f3O9ac8jPtVtoYnLAdP/ANfeqxfaynaA4UBSR04/rmgDIm0nSH+UaLowXjIOm24/9krNu9I0pYSx0TR+uMDToOPfOyt8jLbcj5eB6fT61l6uSFyeSoz+PvQB438Q7e0hiPkWdlDuYf6q2SMj8gK4BVUMcouPpXffEMlyDnndnpiuBbge9AGzpKw3bLH9mgLAgf6peR69K6B7C23oi2lqSMH/AI90Gf0rA8JL/wATMZJwVII9a7l7f73PXvQBhahpFjcLgW8K44BijVCD74HNc5faDLAu+Nd8ZHBA5runt2llC4IY+nb3/wDrVesrT906PuODn0/KgDx14in3lHHtTMDPQflXoHiXw8LefcIyI3G/I6EetcXf2clpJhh8rdD60AUsD0H5UuBS44pKAJIgM4IU/hWnZaeLrIjRCehGORWXHxg10nhKUJqCoTjfgfjQBzMsZjkZGAypx0pmBW/4zsDY61Idu2Ob514xz3FYOOKAE/AfkKKXmigD9Hg/zAD7vr/n8qepDKGyAT3I/Sq6SbsYzgEZx61KrbdhbBHr2oAnyWbJALdCwOMe1SDAUcYbJPPbFQ53dRzgnp+ZpY5Rj52OM4LH6UATgjqDtAHzHuuaEBZsgALnqO/vTA2HIVh2xu70CRVJ5xjk5Hr/AJNAE7ZKnaMAjt6H29aXcxJViWHByO/0NQebhh1BB6/0P+e9OWUMGBOee56+lAE3mnb06cYx600nBIYAnH4U3ccjdkHpg87famh2+XC984P8P1oARxtUggbQRn3FRTSYfg/pkEe9OLY9sdhz1qM4UZzxx7YoAjeTO4OQF6/U0xhjIJ9zz19xUnBwGHIOCP7ppCeA23IHQH+f1oAiY/KoPv14+tVHYFsrjkZPvViXJzyCT0Pr71CxXP8ACB2z1oAY7seB0yOcfjj+lLES2AFGGOFz09TVeaUAhjkrxu/xx+VAZz35zg57+4/CgC0WDgtw654LdetRSMVZiRnPJ7/jUYlLMARz2Prjim7v3jsvOAFP40AO3cfIMZ9ehHXisnUpQSN27p8uR0PrVy4lWNAUJGR168Z5/CsDU58yZVmO85wOw/8Ar0AUBtbcM4CYJP8AnqaJYiwP7oZODx198VXSVPMbawK+hPpzj/ParcL+ZjBORznHNAFO5VfLwpIYHk54PuKy7+PMTxHk/wAII6VrzOuWQ8PgnOODWJqU4KHnJxk8YNAHlPja0ebzABwpPJ7f/qrzZoiXxx17dq9Y8X3Cm1kcx4xkr71xeh6QNRZXXCuXyUJ/hoAf4Z0ieOWO5Zc+gx29a9Bt7DzI+cjAzx+uai07RmhjWNcAr3962LS0uQNxLDjBGOlAGbFpzrIWK4AOD8uRWrbWp3EbQQRjgVfSKRQPMGSOQe9XIYgSGHHRvSgDKutOjvLQxyqMgfKxHSuE8QeGRLbyQqm1v4e+D/nivWjbhJgeQOp7g+3/ANeqWrWHnIZNqggY+v8AhQB8xXltLazNFMjI6nBBqD0r2Xxr4V/tGINFhbpAWU7cZHoa8lvbKWzuXhnQq6nkHuPUUAVgucDmtvw7tTUImzjBHPpWOBWhp0vlXCsOO1AHpeuaTBrdgIZeHGDHKByprzPVNAv9OlKSxb1HR1HBFeqaNdq9ojA/Nkde/wBalu4IrsfOv1B+nSgDxXyX/uvRXrH9kp6JRQB9aK4OwBgM9MD/ADk1IJNpGDkHoeg+tZyShHGGUg9Pcev9PxqKW9BcoWXevGMEAH0//VQBshgsRAzk/hxT1k524YDAGPasu3lL5H+1uOefw9DUyy4yCQcHI74H17UAaPn4UqSWAOenQf40wyKjlsZIIwxxg+mKpiUDg5GeRx0/H9aa02wAgjB4O0cD1x7UAXPP5IJySDnP14P9KmjlHckdM/Q9cVlGZcffGG43Dpn/AD+VWInHdjz2zyRQBrKF2ovBA9M4xSsAUbywd3v/ACqOE/KCMNs6Htz2qZ3IHXGM5FAEbHcowwwOMdj7Z/rTcbSwILHGMY6j0pZHJRgQWzngjn/9VVg+5iBlcADk9f8AHjFAD3YBgwZRzwcfgDUchwVLttJ6nrz60x2Y5yQRg9+n+FRFsnDEADk9s0ADsSARyw5ORnFVJnUbiSdpbn2+houZfmYBjnOTgciqd1OEB4HH48f5/GgB7yLvOwhGXljnJOKi80iRsbtuMA/0/CqTThTu3Y54HbGM49D6VmXerohOHPQDg/1oA6H7RtJUtxgYIPT6etQyXAWIohGTknH+ehriLvxK8bZyM/Wqn/CTxSbg0gBP3Wz0P8qAOoutVAkJJDrjGR1HtWNLdB2dtyMuOduSVrBvdS/d53HaR/Ccn61kXmtrFIsfG5+Dg/mPagDqLR43lkbgZ54P9K0I5SkfzY2g45788ZrnNOmV4xsIbPU559/xFaRmG1S2Rgd+xHAz+tAFy6w0fDBm759PrXNanOqnZknBzkHOPetm7kITG1hg5zjqcc4rjfEEpjyVySckHp+NAHKeIZzdmWKP179Kf4Xt/s92jqRnOMDjB/wrkNZuZnuXhjZyS3GDyTXaeHNPnhtVMrfMfm5OOT2oA9Es4Y2jWQEbX6nP+fStGK1ON4XIY4x6/UVjaEVhK5dhn17iuttljEe/J5+7yMH2oAqPaDawKAIeuf8APSomsl3ALvJIwMfyrYXYWDbsnJ7cD/P50hjJUFmDMcZxkc/SgClDE+AhYEMMYJ5X0IqYwoA+CuCcA+vtj1xzVuPy85IBz0I7015CcEhQF4AznmgDBuNOjuIiG3AZ45yTXC+MfCkV8kr+WNwy24Dnp29a9RZwQykHcV4X1rJ1GMMHGMk8nigD5h1TTZtOuGjlGVzw3Y1XhODnA4r0j4kWKLZvKMFlbOAOleZxNgkZFAHc6Ff4jUI4Unueo/CtsXasM/KAQSR6159Y3Qg46E8Z9K14dQVhl5l98HBoA6j7W3qv/fVFc5/aS+q/pRQB9Uy3jMAqHtjA7DuKjSaRpwz9Mn5sdPf+tZUUxlPzHJxxwR/njP1zVrzEjO5CMjkZGB7/AI80AdHDJJGFGQSOjYI5+meKnM5KZJjTuOOPpXOJfKFABzngA8VI1+jD5iQc4HfH0NAG0tywx8y5zkDJBAPpSec7qQuwHHGCT/SsdLlXcknJwcE1at5JG2bSNy8IO2B3oA1PMY8qq/JjADY/Hp+lWLZjuUYU7cjlsD+VZ0RU7w3JJzkj/PIrUghUuxOGUAKM9c0AacUh2LkDK4B+f+YxUwlLcFCMH+FwKpB9vAcfNgkrzz/hUil2bbxz1oAkaRyRheegwR05wOv+eagZiAoEZ54ADr6U2R2VWBYbhkknnHv9KqSHOcHBOOnOB0OKAHGYhULRbuerOBz/AJ/CoZp8sXCjaeSS/IPvx0qrPOBjdw3thsVm3d+qltpUgH1oAt3N22wthcr0IY9Prisa61DylUl484OACT/QVl6xrSQRM0jKFHOWYD9a8v8AE3xAtIGkSKQzyHjYnOOe56UAd/qevEfcZRn0z/n2rlNU19drEzKOf4Rkj0715Pqfi/UryQlWEKdlHzH8SaxptQu5gfMmds9c0Aegap4kVc/vhz8pxxgVzV/4nuJGbymKAnviuaZ2bqTTD9KAOgi8VakuQZy4Pr2/KrEGvTSSA3ID++TXLZNTwy4OG5FAHrfhvVw0CbcYzyc5/PNdVBfIV3FQx+7jr/OvGtI1T7OSN4Ckfhmu2sdZTy4xIeg5NAHVS6hAf4QCAOCODXJeJ7uJYS+0dO/Bz/hUd/qkZQlZAB168fWuP1jVVnbaGDKO2O9ADNKlt5dUDzLnnAr0fTLq2KLGqsSTzx0H+FeRW0ypco57GvRfDtys6hmGOent/hQB6Fp3kSBccBs564zity3eNNhQbiBjknke1YWmuoMYVCVxyOp61p28u+OOUiJoX2lWQnGDwOvXtnFAGtC6nCyPIT93G44q0EQKWLSDGBjufrxWbGNoBU4btj1/xxirdtISy5+YjO0HnP8A9egCfBwW83k/7Oef0pjCQnPmZxjqOf55pzv8wyuHYYOfTNVp2VVLZU8kNnucUAExHfYwf+7/AAj/APXWRqE20AZjUYwQCf04q1NcKd+cB25wTXMa7feTDKxIBAIU59KAOE+JV0H0xwCuS3Zuf5V5Tkg5ziun8Y6rJezrEx+RDn6k1y/QUASCWl8846VDR60ATee/qPzoqL8qKAPp+11mMrjeCT0+gNW570SQkx4L45B5ye5/z7V8/wCm+K7q2IE3zjGMjg109h42idQHkZW77u5oA9EbXtikAtx26j60WWvea+ASVycE/wAq4uG4gnk3s5IfkKDwKngjiPzQylSpJ55oA9V0i8SXcznA6jHIz710lo+VQBeCcDHp/wDWry7Qb598a4yp9OOK7rTtVQFPlY98ge9AHXW0RG3cSD2Ofzq/EVAXIBz2HH4+1ZdlKJEDIwKscqfTrxVwSKxzjBHc/qaALqkEMQeCeM05pMI3IU4w2R2qi1wBjbkAjgHtjvVO51BYkOMgHjk9D/WgC9c3SgNyAw5K9vwrMvNSRPm3DaB3Ncp4l8W22m2hmupQkaA/MeOc14p4i+Kd9fXD/YIhFFnh36n8O1AHt2ueJLS3UtJMqgE59/fNeXeJfijBGzw6erTyAY39FH415Zquu3+pEi5nYr/dXgGsstmgDa17xHqGsysbqdth6RqcLWIT6Yx7UGgKWOAMnPSgBPSk9q1rDQL692lItqk4JbiujsfBWVJmZy3cdMD3oA4bBJpRGx7V6MfB0WAVVhx29akTwzCqAbPrn1oA8zKMOtNziuz1bw6Yg7xduwHFcrdWzRMdwwR2oAiSTGM1ci1CVEKhuCMYrOoyaALk928udzZqs8hzUeaPSgByt8w+tdP4bvbiCXbENwPUYzj1xXMIhzXb+DYlZoyQu7pnP5UAes+GWkkto2lQrnHUYwOgz610EVpCHaby4vMbktz36nHQH3Az1rO05WjiRTyAAce+P/r1rxOocBW2/MBjPt15/lQA5YBk8/MRxu/hqaJAkeeASOT1P4VGX2/h2xmhpgu9epODkD1/lQA5m+cKSxA6c1SnlAlOGIG3kHr3HWh5VDlVGSeMHuaqXUoKAhcn+Ee/cUAVdQuQqgJnb/e75HNcH4ou2KnLcKK6e/lBZs7zz2PGK4DxXcqYXLMCWXAoA871GUy3Ujk9WqmalmOWJPU1FQAetHaiigA4/vH8qKMfWigCUH3p30pgpR1oAvWeoT2vEcjBT1GetX18Q3igbGAA6cViCnAd6AO10bx1PZuv2mAPj+NDgj8K67S/HVnc7R9oMT/3ZDjn+XNePBT6GjpQB9KaJ40gjVVaUGInBKnpXTp4usXiJ3rk5+YHg18lwXU8H+pldPo2KtNrF8ylTcvjoecZoA+ltW8e2VmhaW4RAPVuv4V5v4n+KskpaPSo9xxjzXJx+AryaSZ5W3SOzH1JyaYTzQBoatq97qs3m31y8xH3VJ+VfoKoZORSVLDbyzH9zG7+u1c0ARU5FZ2VEBZm4CqMlvoK0LTRb+5nSKO2kBY4y4wB+Ne1eAfBEGnWiSzKr3j8tKV5wfT0+lAHmWh+BNV1Aq9whs4T/fHz/l2r0PRvAdjYhd0JlkXqz9G969Fg00DggD0OM/n7VZ+xg4Bzk8bR1P8Ah/KgDlbfSY4lXbGoC8DI6/59KsNYqNoCgEdDjqK33t9xAG5Wcfxe3cUzyAE2jGxuDnAI55oAw/smGAYAduB1qKWy2qVwG45HQV0DRAKFIION3XOPX/8AVVa4i4A+VWHfGMelAHCatY5YflyOtcPr+jhxIwX5xkn0H+fSvXdSgD5Zjh/Unr+PrXMappquSBg8fxUAeHXFu8TkEYx61AR1rv8AVdC82VyPlw20cciuY1fRbixAdl3Rd2UcD60AY1WIIDJ061GE5yav2UhikUjOO4oAt2mnMygkZbqB3rrfC1pJBcIdoweRkDiodMtxOgeNQMnPHSuhsbMq4I+VlOR+FAHe2R8yEEknjOQOT9BVwZChgNwOOcfr7VjaRcM0Yjf+H5gen1P0rRE+CCD0+UE9foKALjy9VfJIUYx1H19qiecDk5yBnac1Te5+UdcAdhg/X86ryXBUtzjjIB649aAJ5JMsA+3ceAQePaqV5cEBsnOQeBzz/kVDJKcbE2nPOS3es++uAqspJUnn73+elAFHU7kGNgCenPPX/wCtXmXiW+D7olwRnrntXTeI9TEcZUNgDseea86vJjLK5J6nNAFZjx+NMpT+tJQAe1HNHrik7UALz7UUfL70UASD8qlhheZwkaFmY4AHer1pps00gRImJ9cV1nh7QpYpgzx7WOOo5FAGfp/g27n2NcMIw38I5atOfwva2lrukRyeeSf84r02ytCLFi6jOMEhePwpI9P+1WUwnRAh+4CP1oA8i/siCTKoGDZ4xzx/U1BfeF76CMSrFvjP93qPrXoUWliS7YWkXzr0yf8APNdRpVo7KUmGzPYjINAHzvJC8blHUhh1B4NMx9a+idW8CWWqR/vLbkjAYcEHp19eK4HVfhbfWmWt7jzUJO3K9s96APNACanitppSBHG7n0AzXdaV8P7hpN144Kg4CoOD+Nd/4f8AB0dsytIMIvYDr6UAeWeH/AusarJGzwG2tieZZODj2HevYNJ8I2VnpsVtHACFJbgZJz3z3/ya62zs0ghBKFlxt47H6VajUGcc5weoOf8APNAHO6X4ch3rmFWUHp2I/DvXWR2iIu2MYOMcDjPoav2lsyKFKcdBjnkH171P5R2ggBgT82R1oAoxQDZuZS27t3pphYBWC8HvjIGP884q+0Qz8pBz0PqP8aR48gFhkNyBnGR6YoAyjDk78FVBwU+gpwUCMjAJAwQRg/8A1qtmLcG5wM4BPVfoO9AjUEMzfOuO3UD3+v8AOgDPnjABEeAh6/L1yPT8qzriBgMrwR1HX8q3JIwrseQuMYxxnP8AnmqkkBK7cFt3zDA/z0oA5+5hHmZwdpGME5/P3rOu7bcvIJyPunjA6V0c8JY7cDJ6+/rWXNGT854HIPOASO3txQBylxZDzM7Qw6/d4GeCc1UutJWUMoUndnjHX610lzbhWHKjvjPJ4/wqjNxgp93APPQ9gc/hQB5prPhRYXZoIygzyPSsJtPeEnKbcHnnrXrFwgdirEYwQf8ACuX1W0BIJAyOxGOaAK/hV23FZGyhOOemK7aGAKm5FOcn15x3/wDrVw+mqIpgyDJTggjrXoFhma2U9CQMjPAoAiT5Z0O05yT8vJI960ILjagJ3bOh2nke361E8OxiQoAJ7cCmThmHAXg5BPrQBNLKApz0J6+v+BqB5xg8ofQY6fSobiVUj8sD1464rOiuBI+GckjJYdCKAJLifZjdgBj3HSuT8RawbdHDNznAAHetXWbyODfI7YRRwe4FeVavqD3t28jEhCflX0FACahfPPIWdic84rNYkkmkdiaQGgBe1NpT0pKADsaTtR64ooAdx7f5/Gik49vyooA+h/Deix+QrBAGx94f5/Guyt9NtVO9kThd+ePm9aw/D7EwIHOOAMgc/SujtPnkAIAyepOM0Aa+n2lsyBWjBBHQ1HqWgNKyrAPkxn5RgY960LGIKQSMEjuMYFb9lGHVCFOw/eB7/SgDmNJ8NW9srSeWCx+8xHTvkfSnXWkRmQ+WAFwCR6D/ACa7DbkZ+XapzycZ+tZuoGSKF/vY424Gc5PegDJtLclSJVDkfMcnuO+KlNissTrInzMMg98GkhmAnKvwehYdB7/41sW7RsOS24/MSOMHH8qAOSOlrbyYQZ4znHSnraBB0OM/h9Pat+8jUuSxBU984yajWKJ5v7o+7uPQ/WgDKEO2OTBYJ0PGOewNJBCWkzs+cHBJOB17/rWpcxqrLnJK8AE9evekihEeHIIyAAGHbHFAEojwc7iG+XPbBzSjYCFGBxnC8H3qs8rAEkAOPu5756598UJOsqq2RvOB05xQBYIH3gWJHGCeKHTGeCwGGOf4aEdW3bVGMd6VCEC8A89Tx+FADfK3fO4AI6gdvU0zBBXjBxnHp7/59afuGOTk7T25BxVeWRt27ILAcenHTFACbQowCqqV4568/wAqYwEkW7seAynA/H2olkDOF4AIG3tnrz/9akMqsq46dAR37dKAM+5jYuN2C3HPTPsKz7lB5ZK4O38yfp9K1LhlVm6HaMc9+KybiYKSoPOeuOtAGXfxjbuK5Ge3GOOvvzWNc7gwQL1Izgdj/WujvFKhiMbcbsEcEdsVzd6yiQo+4Lwcg9fagBioHQgHk5wCO/8AnisTVYC6MX5wOB0xWwt2M4Yhmxw2O/8Aniq19Mo3HaD2z6Z7UAc2kHzlnA29+4rq9AdTGU7DoD3Jrn7iZCSduP8AGrOk6iEnwehYZx/SgDrpFDnPTrkkdumKgljBVyFz0z9PaliuUMatnPFRXdxiPCsvsB1/zigDGv2WMlQwYDgZPX3z61ivcqC756evatHUH81yxJIPfjrXG+Lb0wWzoGwznaOegoAw/E2sNczNDG2Y14J9TXNOd3SnTNnk1DnmgBOtFKegpKAF7UlHakoAKKKSgBaKKKAPqDw/zawlAOg6fTnrXVWMAbOQTnA69PSuE8DaiNQ0q0kVRv2qT6ZI/rXpWlw5B3ZDZ4J4Ax/WgC/aFpW25+bI/H2rdtsqnRePYgYqhHbKpIc8D+Fe9a9syFCFAHoCvb/P40ATQpIISwK8dQR0/P1qSS1LqyvtIwRnHTnoakTyzKMevytnAA7/AF+h4q5HyuVBCntnGD/n0oA52bS1DZUJnJwfTniqi28yzccLk/ifSulnQbs9FHHAzj8fr+NRGJXkdskge365oAwNRRwoLgq2MfKRWUkoEwKbmHA5OevQ81099ECFVhnByQa56aDy7hmIxgHaaALXDl2ZV6DK+nsPwqC4chxHkAYB+U8DPUc96Rz5YQYYEY3DOOCe3p9OtU5nIQLvDD0P+Pr1oAj83k5UAsTx+PalBLP93IzwAePpVVZMHHGSRkjkZ7ZHTmlMohjZnyO4/of/AK9AGiZOQzuytgbdx/SqV5rUaqyhRnjr29qwNX1Xch2YJBOBjOT6VzdxqvmfeYsP4h6+v/66AOrk1l1cBXJXGAAevvU0Wu7cZG4A4dCcA/8A1s/zrzy61La5KNjqMDrVIay/XexPAzQB6zHfI52lWU8fKx4q1jeg/eL0yTycj29a8nstfPmYLsOmD6eldNpOvBlAMhaJh0HT8P6igDq5sOdxI3DljjJBrNuFXdJyw3DjjBB/+tUM+ohgAGXaRnrwB0/Kqj3u0nBBweCTk0AOvGCxE/P05wfbr7c1x+ozMJHyzZAIJ7H8a6S41Py4SrBCevT2rjdSv4yXYlEYjrnI/CgB6TDzApbqOvc/hRKzyRjk8HAweB9aw1v4S4bzixznnsa14ZFeIlGDY4JHzfWgDNvQcncM46VBYvtkGRwfy/Gr1woK7s/IeOeM+3tWPO4jk4OecAE8cdqAO6t5ENsnIYAHJPB7dahvrpAjbiO5OeB71yFtq4VfLMinPXB/p6UX2pHyzltyjgk8/hQBc1G/SLcecDrz09q841q+a7umYn5FOAK0tW1EzAjJ2sT1rmp35wD9eKAI3OT7U2ij1/lQADoKKSl60AFJS9qTFABSdvWlo9qAF/z1opM+1FAHpvwh1kwan/Z0rDY/zxr3OOoHv3/Ovo/RnXaCrKRnOcdffivjOxuprK7iubV9k8TBlPv/AIV9L/DzxOupaZDcHksvzL/dPQ/hmgD0yNgwz2Y9egFaNu7Yw33s8Dufx9ayLKdXO5hngZYdM1pQuqEAt82MkMCc0AbVu4HJJDEcmpVkUMRhiVAzx1rNibkFXwc8DOc+1Ww27JPyjaRkk/KD0+tAFlWV8Nyc9APrjJxUkSJ5ed2SehHt6++e1RBdoy5BXHX1GelWIFxgg7R2OeR6UAQzwBv4VHcjt+FYuo2jHcWQZxzj9MYroZW2jeeOPXv2qvKu6EjcBjsR0FAHCTSt5m3Hc5BOMDufeqVy+7JAAUdBng+351q63YlZTJbhiQRlema5xnLyr5UjADkgjt/9cUATpLFbhvMO1l65Jz+tYGp6gu4nzBtPA4BGPSjxFqCxKUB5J4I7+h/nXnusa+scUgyCepzQBratqkaKypJk8jBOM/SuO1TW9jlmce2OKxtR1oyglWIJ/OsC7ujMcsfoKAOls7291W/jstNgkuJ5M+XEv3jhST+gJ/Cs5NdmDZfBHcHv9PSvZP2P/DRvvFGp+I50zDp0X2eAn/nrJ1I+iAj/AIGK8w+M3hs+EfiRrOlomy1Mv2i2HbypPmUD6ZK/8BNAFL+2QTuBJfHOOMVuaNrQyFV+o59jXnfm+lWrC7eKXKttz3NAHtmk6qZIjE5GQPlGc/hUs9zhd2NrAcZ/rXnnh7U2dlMpXGQGPpXT3F38vIGAT7kGgCzcXBAf5jnuR3x3/wDrVw3iu5MTKE6MfXNbkt5uDFjg5PI7cf5Fcd4pcPJExPG3vQBnfbWZyxY59q3tC1Z1k8tjn0xxXIF8evFXtMuoopwzjkdM0Aei6hexx2pYsDxn0P41wesao0zbVY7eh96brOrSzhY1JCjng1iu5bkmgCyLth3PtUyX8gTG8kEY5rO+nFJQBYnnLE8nJqv3o+tHQ0AHbrSfWigUAFL6UlA60AHail4xSUAAo7UUlAC/iKKOf7p/KigCyK9C+GXiCHT99ncNt3Pldx+U57V570NPQ4YUAfYmiapHJArfKwZQM9RiujjuxIjNGcjPJ9R6/wBK+Z/h14tZWjsLyVtwPytn7y+n1r3TQ9QEwikjbpjOD/n8qAO0tiygAD2GTj8R/hVuJiW25bOcZHUe9Z9tLu2EjIIwM+lX4QI0bnLE89se1AF+GQxx4/hz2/SllmcBwhLHGVwvGfT6VWMhCpjaMDAIGOlSwhySd5HGCVOOfpQBbjLGIZIY8Z44PHOKJSCGAyM8nucf41GrHGMvt9fSq0l3mQoOCAME8Z7UAV723X5lIO3ocnOOe1cxqunFN8y4zwScdfY11iypnKkFT69PpWXqiqIGIAZlG3joRQB87eMtWJmlGdqknAJ6/wD1uK8x1O+eWVgGOOh969E+KelNA01zGUX5txU/XqK8mmbqRQAPJyagZs0jUw0Aen/A/wAe+JNB8W6DoWlaiYNJ1DVrdLm38qNg4eREbkqSCV4yCK4zxf4s1vxhqa6h4kvmvbtYxEshjRMICSAAoA6k9qt/Cv8A5Kf4Q/7DFn/6OSuWoAcDmnqcd6izzS5oA2NIuWimUZPJwBXX3t7tRTuIAA71xWkRGW5XbklfmI9hV7U7p3kKhs+hx2oAvPeu0nD4B7ZrE8RSM9xErZ4Xv1zSJKiuDMeBz9ap6hc/aZy4zjpycmgCqelJk5o/Ok6Y60AKxJ5PWkzScUUAHekoooABRRRQAUUUUAFFFA60AL2pO1A6UUAFJRR25oAOfWijcfb8qKAL0qFHIIwQSOfWmV1/ivQ5La5llWM7CxyQOM5rk5EKmgB0MrwyrJGdrqdysOxr2r4c+L47yCK2uJNlwowV6A+4rxGpInK4IJBHIIOCKAPtjSrtZbdOd2OcZ7DFdFbtxgnOMgkDOeOc5618/fB/xd9utorW6l/0y34bPJYdm/z3r3KyvA8ezPzHBHt6Y7UAbUZz8jYYZztz0/yKmUrgqVUk8n1P+HFU45iZM4IIx14BFSSTsCcqpOM8HJNAEs0qgFlB+Xkkk9P61h3TM7EqckHPHGBWhJIwAG88ZOR/npURgaX7wGccAdM/0P6UAUHZpIRwwGMkD27j/H3ptxcqyAkcdiO49P61oSxgLjGMEZHYH6du9Zd0gKsu8AsOrZ4HpQB4h8Zhs0qaInqcA8evSvDpOD2r2T44vMqIjL+68wDcPavG5fXvQBCw/Om0ppKANfwdqsWh+L9D1a4jeSGwvoLqRExuZY5FYgZ4zgVjdutHekJ4oAU0gNFJQBdsLxrRzIhwSMUtxfM7EgDce4FUPyo9u2KAFdyx+Y5+tNJyaKKAEo7UGkoAKKKD0oAD1pKDRQAUUUUAFJS0UAFAooHtQAUlL2pPpQAf1oNHrQelAC4HoaKP++qKAPrHxX4aS4MnmRgqeMkcj/PvXhnjrw0+kXRdBmNuTgcD3r7EvbFZlAwCRxkdsV51448MRXcMimP59pxkEUAfJ7DBpBXTeL/Dc+iXO4ofs7dDj7vsa5kjFAG54R1U6RrUM+4hGwjEHGBnrX1X4V1OO7skdcPuODznBz+VfHAPFep/Czxe1oxsbqcqQMxknAYDt+FAH00ZciMhMqp5x0H0qzHK2SMgjJG4c4P0/SuR0jWVniQh1yAeOCDn0H4V0NvdxhSd8Yc8YHT8aANOFNxAIbthepx6/WmiQ7QQvOduOhBHfiokuD05GByD6/1pTIQwJAJByPb1oAkly4+U7gOh3enr3rF1a48pBglXYcsen44q9eXAER5DMvY964/U7tmVirhkK88/5/zigDgfiBZLq8Ekbg4z8px0PpXid/pk9pO0cyEY6N2I9RXvmpxmc4Kg5PAzgZrDu9FWbcsqBt3XjpQB4hJEQemRUWzJr1a98GQTMdsTJjqQayT4N2kl9xx14oA4Hyveo3Qj6V3N74VEaEo7bv4RjvXLX1jJaShHHU8GgDL/AJUh71ZeLHOKiZOOlAERpOKcQQaQ9aAE6Gj+WaO9Hp/hQA2iiigApKWjmgBD1ooNFABRRRQAUUUUAFA60Uo/SgA7cU0npTjSUAJ60GijtQAv4N+dFGD60UAfpHLa8seARgjB6+5rG1OxDxhXUDg59T711RhIO7aQc4xnng46d6q3EKMi4A3dM96APDfGPhuK8hmimUOrA9T6/wBa+bfFOiy6Jqj20nKH5o29V9PqK+3td0pJE3MqEA7sivEPi34RN/p++JP38TFo2A60AfOx60A457g5p8qFHKsMEHBHoR2qOgDpvDXjDUtDlTbK89sDzGx5Hupr3Lw940ttQtUlinRg4BIPBB/xr5nzVmzvZrSTzIJGRh6GgD7Bs9dtt65fnI2gHp9asy69bxgIlwpbJ6HjH+e1fI0niXVGQKt3JHgfwnFNt/EOpwyq/wBrkfBBw5yDQB9U3Op/aCVUgknIUHGPp9Ky55EllHygbuuOAfWvI9C8fnCrOxQgdGPAPsa7HTfE0F2uZGXdnqDxjt/hQB0nlDc25A49xgj8KswwRu+3b1BAz7VFY3UdxJ+7ZGI5x7mtiK3ZFJOD/skUAZj2ke04TLdTWZdWSGQZPJ+Zc9eO4roZ9qxgsdrDgHPeqk8YIQyfiOhoA5O70vcSFyep+pri9e0EXPzBgCDlcDr/AJzXp94pSMlyDnuPSsC8hRwwKLgEmgDyG+0WVUJjwdvUelY8tpNHy6ECvS9SgUg4HHIrl9Xt5ZkIRGwPTt+FAHKmMbcHrULx4/8Ar1auLeSNsOGH4U2OIyfJ3xQBRIpD14qZ0KuQeoprIeuOKAIscUlOIpDQAlHaj+VFACGil70lABRRRQAlLRRQAlOA5pKB1oAXtSUppKAEoP1pRSdqAFwfWil/75/OigD9P2Tk/mKrzRsQcqduOgP+eau45IOOtMZAck9+hPX8aAOfvrfduO0ksCcDnBrivEGntLbyB43weM9CCfQ969FulyuAQHOD06/jXOanbnaxDbGHR/QeooA+Ofix4bbSNbe6hRhb3B+bHRXx/WuCNfTnxV0dL3T7lJB2yuemfWvmq9t2t5nSQYIPNAFUmlBpDSdzQA7NGaSkoAcCRjFaek6i9tKoDEAn1rKFKDjp1oA9s8PeIYIJVjWRWkAAJzXpukajHc2oAwHOM88fWvlTT9Qe1lDckA5POK9c8JeLLJrZFWbEi9Ubhun+eaAPV5xvyEO1j0zz+PvUIi3HAVsisix1y3nhBSZSwGQB1/8Ar1rfaQwDqQTxn5s5Pv8A4UAUru1Z2DBccZI9qwZrDaSNjseRnI6iuryxjITBXbtOD1/z0pssMThgwU5G5SBnjPegDjZrONkYOmCM8jp161m3VhCpdcYJ612M1um1yQB8uCc4/Sue1KMeXtUggk5GOtAHEappwk35VdqggY5wK5CWzkhuyqqXXJwema9NNi9wgbdujbgHGR9OKqXGiKD8wyAev+f/ANdAHldyA0xyNpzzV6HT3kt0IwSwzWzqnh5vtBKKw55H+f51Ys7GazQAICMYwen0NAHF3do8Wcgg5qmR2rs9RhjnDhkO4DOSD/nFc9fae0HzgHYehoAy8UlT+Q7ZwOKjdSvB4oAZSDpS0nrQAUUUUAFFFFABQKKKAFPSm0tJQAtJ+VFLQAmfeinf56iigD9Rx1IGRj2prqG5OeP0p+BxwODn8aQKFzgAZOce9AFK6XdtAwcDB/oc9qw78GMFhyDyFI4H0/z3ropVJQjaDnpj/PNc3q0qrHuZTkdz/hQB5h49gDQTqAAHXHTOfY182eN9PFvKHHXcV6dMV9L+JW+072BBUZwF7V4f8Q7NUsZmwDg5GO1AHk5pvrTnGDzimfSgBaTr0oooAPwo/rSGigB2TSo7IQVJBHQjqKZRQBq2us30EivHdShh6tkV2Gj/ABGu7QIt3GZQvIdMZz6kV51ml3HuaAPc9N+I9tO0QSQg9MEYIz14rfi8TQzoQrDPHU8HH+f/ANdfOMUgVwW6A9q7LT9VsEtionPmkc7h+lAHsj3huFBQ7yRkbcd6YLISkNPkJ1A681xula1aW9sjrKJCOQGPf0rrNM1yC4iYK209+/8AkUAWbmzXIWNfmxyR6djis+eyIRGzuOMdOo960lvbeQoiShWxlSMkZ9vappIfMgDk8c5AoA5mS1XOMKH5BAOPwpfsMbqP3aAZ6Y46VsPZSSS5VlI6de3rz/OrItcKSG3qc43DH0/GgDh7/SYlLYTJPGAv+f8APrXPX2kS3J2xp7DjivTWsyFYld2eoHGPfFUpbSQBmKghjjjpQB5idCa2UmVBtIJ7/wBa46/BM78YGeK9X1O0ub+6aNMCI8exrgvEumfYcDHJz0FAHNHrSU4000ABpO5pc96PXmgBKKO1FABRRRQAUn4cUtJQAtHUUlFAC/lRScepooA/UrrSEgYz+FI5/nUMjnaGBO3JGO57Y/OgCC8mICgfeB9elclq7F9+47dp5xztJ710E7KxZmYggYIPODXP6hGZO8i4+UHPT1x7UAcTrJQLIAOpxuA715P45s2mgdiBjnGBXseqW4VW3D8+T7j61534tRRC0bKOB6cDI/lQB8430RimKnqKrE9a1/EoC6pMF6cGsg+lACUGikzQAfSjuKKKACkJ5oz1pKAHdvajNNzRQA4GnbsdKjyaD9aALMVw8R+U4710Wk+KJbZCskYfjgg4rlM880oNAHe2/jGVJEcgBOMgdV9xXp2heKILmGN12sCMepPHNfPSOgGDnPrWpo2sPpk2+Bjg8MpPGKAPoKS9VeCRgcqKs2n78bQxwe/c/X2rybR/EU11LvkIaLPC4r1PR9Ys1gjXzIzNgHbuHJ7n+VAGsLRdpkbd03AnsehqrcRJKrEYzyGB42/Sr6XjO4KDeCfunp9aTyMgsFwRn8qAOee0RIiEUcdcjFcV4o0Y3pwqN8+Tgf55r1K4t4Fj2u+47eAv6ZNcxq92qMUUIMdT3H+cUAeRSeD3TLSOR1xhe/8ASudvdO+zuymVTjjivQNf1ZmJXceR/COD7muUuLczRvLKpSIDIJHJPpmgDmWG1sdcdKbxUs+BKcYxUfrQAlFHT8KKAD8KKKKAE7UD1paSgAoNFFABxRSUUAfqQ+FUk9uajkTIIz17Dt3qVzgE84FQOTu6BQSOSR0oAqTKGXoQg64ABrCvejY6dfb6etbV8sbp+8VWVSGAI6EdCPcVz+qy7Q285zxQByeruAG4Krt24b868u8ZXHlW8mWYseQOmDj/AAr0TX7oKjbsEDkBufxrwz4mawyWzIjjL/KF3dv8igDy7V5vPv5pOxY1QNPc5NMNAB/Kg0H3pKAD6UnpnilI9qae1AAQKKKT8KACj+VJzQTmgBR1xRRzQOnPSgBf5/Sk6+tJmlz7UALS554pPSjOD/jQBo2N+1vFIikjJByK09J12S0uEdFDuDwWPNc4DU0LHcAvU9KAPojw54qt7u1TzwqNtG7HeulS+huB+6fnOCBXhmn3Fnp8avcXqPKV+bYwbH0xVq38ZwwzMVeQdeo4NAHsd/va2dkWQOQevI+leY6jo2q3d27vI6qX3Ap9a1rHxsLoIjPEwI5J4/yavprkU0X+j7TKDtI9KAOU1i0soYli3g3AB3DoT715xq2oPcOY0JESnhR612+qaTqN7rIuVikCNjnB+n61jat4YIm/cv8AvWPKNwM+xoA4w8nNHvXT/wDCKXcal5zEiDpznNZF/BHEdkfO3qfU0AZxooNFABSClooAKSlpKAAdDR2o9aO1ACUUUUAf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Small bowel follow through examination demonstrates a smooth, well-circumscribed mass arising from the wall of the terminal ileum. The appearance is consistent with a benign mesenchymal tumor, such as a lipoma or a carcinoid tumor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Norman Joffe, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42869=[""].join("\n");
var outline_f41_55_42869=null;
var title_f41_55_42870="Endometrial polyps at hysteroscopy";
var content_f41_55_42870=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F51898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F51898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 552px\">",
"   <div class=\"ttl\">",
"    Hysteroscopic view of endometrial polyps",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 532px; height: 547px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) A large functional polyp covered with normal endometrium spread over the posterior wall of the uterine cavity. CO2 bubbles are seen above the polyp.",
"    <br>",
"     (B) An endometrial polyp with a thin pedicle tending to take the appearance of a nonfunctional lesion as it grows bigger.",
"     <br>",
"      (C) Polyp prolapsing through the internal cervical os.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced with permission from: Baggish MS, Valle RF, Guedj H. Hysteroscopy: Visual Perspectives of Uterine Anatomy, Physiology and Pathology. Philadelphia: Lippincott Williams &amp; Wilkins, 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42870=[""].join("\n");
var outline_f41_55_42870=null;
var title_f41_55_42871="Chromophore absorption spectrum";
var content_f41_55_42871=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F74419%7EDERM%2F60561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F74419%7EDERM%2F60561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 507px\">",
"   <div class=\"ttl\">",
"    Chromophore absorption spectrum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 487px; height: 298px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The absorption spectra vary among chromophores. Absorption of light by melanin progressively decreases with increasing wavelengths of light. In contrast, the absorption of light by water molecules generally increases as wavelengths increase. Oxyhemoglobin has two peaks of light absorption within the visible light range.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 482px\">",
"   <div class=\"ttl\">",
"    Laser penetration into skin",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 462px; height: 493px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHtAc4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooqOWeOIgSOFJ5pSkoq7YElFQfbLf8A56ij7Zb/APPUVHtqf8y+8CeioFu4GcKsi7mOAPWp6qMlJXi7gFFFUjqlkpINwoIODwad7EynGHxOxdoql/atj/z8L+Ro/tWx/wCfhfyNHMiPb0v5l95doqG2uYblC0EiuoODjsampmiaaugoqpqt/DpenT3t1u8mFdzbBk49hXJf8LP8P+l7/wB+f/r1EqkY6NmFbFUaD5akkmdxRXD/APCz/D/pe/8Afn/69H/Cz/D/AKXv/fn/AOvU+2p9zL+0cL/z8R3FFQWN1FfWcN1btuhmQOhIxwanrU7U76hRVa4vIoH2Sbt2M8Co/wC0oP8Ab/KuOpmGGpycJ1EmvMpQk9Ui7RVL+0oP9v8AKnRX8EkqRqWDOcLkdTjP9DRTzDDVJKEKibfmNwktWi3RRRXYQFFcS/xU8ExuyPr9uGU4I8uTg/8AfNJ/wtfwR/0MFv8A9+5P/iaz9rD+Zfedf9n4r/n1L/wF/wCR29FcR/wtfwR/0MFv/wB+5P8A4mul0DW9N8Qaet9o12l1aMxUSJkDI6jB5qozjLRO5nVwteiuapBpeaaNKiiqGr6xYaRHG+pXKwJIdqlgTk/hVGMYuTtFXZfornf+E28O/wDQUi/75b/Cj/hNvDv/AEFIv++W/wAKdmbfVq38j+5nRUVhWni3Qru5jt7fUYnmkbai4YZPp0rdpGc6c4O01b1CiiuJ/wCFqeCf+g/b/wDfEn/xNJyS3CFKdT4E36HbUVxP/C1PBP8A0H7f/viT/wCJo/4Wp4J/6D9v/wB8Sf8AxNLnj3NPq1b+R/cztqKpaNqtjrWnRX+l3CXNpLnZIucHBwevPUVdqjFpp2YUVgeKvGGgeFPsv/CRanDY/at3k+YGO/bjdjAPTcPzrB/4XB4B/wChltP++JP/AImguNKpJXjFteh3tFcF/wALg8A/9DLaf98Sf/E1e0P4leD9d1SDTdJ122ub6ckRxKrgtgFj1GOgNFxujUSu4v7jr6KKKDIKKKKACiiigAooooAKKKKACiiigAooooAKytW/16f7v9a1ay9W/wBen+7/AFrkx38FgcB8WNRvtK8Fz3GlT3Fvdtc20KvbIjSYeZEIXf8AKCQxALcA1d+H8l5N4Xt31J9Qe5LPua/MJm+8cZ8n5Ppjt1qh8XYLi58C3cNnpq6lK8sIMDWf2v5fNXcwiyNxVckAkDI6ipfhXaGx8F2kDWzWpV5D5TacLAjLn/liGYL9c89a8iy9l8wOpb/j+0//AK+B/wCgtXT1zDf8f2n/APXwP/QWrp69TL/4XzAK4SUDzX/3jXd1wsv+tf8A3jXVUPKzTaPzPKvi7qN3ba9odrbXl5BDLb3Ejx2+pxaeGZWiAJkfOcbm+XHfPY16db828WeTtHU7u3r3rzn4tafrN/qGkjS9OlurVIpvOeCytLiRXymwf6RwARu6egr0a2BFvEGBBCAEEAY49Bx+VZvY82dvZx+Zv+Dvuah/13H/AKAtdFXPeDvuah/13H/ota6Gt47H0GF/gx9DA8ef8ifqn/XL+orwCvf/AB5/yJ+qf9cv6ivAK8/GfEj5fiL+PH0/VnCaXdvL4/u4pLp3CXDokb6mFwBEDgW38Qznn8e1d0RwfpXIWdjqw8ay3NxbTCx81vLkU24j2eXgZH+sznP6ds1156H6VhUtdW7Hl4xpyjy2+FbO/wDXofQvgv8A5FPSf+vZP5VtVi+C/wDkUtI/69k/lW1XrrY/QYfCjG1b/j7/AOAivMfjZqF1p/h/SvsV3dWrXGpRwuba8jtGdfLkYqZn4QZUHPOcAd69P1b/AI+/+AivOPjBperav4dsrbQ7Fr2QXyPPGi2xcRBHyV+0ZQHJUZxnBPbNfCYnlWZS5rWv12O6P8M3/BTvJ4V0x5XkkcxDLS3a3THk9ZV4f6it21/5CVl/10b/ANAasPwVaT2PhXTbW7glt54ogrxS+VuU5PB8oBP++eK3bX/kJWX/AF0b/wBAassBb6/G38w5/AzoqD0ooPSv0E4j4Hv1H2244H+sb+deh/DPTdNl8OaleX1ppckq3cUKSXtpcXQClHJASHleg+Y8dR6V59ff8ftx/wBdG/nXonwr1fTdM0fUReaqLO6edCkcl/d26Mm05OLfqc7ev6d/Bo259T9YzFS+re4nfTbfdHme0egr6l/Zp/5J/KP+nyT+Qr5br6k/Zp/5J/L/ANfkn8hW+B/iP0PK4rX+xx/xL8mes1518ZgDp2m5/wCerfyr0WvO/jN/yDtN/wCurfyr2FufFZb/ALzD+uh5Zaxq91CjKCrOAQTjPPr2roPG9rZWt2kVjFZRhHkUi3Em7ggDdv4z9Pf2rBtCBdQlmKAOuWBxjnrntXTePbyK7ltRb3cdzGhk2lbqSYgfLjIYDaTjtn9Ks+nqX9vC22voYvhgAeJNLwP+XqP/ANCFfRNfO/hn/kY9L/6+o/8A0IV9EVMjw87/AI0fT9RG+6fpXwVtHoK+9W+6fpXwXXFiuhtkf/Lz5fqeg+G9M0n/AIV7NfXdtpZvZJriNZbszs5CxxlQgj+VSCx+91yO1ee7R6CvTvBl9b2vw8v4v7W8u4ke4DWjaubUBfLXaREEbeWO4EEjOAO/HmVYS2R61BPmnfufV/wA4+Gdh/11l/8AQzXo1edfAH/kmlj/ANdZf/QzXotehD4UfIYn+NP1f5nzl+1+oZvCe4A8Xf8A7Rr5z8tP7o/Kvo39r373hP6Xf/tGvnWsKnxHv5f/ALvH5/mz0H4neGdD0CxtYtLtLeK5DIJGOrJcTnMeSHgVR5fPfJH51V+BqBfiz4bKqB+/f/0U9dP8Z5g+g6ag1D7ftkT9951idx8r+5AgkXHT5iRx3ODXNfA8/wDF2PDf/Xd//RT0faQrt4aTfZn27RRRXSfNhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWXq3+vT/d/rWpWXq3+vT/d/rXJjv4LA87+J3iHVNAttPOmtFa288jrcX8tjNeLBgZUeXF82WPG48DHqRWr4D1XUNa8MW19q0Cw3TtIuVheESorsFkEb/MgZQG2tzzXKfHV4INAtLmXxFfaRPE7mOC2nnjF4NvzI/kguAAMhsEL3BBrovhdDBB4B0VbW/l1CP7Ou6eWdpiX6OoZucKwIA7Yx2ryWl7JO3UDpW/4/tP8A+vgf+gtXT1zDf8f2n/8AXwP/AEFq6evTy/8AhfMArhZf9a/+8a7quFl/1r/7xrqqHlZptH5nlvj3VvFtn4jmh0l9SjiMa/YIrSwgnhuHx8wmkdgyfNwcYwvPJr02PcY1MgAfA3AdM14j8V7LTpPE19NNdWMrzqkEzTaXPdXGnqkYYyQsjAKoVg5ODgnPsPbYcCFNrmRdow5Od3HXNZvY8+qkoRa/I3/B33NQ/wCu4/8ARa10Nc94O+5qH/Xcf+i1roa2jse9hf4MfQwPHn/In6p/1y/qK8Ar3/x7/wAifqn/AFy/qK8ArgxnxI+X4i/jx9P1ZyWlXHiEX2lJfTQSxXDNJcqiKrwYjf8AdkZO5d+zDDnIwetdb2P0rzvwva6PDqujrYeabhVWRrprYqJi1uSI92eGKsJCOcnmvROx+lYVVZnl42KjNWVtO1ur6H0J4L/5FPSf+vZP5VtVi+C/+RT0n/r2T+VbVeutj9Bh8KMfVv8Aj7/4CK8v+KOp+IdOvNP/ALKm1S101o38ybTLGG7lMuRtVllOFXGeQOvcV6hq3/H3/wABFeLfGu1s5tSsLiVtPvLqC3KJpt/ps16sgkkVQ8SxkfvMjGOcj0xXw1dKWZTUl1fS/Tsdy/ho9H8KS6lN4b06TXYxHqjQqbhQAuG9wCQD6gEgHNbFr/yErL/ro3/oDVzfw9jt4fBGiR2V417braoEnZChYY/unlcdNp5GMHpXSWv/ACErL/ro3/oDVhgFbHxS/mHP4DoqD0ooPSv0E4j4Jvv+P24/66N/Ou68I2ngqfwvcXGrQ3U2q2sMjTRG9EG/5vkMQ2nccEAjOQRnBHI4W+/4/bj/AK6N/OvYPh7qF+nguCytNHnuUKAywtPAlvdxNcMScN8zTMIpIgPRcjkCvCopOTv+Vz9XzKbhQi4u2q+1y/ieMV9Sfs0/8k/l/wCvyT+Qr5br6k/Zp/5J/L/1+SfyFbYD+I/Q8ziz/co/4l+TPWa87+M3/IO03/rq38q9Erzv4zf8g7Tf+urfyr2FufE5b/vMP66Hm2jW0F3fiG6mSCNo5MSO21Q4RimT6bsVc8R22mQeWdKckCWSFgZlk3hNu2TjoGyePao/C0Xn61FD9me5EkcqGKNlViDGwJBbgEdefSrPizUDeTrFNavbTwyyAI8SxlIjt2R8dduDyfWr6n1EnL26S2t/n0Kfhn/kY9L/AOvmP/0IV9EV87+Gf+Rj0v8A6+o//QhX0RUyPCzv+NH0/URvun6V8F196N90/SvguuLFdDbI/wDl58v1PRbTwpocvhJb55JSxs2ne+GoQKkcwUkQ+Qf3h5AX1OcjivOq9R0fTI4vDNvqC+BTIg06VptRe6bLOVkAkSNn2n5QGxtyMMQMAGvLqwmrWPWw8nJy1vr5f5v9PQ+sPgD/AMk0sf8ArrL/AOhmvRa86+AP/JNLD/rrL/6Ga9Fr0IfCj5DE/wAafq/zPnP9r373hP6Xf/tGvANIhtLjVLSHUrlrSyklVZp1QuY0J5baOuPSvf8A9r373hP6Xf8A7Rrwfw1JbxeIdNe9tHvbYXCebbou5pV3DKgdyew9axn8R7uB/wB2Xz/NnU/Ejwponhi00v8AsvUb68ubtWlzLEgieIMyh0ZWPB2jA5yOcjoG/A//AJKx4b/67v8A+inrb+L9hp+laJotlb6XPbSoFEU0mlvZsUEYDq7MT5jl/m/2c4yc1h/A/wD5Kx4b/wCu7/8Aop6X2huTlhpNu+jPt6iiiuk+bCiiigAooooAKKKKACiiigAooooAKKKKACsvVv8AXp/u/wBa1Ky9W/16f7v9a5Md/BYHlXxgtk1B9FsItMvr+9uDOAtnqAsmMIQebHuIO/cNvycZxnIxmtr4Y3tlqPhua60yzlsraS+uj5M2d4bzm3bgeVOc5XseK3NZ1i10j7D9s87/AEy6Szi8qJpP3j5xu2g7V4OWPApNA1az1mzkudPWVYlmeJvNhaI71OCcMASM9+9eO5N07WAut/x/af8A9fA/9BaunrmG/wCP7T/+vgf+gtXT16uX/wAL5gFcLL/rX/3jXdVwsv8ArX/3jXVUPKzTaPzPK/iWvgltXlbV3Qa6tuFIMlykLKc7VuGhBVVP+129RXpGmSTy2EL3dvHbTlfmiil8xF+jYGR+Aryz4kT6TFresq9j4vlnjs0mvYtMdo7W5jKMFMpB4BCMhYDop64r1ezdZLSB0QIrIpCjsMdKzex59Ve5Hc6Hwd9zUP8AruP/AEWtdDXPeDvuah/13H/ota6Gto7HvYX+DH0MHx7/AMifqn/XL+or5/r3/wAe/wDIn6p/1y/qK+c9avxpekXl8yGQW8TS7AcbsDOM1w4xXmkfMcQRcsRCK3a/Uh0/QdM04RCytEhWKQzIqE4DldpbGeu3itM9D9K4XwZPp15eiG5t7W21KykeSFYb8zK/mrliPm5OAcg5xjIxXdHofpXNNNOzPGxUJQnyzbb8/wDh2fQngv8A5FPSP+vZP5VtVi+C/wDkU9I/69k/lW1XsLY/RYfCjH1b/j6/4CK89+JuneF57KzvvFUd1vhl8q1eyaYXBdudiCL5mzszjnG3PGM16Fq3/H1/wEV5p8VrXW79NGttF0a4vkW5M8l1a6gtpNbEROoKMehO4gkgjaWGMsCPg8X/AMjGettd726dzuj8COq8L/2X/wAI7p3/AAj+z+yfJX7NszjZjj73OfXPOc55rXtf+QlZf9dG/wDQGrA8D2NzpvhLS7O+torW5hhCyQxyGQIfTeSSx9Tnk5Nb9r/yErL/AK6N/wCgNWWX2+vws7+8OfwM6Kg9KKD0r9COI+Cb7/j9uP8Aro38639F8b61o+krp1pJbNBG/mQNNbJI9u/PzRsRlSCzEehYkYyawL7/AI/bj/ro3869O+Gmj6vrPhtG0XVjYT6dcyXSG7sFa13bNpPnlTg4JyrZHevApqTlaJ+uY2dKFFSrJNab7fk/yPKq+pP2af8Akn8v/X5J/IV83eJNJvdE1eay1MR/aRhy0Tq6MGG4MCvGCDmvpH9mn/kn8v8A1+SfyFdOBVqrT7Hi8UzU8DCUXdOS/JnrNed/Gb/kHab/ANdW/lXoled/Gb/kHab/ANdW/lXrrc+Ly3/eYf10PL7O5ktJmkixuMbxcjs6FT+jGpb3Uru+gt4ruZplgBEZflgDjjPUjjv0qTQI2l13T0Sf7O7XEYWXj5DuGDzXReN7SW0so/MlvfLluWmSO6ChiXjR2bAA5DMwPbt2NWfUTqRVWMWtWYHhn/kY9L/6+o//AEIV9EV87+Gf+Rj0v/r6j/8AQhX0RUyPCzv+NH0/URvun6V8F196N90/SvguuLFdDbI/+Xny/U6m38daxBoy6aBZPAkLQo72qGRQVKbg+M7ghKg9ga5avUfCOgz3Hh7Q7sJobO8kyxRTaf5zyK4lG+VsgEBomCj+HrXl1c8k7K57FGUHKSgrW3/E+sPgD/yTSw/66y/+hmvRa86+AP8AyTSx/wCusv8A6Ga9Fr0YfCj47E/xp+r/ADPnP9r373hP6Xf/ALRrwzwhLew+KtIk0oQm/W6jMAmYKhfcMBiSMAnjqK9z/a9+94T/AO3v/wBo188QLK88aW6u0zMAgQEsWzxjHfNYz+I93Aq+GivX82en/Ey1vrfwrGr2OladaLqA8yCz1Fr13mMb/MzGR9gAUjbxnPfHGN8D/wDkrHhv/ru//op65O7s9StoJGvLa8ih84o5ljZV80DkHP8AEATx1rrPgf8A8lY8N/8AXd//AEU9JO8kXUjy0Jq99GfbtFFFdJ8yFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFZerf65P93+talZWr/65P93+tcmO/gsDxX4t+IZdB1y6TUdW1DRtMvtJEFlfwpI8UN15xL7hGCQ5Ty9px/erpvhBLqE/gqKXUp9QuFe4ma1m1H/j4kt/MPltJ7kc/TFYfxi1HxzZz2qeForiPRWhJu7ywtEuruN8n5VjZx8uMcgEj8hWv8Fp47n4e6dONSv9Ru5BuvZL5mMiXJA82P5gCArZA9h1NeXL+CmB25/4/tP/AOvgf+gtXT1y/wDy/af/ANdx/wCgtXUV6OX/AML5gFcLL/rX/wB413VcLL/rX/3jXVUPKzTaPzMDV/FmjaRcXkGoXTxS2lut1MBbyPtjZtgOVUg8noMn2xW1G6yRq6HKsAQenBrmfE+l6/qGr2z6Rq8mm20Fu7rsVHSSfcuBKrDLJtz90g+/StHwjFqUPhyyTXTnUwp8/D7xuLE8N3GMVmeXKMeVNPU7Pwd9zUP+u4/9FrXQ1z3g77mof9dx/wCi1roa3jsfRYX+DH0MHx7/AMifqn/XL+or5m8ZSmHwpq0iqjFLZyA6hlPHcHg19M+Pf+RP1T/rl/UV82+I9n9g35ll8lBC2ZPL8zbx12/xfTvXDiv4kT5zO3bF036fmcv4WW3/ALUtGj8HPpzlT/pmxAE+Q88c89Pxruux+lea+EfFd/rniSztbu4jt4YQwWOCBwLtgjfMSR8qgc49RXpXY/SuesmpankZhCcKiU1Z27t9+/8AXzufQngv/kU9J/69k/lW1WN4L/5FPSf+vZP5Vs16y2Pv4fCjH1b/AI+v+AivN/H0vik6xZ2uiyvaaPcRqLvUEeANaBXy7gSHJOwY4BAznGa9I1b/AI+v+AivDfjnpWn6nrWlvPNO9/bRAwWKWC3f2ktKoVVDOuMsvzjPzJkZFfD14qWYzT7vdX/D+vM7l8CPTvCM2oT+GdNl1rB1BoQZiAo3H+8QpIBIwSBxzxWza/8AITsv+ujf+gNXM/DeK3h8CaHFaTyTwpbKA7xeUc9xs/gwcjb2xiuntf8AkJWX/XRv/QGrnwCtj4pfzDn8B0VB6UUHpX6CcR8E33/H9cf9dG/ma9n8IeB5m8M6bYa3o093DeXLNNINZSJLKNgm2VIg+1zgknIJ+XGOleMX3/H7cf8AXRv516X8KpbCKxibWJPBY09bhjOupwCS9KYGdmVOR6D1zXh0Lc1mfqmaKp9XUqbtb1vt0s1/wTzC4jEU8kYOQjFc+uDX1D+zT/yT+X/r8k/kK+X7gg3EhUYXccDG3v6dq+oP2af+Sfy/9fkn8hW2B/iP0PO4q/3KP+Jfkz1mvO/jN/yDtN/66t/KvRK87+M3/IO03/rq38q9dbnxWW/7zD+uh5/4Xtba51eH7dDczWqOu8QLuPLBQD7EkDjnnitTxjbR29tb7bXV1cyN+/1EYO3Awi8njvWP4dhnm1W38iC4niSRHmWCNnOwMCchecVp+L7AWqxyLLqjLJI2EvLZ4lUeiljzV9T6Sb/2iOvyMzwz/wAjHpf/AF9R/wDoQr6Ir538M/8AIx6X/wBfUf8A6EK+iKmR42d/xo+n6iN90/SvguvvRvun6V8F1xYrobZH/wAvPl+p7x4btrMeGbWw0DUPGK6Tqsc7gi2t2ji2lldXfkx529j0YHvXg9eueB7G0fwFtLT/AGK6Sc6ndJrBtxZsNwQfZwQJMqFPIOd2OMV5HWNTZHpYRWnNef8An/X49T6w+AP/ACTSx/66y/8AoZr0WvOvgB/yTSx/66y/+hmvRa74fCj5TE/xp+r/ADPnP9r373hP/t7/APaNeOfD7RzrGq3qwi5e8tLGa7tY7Z9sjzIAVCkc5B+bA5O3ivY/2vvveE/+3v8A9o14/wDDHSJta8Y2Vra6yui3AzJHebtrKQOi8jLHpjNYy+M9vCO2ETvbf82dP8R9Pt4vA+m31td+IXaa8H2hdTlfy7icwhpZY0YA5ViULEc+prG+B/8AyVjw3/13f/0U9dR8eLRbG10ZLyXX7/VJQ7teao+0IisyGNIx8q5Kh/XGPWuX+B//ACVjw3/13f8A9FPR9pFJ3wsn5M+3qKKK6D5wKKKKACiiigAooooAKKKKACiiigAooooAKydY/wBen+7/AFrWrJ1j/Xp/u/1rjx38FgeO/E1vEo8aaQvgWPUjrPkgztKwGmeRvb/XA8l85xtw2M4ru/Co18aSv/CV/wBlf2pvbd/ZnmeTt/h+/wDNn1rn/itrlj4esdAvtVvLuzshq8Aklt7loeAkjYcKrGRDt5TjPXPHOl8PrzSr/QDc6DrF5rFlJPIwubqV5GDE8oCwBCjoB2ryZXdNO3z/AOCB0f8Ay/6f/wBdx/6C1dRXL/8AL9p//Xcf+gtXUV6mX/wvmAVwsv8ArX/3jXdVwsv+tf8A3jXVUPKzTaPzPnfxDYWzavqwvtI8TTfEJrqY6bfW5k8pQXbyCjA7BEF27sjjDV9Bw7xEnmkGTaNxXpnvivGNYHim30nxF4Vi8O6ld32pXs0ttq0c2IAskm5HZ85QoMDb/sivZ4VZYkWRt7hQGbGMn1qJHDiHdL+u33LyN7wd9zUP+u4/9FrXQ1z3g77mof8AXcf+i1roa2jse5hf4MfQwfHv/In6p/1y/qK+f6+gPHv/ACJ+qf8AXL+or5/rz8Z8SPl+Iv48fT9WFHY/SijsfpXIfPn0J4L/AORT0j/r2T+VbVYvgv8A5FLSP+vZP5Vl634oll1M6L4cjFzqRyskx/1dv2JPqR+WfU8V7LkorU/TqUXKKsWPE2p29jexxNulupF/d28Q3SP9B2HucD3rn5NDstR1Wx1XXrOyOo25xaZAZoe/Dnkt9OPr1rVs9Cj0mZ5JJXu9QmUGe6l5Zz6D0X2ri/HvjbwFoWvWFt4vvI4tTs8XdsGtppDHuyoYFFIzwRXwmNjOeNqRpp3121f9dzvjZQR2ulW1nZ6fBbaakaWcS7Y1jOVA+tXrX/kJWX/XRv8A0Bq4b4MXtrqPw40y50+0tbOzeS5EMNqjJGEFxIAQGJIJAycnqT06V3Nr/wAhKy/66N/6A1RgYOGYRg91IU3eFzoqD0ooPSv0E4j4Jvv+P24/66N/M17r4e13wjbeHtN/4mnh+DULazt/sxn0x3e1uPLHmuzD75LEkehAPNeFX3/H7cf9dG/nUFeBTqOm20j9bxeCjjIRjKTVu1v1TJLhi1xKxfeSxO/GN3PWvqD9mn/kn8v/AF+SfyFfLdfUn7NP/JP5f+vyT+QrpwP8R+h4/Fatgo/4l+TPWa87+M3/ACDtN/66t/KvRK87+M3/ACDtN/66t/KvXW58Vlv+8w/roed+G7y6stas5LFZJJfNQeUjFfN5HynHrXQ+OYp7XTrW3e3vUi85333d2kzbiANo2k4Ax3rm/D3nDXtONsgeYXEZRS20Mdw4J7D3rf8AG2nW1pbwzW9rYRNJKQ7Wt3JMSdobBDAAcMDx61fU+jq2+sQ/r9f0Zh+Gf+Rj0v8A6+Y//QhX0RXzv4Z/5GPS/wDr5j/9CFfRFTI8fO/40fT9RG+6fpXwXX3o33T9K+C64sV0Nsj/AOXny/U9mtLONNMe3Nn4JbxBPG12mmSWUhlVXXzAgffgMFPCn2Ga8Zr0GP4o3iNHL/wjnhhrtECC7axYz8LtB3785wOtefVhNp2serhac4N8/U+sPgD/AMk0sf8ArrL/AOhmvRa86+AP/JNLH/rrL/6Ga9Fr0IfCj5HE/wAafq/zPnP9r773hP8A7e//AGjXj3w10iHXfFUGm3Ol3epRXCMhS1lEUkX/AE1Bb5fl9G4r2H9r373hP/t7/wDaNeMeA9G1XXNc+yaLBJcP5e64hjuktzJBuUOu5iBzkDHPXpWM/jPbwmmEWtt/zZ0XxL00aJpyaXa+N4tesYLoiOxVyxt8KeepUY6EKcZNU/gf/wAlY8N/9d3/APRT1L4+8ITeHdHFxc+H5tN86/dYZm1KK5Aj25ERVCTuGM7qi+B//JWPDf8A13f/ANFPS+0jRtPDys76Pt+h9u0UUV0nzQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVk6x/r0/3f61rVk6x/r0/3f61x47+CwPGvirqPjXT/ABCv/CKafqV7Zy2US5tghWOUXIZyQ3cxKy/8Crqfhnc63eaHeXPiO2urS6m1C4kht7kgvFAXJjTjjAU4/CutorxnUvDlt8wGf8v+n/8AXcf+gtXUVy//AC/6f/13H/oLV1Fevl/8L5gFcLL/AK1/9413VcLL/rX/AN411VDys02j8xlFFFZHjm54O+5qH/Xcf+i1roa57wd9zUP+u4/9FrXQ1vHY+mwv8GPoYPj3/kT9U/65f1FfP9fQHj3/AJE/VP8Arl/UV8/1wYz4kfL8Rfx4+n6sKOx+lFYXibVjZQfZ7Zs3UowMdVHr9fSuRK54VOnKpJRieynxLdS6Ho2geHctfS26LLKh/wBXkfdB7HHJPb69O68J+Hrbw9p4hiAe5cAzTd3b/D0Fc58G/Dq6R4Ssbu4UNfXUKszdSi44X+p/+tXf161OLfvy3/I/TrpRUY7GPq3/AB9f8BFeHfFLxYtv41OjXvjR/CdlbWcVwjQ23myXUjtIDk4OFUIOO+78vcdW/wCPr/gIrwD4xeKdY0fxsFsprmOC0tYJoraLSRdJeu0j+YskmMoAoGMeua+PqQ58xqK19/08n+XmdKdoI9I+Fuuz+JPAum6ndzxXM8hlia4iTYs3lyvGJAvbcEDY7ZrrbX/kJWX/AF0b/wBAasfwtq1nrmg2uo6bDNBaTbtkc0JicYYqcqenIP8AOti1/wCQlZf9dG/9AauTA/8AIwjpb3tu3kVP4DoqD0ooPSv0E4j4Jvv+P24/66N/OoKnvv8Aj9uP+ujfzqCvnHuftMfhQV9Sfs0/8k/l/wCvyT+Qr5br6k/Zp/5J/L/1+SfyFdmA/iP0PmuK/wDco/4l+TPWa87+M3/IO03/AK6t/KvRK87+M3/IO03/AK6t/KvYW58Tlv8AvMP66HmmjyPFq1lJHJJG6zIQ8ab2Xkche59u9dL42tb6w02xttQuo59rsI/Jg2LtACjc2BlsADb2ArnNCWN9asFmna3jM6bpVOCg3DkHt9e1dD4102LTLWJFR7dp5hKsDT+YQDEm4nnrvLjPf8BV9T6Wq19Ygv0/Uw/DP/Ix6X/19R/+hCvoivnfwz/yMel/9fUf/oQr6IqZHi53/Gj6fqI33T9K+C6+9G+6fpXwXXFiuhtkf/Lz5fqFFFFch9AfWHwB/wCSaWP/AF1l/wDQzXotedfAH/kmlj/11l/9DNei16kPhR8Nif40/V/mfOf7Xv3vCf8A29/+0a8T8D29xN4nsZLK/wBMsLm1kW6im1KYRQho2DAEnjqOnevbP2vvveE/+3v/ANo14r4E8QweF/EcGq3Gl2+qCEHbBOcKGPRuh5HbisZ/Ee5g7/VVbfX82d/8ZNJutH8NacBpehabY3t2bojT76S5aeUofnG8fKmM8DjkVzHwP/5Kx4b/AOu7/wDop6g8f+LdO8VyC5h0FrHUmk3S3T6jNctIuD8mJDgDkdOmMVY+B5/4ux4b/wCu7/8Aop6X2kW4yjhpKW9n/W7Pt2iiiuk+aCiiigAooooAKKKKACiiigAooooAKKKKACsnWP8AXp/u/wBa1qydY/16f7v9a48f/BYFCiiivAuAz/l/0/8A67j/ANBauorl/wDl/wBP/wCu4/8AQWrqK9zLv4XzAK4WX/Wv/vGu6rhZf9a/+8a66h5WabR+Yyiiisjxzc8Hfc1D/ruP/Ra10Nc94O+5qH/Xcf8Aota6GuiOx9Nhf4MfQwfHv/In6p/1y/qK+f6+gPHv/In6p/1y/qK+fq8/GfEj5fiL+PH0/VlTVr6PTrJ55OSOFX+83YVz/hmxkvbqTVL35iSSme7ev0HQf/WqnezP4h15LaIn7LGxAI6bR1b8e34V2sMSQwrHEoVEXCgdhXLsebP/AGany/alv5LsfQ/gv/kUtI/69k/lW1WL4L/5FPSP+vZP5VtV7S2Pv4fCjH1b/j6/4CKpVd1b/j6/4CKpV+d5r/vlT1PQp/Cgp9r/AMhKy/66N/6A1Mp9r/yErL/ro3/oDUZV/vlP1Cp8LOioPSig9K/RThPgm+/4/bj/AK6N/OoKnvv+P24/66N/OoK+cZ+0x+FBX1J+zT/yT+X/AK/JP5CvluvqT9mn/kn8v/X5J/IV2YD+I/Q+a4s/3KP+Jfkz1mvO/jN/yDtN/wCurfyr0SvO/jN/yDtN/wCurfyr2FufE5b/ALzD+uhwfhOO6m1JorLTrO/kZDlLtcoigjLdRitPxrBHb2dkrro6XUmZNmnRMBs5GS5JB5BGPauasL660+5WeynkgmHG5Dg49D6ir2ta7cazDAt9FbmeHgTom12Xk4OOOpJ4A61Z9NOlN1lNbfiR+Gf+Rj0v/r5j/wDQhX0RXzv4Z/5GPS/+vqP/ANCFfRFTI8TO/wCNH0/URvun6V8F196N90/SvguuLFdDbI/+Xny/UKKKK5D6A+sPgD/yTSx/66y/+hmvRa86+AP/ACTSx/66y/8AoZr0WvUh8KPhsT/Gn6v8z5z/AGvfveE/+3v/ANo18619Ffte/e8J/wDb3/7Rr51rCp8TPfy//d4/P82Fdz8D/wDkrHhv/ru//op64au4+B//ACVjw3/13f8A9FPSjujbE/wZ+j/I+3qKKK6j5QKKKKACiiigAooooAKKKKACiiigAooooAKydZP79P8Ad/rWtWRrX+vj/wB3+tceP/gP5AZ+aM0lFfPXAaD/AKfp/wD13H/oLV1Vcqv/AB/6f/13H/oLV1Ve9l38H5gFcLL/AK1/9413VcLL/rX/AN4111Dys02j8xlFFFZHjm54O+5qP/Xcf+i1roa57wd9zUP+u4/9FrXQ1vHY+mwv8GPoYPj3/kT9U/65f1FfLnjLVPsdl9libE84wcfwp3P49Pzr6g+ILrF4M1Z3IVFgJJPYAivkK0R/EfiQyyg/Z1+YqeyDoPx/qa4cX8aPDzamniY1J/DGN/xZ0fhHTvsWmrLIP304Dn2XsP61u9j9KQdKXsfpXGfLVajqSc31PoXwX/yKek/9eyfyrZrF8F/8inpH/Xsn8q2q9tbH6VD4UY+rf8fX/ARVKrurf8fX/ARVKvzvNf8AfKnqehT+FBT7X/kJWX/XRv8A0BqZT7X/AJCVl/10b/0BqMr/AN7p+oVPhZ0VB6UUHpX6KcJ8E33/AB+3H/XRv51BU99/x+3H/XRv51BXzjP2mPwoK+pP2af+Sfzf9fkn8hXy3X1J+zT/AMk/l/6/JP5CuzAfxH6HzXFn+5R/xL8mes1538Zv+Qdpv/XVv5V6JXnfxm/5B2m/9dW/lXsLc+Jy3/eYf10PKaKKK0PsTS8M/wDIx6X/ANfUf/oQr6Ir538M/wDIx6X/ANfUf/oQr6IqJHzOd/xo+n6iN90/SvguvvRvun6V8F1xYrobZH/y8+X6hRRRXIfQH1h8AP8Akmlj/wBdZf8A0M16LXnXwB/5JpY/9dZf/QzXotepD4UfDYn+NP1f5nzn+1997wn/ANvf/tGvnWvor9r373hP6Xf/ALRr51rCp8TPfy//AHePz/NhXcfA/wD5Kx4b/wCu7/8Aop64eu5+B/8AyVjw3/13f/0U9KO6NsT/AAZ+j/I+3aKKK6j5QKKKKACiiigAooooAKKKKACiiigAoorlNRu7yDUrjyZXChuBuGP1FY166opNo1o0XVbSOrrH1r/Xp/u/1rBk1XUW++8qj/eUfyFRR3csrHfMz4/2ycfpXm4vGQqU3FJms8JKEeZs06BVMMf75/Wlzx1NeRc5+UsggX9hk/8ALcf+gtXTtLGv3pEH1IrzvW13C0AXP+kL29j70jo6AbjEg7bzt/kTXpYTGeyp8trnVRwntI3ueg/bbX/n5h/77FcJLeWvmv8A6TD94/xio0jJXIZs/wDA8fzFcZMkvmPnkbj0Lj+tbvHuX2TgzTAK0fe7na/bLb/n5h/77FKLq3J4niP0cVwm0A8tIvvtLD+ZpSpxktvX13Mv/wBal9bfY8f6iv5j1nwa6FNQwyn9+Oh/6ZrXSV4v4VSMrettPMwGXIb+Be4OP0rdmuDbW8syzPEYVLFgxG3Azk44/MCtFmFtHE+jw2B/cxtLoVP2iNd+weDW0yF9s19kye0KYz9MkqPpurxXwRbeXpAumXD3J3j/AHBwv9T+NM8da5qHie0uLy+mMk10RDBkAbIgTtGB9SfxqC2kmt7aKLz5NqKFGWIAAHp1NcjxX1iUpLZOy+X/AAT5/iOg4KFNPVrX7zrKQ9D9K5dp5CMtJKR7naP8aiM24Hvx35/rS5j5RYN9z6x8Fsv/AAiekcjP2ZO/tWyXUdWUfjXkfhQiTw7po3Oo8hOFKjt/vZra8okcK5Pqdn8+a7P7Qtpy/ifqNPA3iveOo1aaIXOTImNo/iFZ5u7cf8to/wAGrnpICJslXz/wGpAjjs35/wD16+KzCftMTOXdnXHDKKSubZvrYf8ALZPzpbfULVdRsiZhjzG7H+41c9Ir+j/99D/GqsgP2qzyp/1h6kH+BvY0sBPkxEJLoxyw0ZRtc9MOqWY6zr+RqI61p+cC5DH/AGVJ/kK4cxsT2Ueytn8wB/KlEMQU5EbH1kDN/Ovsv7Rn2Rj9Rh3Z8n3zg3twef8AWN296g3D3/Ki7/4+pvuffbp9ahyvf+QrjP1KMrJE24e/5V9Nfs5alaWvgOZJ5Sjfa5D9wnsPavmAKD6/pXvnwLiB8IysEcn7U/ICeg9a0pVXRblE8LiOmquFjGX8y/JnubeINLUZa7UD/db/AArz34u63Y3Nhp4gkd8St/yzYDp7itciXHAl/EqK4b4niU2Vlvjb/WN1centXVDH1JSSsj5bA4OEa8WmzlPt0Pq35U06hCO5rHKjPOQfTOf606ONfV/xQf4V0/Wpn03skdJ4e1a3j1/TXJyFuYyeR/eFe6P4sth/q7eV/oRXzxoRK63p+PN/4+E6Af3hXs7mVj8puF+oT/CuWtjKqaszw80w0J1VzdjfbxOWQ7bQjju4/pXxR559K+tGimKnJY8dz/gBXyIVH8WPyrKNedT4mXltGFPm5V2/Um8/6UouB6Z+lQD2XP4f/XpcMf4R+VVdnqWPqP4G679m+H1lCLSWTEknzAgD759a9Cj8RJuPm2kyL6hlb9M15B8HYmbwNaEsVHmSfdjBP3j3Irs2WFfvtOfqnH5YxUvGVYuyZ8zVwtOU5Nrqzy/9q/Ure9Phbyd+U+1ZDKR18n/Cvn/zE/vCvZP2kJIifDojLYH2jghR/wA8vSvFs/5zXVTqyqR5pHfhoKnTUYk25fWu2+Cs0cPxT8OySNhFmck4J/5ZPXB49v1rqvhWu74h6GNrHMzcL1/1be9U5uKui60eanJeR9yHWtPHW5UfUEf0oGtacTxdxn864URRxj5lk/4G5oUxM2A8QPuR/Va5v7QqdkeN9Rh3Z6BBf2s7hIplZj0Aq1XE+Hgq6vB+9Q5zhQoHY967au/C1nWg5SOPEUVSlZBRRRXSc4UUUUAFFFFABRRRQAVxGsAHU7nCDO85yhOf6V29cJq7wf2pdBp23eYcr1Arz8w+Bep3YH42VxH38th/uog/nU0QIY5WQfUj+hqAKSMpErj/AHQP1z/SnxZDHdEyH03Z/rXi1PhO3Efw2XM8dGpDj0P60wHjo/50mT6fzrnueXYzdbwfsgaR0Hnryq5PQ/Wnxi0jztdyx6nO0n8eKbqxTfZhjGP36/f+hqZXjDYWa0B9AvP866Kfwno4X4BC8TLgnaD/AHrgj+RNcY8cPmvgxg5P/LTP8xXceY/aQH/diP8AjXGTGYyPgE8nqg/+KrWJx5rtH5kYhb+HymH+0oP8gKcI9mSse0nn923f6HAqIxy5z5S/VcKf61Iode8w9jhqo8Y1fC7oVvlk+95o++pU/cXuKpfES9Wx8MTRK5Z7w/ZYw33l3A5II7YBrS8LuDHeq5jbMw4b5T9xfWuI+JF6LrxJDZJnyrGPe+f779j64ABz71jXn7OLkfT4RXowXkc5aWSXDXjFCUsbUuuOzHCr+m78qzArdfm/AY/U12fheBW8AeIb8lt11IyIF7pGQv8A6Fvri2UA/OY09jyT+dGGhyU1FnyfEzviI+n6sApHOBn1YilaUgH54vzzQEjByME+oTNLvAB+dundDXQfNntnhWd28OaaGK7PIXkOF7e4zWuqW+c7ISfeTP8AMVleFb0r4d01VMTYgQfM+zHHvmtsyO6/KYT9CWrKW5+qU/gXoVniUS/JDAB/s/8A6qUxt/zziA+maYwfzTmIf8Bz/gKcVJP/AC0X8GNfM4v+PI0bGvDxyhP0wKrFFS7tCEZf3h5yP7jepq0Y/l52n6xmq0gVLm0JMKjzDyY/9hvejB/x4h0L4uIxx5pJ9tp/lSGXd92d1H+6v9aekoYfu5omH+whP8jStKwUncT9IWr6UR8hXf8Ax9zfNn527+9Rfhn8aluiTdzdPvt1+tRceo/AVZ+jR2QBR/dH41778DULeD5dsMLH7U/Ln2HtXgWB2XNe8fBBiPCEwCS4+0vym70HoaOh4uff7vH/ABfoz0fyHP3o4x/uKB/MVxfxOgRbGxzC3+sbq3HT0zXYBS3Id/o8Tn+dcf8AE4KLKx4jH7xv+WRHanS+NHzmD/jRPPSY0HKKo99v+NN82Lsp/Aj/ABp25VON8Y/4Dj+tO3nswP0Qmu4+hLegOp1rT8Bh/pCdZP8AaHvXtux2XhyP92TP8xXieiSMNbsOh/fp1QgfeHqa9pwHQNK1uAe4AP6muXEbo8bMf4i9BslvNtO193/XRiw/LFfIeCOu0fSvr1ooCp4kbj+EEA/kAK+QgAOiGppdQwH2vl+oZH+0foaBtP8AC34ilP8Aut+dJk+jD61seifRPwdSJvAVrvg3/vJP4Af4jXZARL922mT6Agfoa4/4Mmb/AIQW02iJk8yT+Ig/ePsa7hzccbFiHuWJ/pXNP4meBP4n6nhf7SjEnw583/PxwWzj/Ve1eKc+1e3ftL+YD4c80j/l56dP+WVeIDGfumu6h/DR1UfgQp98flXVfCpd3xE0MAZJlbt/0zb3rlf+A11fwp/5KHoeUJHmtwFBP+ratJ/Cx1PhZ9XxQ3Cd4QO2U5/SpX8wL800a++3H8zVdUgdh+5ZmHY7QfyzU3CDMdqd3sFH9a8o4i74f2jVocTRuxzn+8eD712dch4fLtqsXmbl4PGOOh7119ezl/8ADfr/AJHlY7+IvQKKKK7jiCiiigAooooAKKKKACuU1BbRru4Y6pYphzuV5ACp7g811deN+IY0/t7UNigsbli2Wwcbj+nt0o+rQxHuz6HVhebmfK7HYNbWpx/p+mNnpmYc/pWZfyR2Tptntpw+QBbShsY9ckVyrQqTgIACdxIYg59qaY0M5AKAlfmXnPPcc8d6mWT0JK2p1yU5KzkdINYhUEsJcA4PzJx+tDa5aL95XBBxyy9T/wACrnNibmVR84HfOPx9elIsY2gIUMqDGck4+vOaz/sPD92Zew8zoH1O1u7u2j8xbcRyCR3mICquDycGtppNP5D6tp5+Xdjdxj1rhvLUBRGAzx9AXPGfWlaOJVy0Yxu3cLn5vX/69awyfDxVtTWEZQVlI7J1sGBKavYIBgnZcngHpxiuMZbESuG1m1++V+8xOfTqKUqq7PNZWbd8pYAc1ysiKZXJRc78g+vvSlldGOx5+ZKclG8vyOpL6WuS2rx4Azwrnj86GfS+2rx9cco/881ye1VViyL0I+UZ49KAiBQVVQTyMjvU/wBnUTyfZy/mf4f5HonhT7KyX3kanbP+9BC78FvkXoDnPQ968XuLmbUJb+9gUy3GoXLGBf725sIo/DArqWuv7M8La7drxcHFvEV4+eRQgP4AsfwrC8N2ol8Q6TZgfJArXDY7bF+U/wDfW2vDzLDw9vDD0+rVz6jA3jQTb6HpetWWkaL4Cl006pEPs1qqbI1Z95yMkkcZJ5PueteSLc6VGxH2iTPH3Y8f0r0DxTEkfhq+VVH+r79TyK8iB4G7AJ7Zr16+BpU2kj5PiCnz1o3b2/U3/tulE8XE+c/3f/rUn23S24E9xk9PlHPv0rBAwvP54pHQMBnoOeKw+rUzwPq8e7/r5H0l4U1XQF8M6Yst9dLJ9nTK7B9P7vTNaD32gS/MmoXQ5wCYTj07DFcF4bIPh7TycbfIU8/Sr21ZEVlZWzyHwDxXq/2dQa1ifo9OMlFe8zrFu9PMjeTf+aoO3P2dl5/r9alM9tzi56f9MmrmNPVSWVE2bDgfLwOB0rVRFHAAB65x3r8/zTC04YqcY9zfW25oPLa7SXuXI/65mqdzd6ZDcWbT3LKvmnkQFiTsbp61E4G0gDkHrjv61kaqOLLZtOJ+p/3HzRlmGhPFU0+4ne251X9raHtY/wBozkLwdtuevoPWg6toQHN/d9M8QdPbp19utcd5K7t2Bjrt7Z9frSKqP84wAeoxwT69M1+gf2bh/wCUi0v5mfN95cQm6nw7Y3t1X3qH7REP4n/Korof6VL/AL5/nUXTk8/QV85yI/RFXnYt/aIwer9fSvoD4E6hp0Xg6Zbm6eKT7U5x5JbPA6YPNfOmAD047DHSvZ/g+NvheZjgqJ2IXb3wOa7MDhqdWo4zWljxs8qznh0m+v6M9nfUtKJP/E1kUAchbNif5muJ+J95pbWdmIr6SVlkOd0D46dsnB/CrDqgAkIO3rtCZyT3xjOa5X4hKq29kchQZG4wOTj+der/AGdh46pHz2EclWi+YwPtliv/AC8N+ER/Knfa7IHBuJOOf9XWOVG1twGOowOaQKMY2gqRkk9SaPq1Lse/7Wfc6fQr7Tl1zTzJcThROhYhOg3D2r2d9V8Osctd3wYDJbywpX6nHH418+6KFOq2Y6/v0BJ9civVUU+UwXO/pukA59ziqWBoz1aPGzFylUTb6HXtrWggFftOoswHI8tc46Zxjp718e/aYf70ntwOa+lJMN8p3jA3ZHA+mf6V8w4zwePpXJi8LSpW5FuPL5Sjza9v1LRuYQM5kx68UfaYs4/eZ9OKq/hxR90dzXH7OJ6XtJdz6N+EGsaTB4EtFuYb9pRM4DRFAGJY9DnNdyPEmiYcmO/2q23JaPDH0HPWvKfhZhPCNsxZzukdQMZA+Y+ldc+1ZFZmYZ+UDPGfpXr08DQlFNxPn6ibm3d79zzn9pPUtPun8OmyjukdRcGQTEEjPl46fQ14r56ej16r8fs79DyRtxPgY5/5Z15GPyrlq0YU5uMVodtCTUErk/nx/wC1XW/Ci8tbf4i6HLdNKsCTMXK4yB5betcWK6b4aceOtGA6ea3/AKA1TGnGUkmVUnJwfofXza54fOVeXUMjkgomceuPT3oj1jw8u7ZcahwM7Qinj1Ax0+lciQiwMVZguCdy/Mfw605kV0wc4I6glT+Yrt/s/D/ynm8r/mZ32haxos2rQw2lzcvO+VUOq7SccjIHX2rsa8l8J5Piey+8ArY5HB4PINetVE6MKPuwVkcOJVpLW4UUUVBzhRRRQAUUUUAFFFFABXj/AIg513UhgofOcB+OeTXsFePeISBr2oeYylWuGCjHQ5NdGH3Z1YX4mUWALoGUtjkN6H/JpQTvYFlPcAdQPemtkhd+Qd3GzP60pzvIO0Ajg9811ncJuAjILMuDty2Mk1GZd2RgqTgYXlg2M4PbpTdryTLDGWZ/lUZJBJyOSBjPb9a6VPC9uLcq8r+eRncvCg+wHbJJ6596zqVo0/iGlcwVJMgwFAK5YH7wPb+tCjaxVUIX727tkmkuIJLKeS2dVVwdqkL8pHX24xz+OKGAGxF3KByNo4wO1aJpq6EIGYxkK6NIvBPbP0rlZcfaCQpOcjcOgrqJZQqBs7eMlWx6fxelco1vdfO62smPmCkIwAH0+v0rOq0rXPOzDaIfxSBM7+vzZxn/AD6U443KGGWxkcf59ahgkUhwN+1QBjrj6d/epCGI8vLj5fv5GazPMM3Xp91paWGeJL1rl8ekcahf1c/lWh4AtzJe6vf91C2UTY6Yw7/rs/KsDUWU+ILti3y28KIR6Ejef0K12vgy2Nr4Ws2fIkugbliBk/vDuU/98lfyr5/DQWIzOU3tE+jw7th4+Y/xbg+Hr8cGVYeGK+pH+FeR9xkfjXrPjCVV0C+QsxdYvUck+o/DNeSMr+V5hjfacZYA9K9jGfEj5jPf40fT9R469eKM5BwaaHHpznmlPXH4jFch4Vj2Xw3/AMgDT/8Argv8qvklW+YqExgeuazfDJzoOnnnHkKOeMYrRYE4KbSMgnPOfpXtR2R+hw+FFzTWD/MpOCc9Mdq1RyCBkH1xWVZcydOM5zn6VqYDD5hkA1+dZv8A75U9TQSXpWNrIDCzEmP9f6/7D4rWlcYPIwOtZOrjBshjcPPzknp8j0sp/wB7p+oPYjyx3cAf3TnOaawLRgMqueMjt9ahkuEQgzAMUZiCB93H1+oH40LcJvx8qAk54zuOexHXoa/RyT5ouubmUHoXP86j9qfc8XEw6fOffvUfevkXufeR2FzyB3r2n4PsE8KSsckC4boMnt2FeLD0/WvZfhAceFJ9rYcXDMcDce3b8K9DLP43yPJzn+AvX9Gd6x2nczHacADHeuS8fti1tlAORIcFj14zXWWlnPqdyyWvyxkDdJxjjkHOOev6fWsv4l+H4IbCzZJ5WkaVjlvu5wD0r2KtaEfdb1PCwkXKrGx5lnJJQZYcc8ClHLHDdOCKiKyQymGQsGGB2qQNwzZyPYVB7Rc0gFtVsweP36dD/tCvVHxNEMBWRjyHHUfSvK9HAXVrIgdZ0/mK9PmdkQBsuVPJKZ3cZ4x0IranseVj/jXoTOw5Jbaq8HIwD+NfL/AHQAHrmvq+HRES2a41a4ECnsDgke/oTgcD0r5TmiCqZIn3L0PqK87G1YyaSfcrBRdpP0EHGABxR0GBz+NNU5IJpQRjJI56VxHae5fC058GW4RgG3v1GcfMa65mOGEW1nX+EtjH1rkfhWVXwfaj5fMZpMepw1ddlgq7lyx4baeB/wDWr3aP8OPoeJP4n6nkfx/Hz6Ecc4n5/wC/deQ55969b+PmB/YSKrAL54Ge/wDq68viiCLyMt615+KdqjOyhFyikipn6103w1ZV8daQWKqPNPJP+w1YzKGGGAIrZ+H6+T450hsgKJSST2Gxs1lSlea9SqsHGLZ9KR/KNpCA8kBfTPFMBWSM+ZtdozlgnOGHNCFghkK7yT8oC7SB6HNPc7DvLYQA5GOteyeebHhHLeI7E5+Ut0I5zg16vXlPg3b/AMJPaDd8zFm2k+inoK9WrkxHxI4MV8SCiiiuc5gooooAKKKKACiiigArx7xTbTWmvXcrrsjnuGIZcYbr149AK9hrj9VQS3FzHLGskTOwKkdRmnGt7J3OzBq8medxS7lYruZmIO1jjaD0/wAcVIFwyDbuCg/OxyRW7eeHYZGL2bmE4GI3GU46fSqy+GbhzhrqPbkY4LcA5HB7+/0rrWJptXudzi0Z+jxvPrVuuWYpJljjAwozn8yB3FdzuzJgdAOao6fp8WnoVt0Znb70jnk1dUeWuTznrXBiKqqyuti4xsjl/GFu4uoLuPoV8vPXDc47HHBP1xisQSqY22BlUgk4Bzknr/X2rv5UWSN45I1lhcYKkZ49MVnDQ9M8wMIGHOduTjsf6CtqOKjGPLLoJwfQz/C2mrIq6hcLuyAY8nPbGf5+vrUVxo+rG4fyvsRjLErudgce/FdWqhYwkahVAwAOABTZQUVWHO081y1ajqS5mZ1MNTrWU0eSa7omp22ryACzDSANhXbqeoHHtk5qIaNqsjIMWRIPHztwenp712XiZg2tKV4wi/ifm44/meKy726/s/Sru9ChHghefH+0FJH64r0VaNHnfRHP9To3tY8kkE8y6nIShmvrsxxbc4wSI1/QCvZrm1Gmww28KkxxRKkYx0VVwM/kK8r8N2pl1/QbLBKxMbhz/wBc1LD/AMexXsGtobjSra5jCMyja27p/nrXg5M2putLaba/y/I7JRUUoLoY17pnm+F9Tu7gZiSMiIMe+ev4A4rzYHI6ZFe2+KrdbbwNeQRgBEgA4+orxTHFb4yo6lS58XxIrV4en6szNRtBjzIVxj7ygcY9cVks2FEeccYODjHNdQRUMltC+d0SHv0rOFayszw4VraM9C8K+ddaPp8VujNKLdcrnjGOD/8AX6da7O18PqUVrqQhyuGVf88/lU3g6JI/DGmeWirmBCcDGeK2cV6M8VJq0dD9OpRXKjmry1XTpxtLGE/xHsfSpGbK4yR9K0r6JZpCjjKkVnGwuE6OGA7+tfDY+opYmfM9blyiRFlJxkc9qx9ebKWwUKxaXAB5BGxu351tpYXLghyqg9TxSyaXALmy81TN++JC4wM7GP8AOry2rGGKpu/UmzYvh7SIVtkurtBLI/zJvXoMYBxjqRWlqOkWV7A6SRLGzDG+MAEf49ehyKuDj5pO3QUu5mB4AHvX2Eq0pS5rlcp8T30Lw3c+fmXzG5H1qvkDHqPU1tXn/H3P/vt/OqrQRsclRn24rxvadz9AeFdvcZQyMnHWvavgtazajoD28Qbb9pYswJXAxzkj6j0ryIW0Q/hP519EfAJAngyYRqFBunyfXgV2YKvyTbXY8bO6Eo0E5d/0Z6DYWcdjbLBDyx5d8YLHGMn8q5P4qcafYAdpG/lXakhBgcsa4f4ogiwsSxyTK38q67tyuzw8Ev30TynVbQzBZol3MOGUAfMKyll+6DncDg/5H1rpsd1OKRkDfeRT9RXTCryqzPdqUOZ3TMfRpC+sWnlKzMZo1Xr13V7foWiusyXV6hUqcrGQMs3I3EfifTtXnHh5QuuafgBf9Ij6D/aFe37Tnj8zSqYiVuWJ4uPp8tRXfQ52SFdU165F03+j2agBM8MxGf8AP0FfJUibbjy14WQHj3r670sC31/Von6yBZFJ7jHP86+RrkgXcBJxjJJrgl/maYfZ/wDbpWKtExUilDc/54q2bqM8YLD6UR/Z5fuqufTGKnmfVHSoRbtGR7F8L5gvgy2XnO+XkdRz/PkcV1iyl5Y44t0r7fl65c9DwP8ADriovg9ptnL4Gs5JII2YSScsD/eNegQQxwACCKKPAxlVxxXqRxkYwSSPFnTfM/U+dvjvpklnF4dkuFCF/tG1CACFHlkZwOOp4rymvcf2mz83hvLbj/pPA7f6qvDq46k3Uk5M78PG0EFdN8M7c3XjzRoVIDtI4Unpny3xXM113wkOPiRoJOf9c3T/AK5tUxbi00XVV4P0Pc+IZWhnA86MkqJGyVYHGOpxwR+dTCWNZNyuG3qScOT044H49q7DUNOsb5t8ykSjo6HBzxz6E8DqDVGPw3Y7ycTyA44dhg49TjJ616ccZBrU8r2bK/gSZn8VWqsoP3zuwRhdpx6+45x06V61XHeFdLtbHUEaCCNX2kF/vMfqx5rsaynVVV3R52LVp28goooqDlCiiigAooooAKKKKACuVvv+PyfnHzn+ddVXIX7RfbbjPXzGz+dZVdjtwSvJjCuf4jUbx4+6X/A0n7s/dD/hTs4/5aY+tYnp6oZ+9HdiPcU9Xx99iPqMU3zV7uT9BTxJG3GfzFAP0FO3qFz9KCx/usKQonUA/hShgB8pH40CGeYc43Af7wp67j1YEewprEnqUNNC8/dI91NAzitdkV9fmUFTtYYAA6hfu9evOfSud8cSeT4XeJV2rdTxwEemW3n/ANAP51u3LGbUbl1MgzIxUuSR97HbjoP1rk/iLPufS7IHBxJcsPXJCL/Jq6szqexwb87IygryK/gWENrGoXzEBYLRIQW6Au5bP5J+tek6TtuLK4sZQCCueBgfUVxPgIBdBupsqjz35jG7+JUjXgfizV0mkziLUM7lBLFWU4z+nsQa58uoXwCS33+aHJ+8O8Q6obbwrqVjqAkEiRbUlZeJBx6V401+83FpHkY+8/AH4V7p43SE+FL/AM0IWMXyZ69RXhEs6LxGwyDyMVhOqqruo6/gfIcRRX1iHXT9WKWvRg+ap9sUi6hLE2LmLK46r1/KpbaYSJyOnUU27QNGwxkYrNT97lkj5/S9pI+hvBsiS+FdLaNty+Qg/StquD+HWoi00PT7GcDa8YKHpk+nJ57V3T8j722u6rTdN2P02lrBFS5/4+PwpQAeetNnA8/75PFKOnWvgsx/3mfqbvYdz7VDNn7TZ5/56np/uNUoPof0qKXd9qssY/1p/wDQGoy7/eoepDL2AvJ/WkaRedwp+W74FB5U55r7gfqfG95/x9z/AO+386hqa7/4+5/99v51DXjM/S47IK+g/gKhbwbLzgfan6fQV8+V9B/Abb/whsuSAftT9/YV04T436HicQf7tH/F+jPSgu37oA+tcR8U932Gwzj/AFjfyrtcqDwwrifiluNjY8jHmt29q9GO58zg/wCPE85+opPpk075vagE1qfRl7QW/wCJ5p+Bj/SI/wD0IV7bweuPzrxPQf8AkOafwD/pEf8A6EK9u5X+AfgaiR4mZ/xV6HPeIM2Oo2epRk7B+5l9NvP/ANf8hXyRc/NeKMbuBgevWvsvWbb7dplxAUO5l+XP94cj9RXxgAVZZeuDisJb6EYZpwd+li4I5WHL7B6KKb9nbzVZpMhTnOOasDkAg8Uv41hdo9NwT3Po74LhT4BtPnIPmSd/9o12xUHjLP7CuJ+C5x4BtPkLfvJP/QjXc+aB/Cw/CupbHgzvzv1Z4V+00pU+G/lC/wDHz0/7ZV4d069K9x/acbc3hvk/8vPb/rlXhbjLKD0zQddK/Ih/B711/wAJDj4kaCR2mb/0W1cYnySFexGa7P4Rn/i5OgHP/LZv/Rb0Dm7wZ9alyDyfyFKJY+7Y+tPBJ6Mp/CkJYdUz9KZwaF/Q2VtQXac8H+VdLXN6G2b9QFI4PaukrenseVjP4nyCiiitDkCiiigAooooAKKKKACuSvHU3s4PB8xv511tchqCo17cfNg+Y386yq7HdgfiYxgCPWo9rj+BaaYVAzvbFKGRf42rE9JLsOVxnD/Kae33flwTTfMjfgkH60nkIemfzoFp1GZl7FBSssmMkq34VIsaDoKcMKPagObsV1Kk4IVT9KZdgw2s0qHlELAAegqyxRuuDWd4gCx6LdkK5ym3CH5ueOKqEbySG5HFQIzASeSqDO4KTkrx2HQHJOa4TxnP5/iu+GfltVS2Q/7q/N/4+xr0XTUK3ERZovs4JdiB1Gck/lmvHmu/tjXN9LkG4kkuT9WYn+lYcQVPdjTRNJa3PR/DcAg8H6eWaUGSOWZhGeTvkbBx64C1qpaPa2ltcllO9jHvL8YBAGffgfjmo3iWysLS0+aKeC0ggDAYJIXoD9c/nXTixM/hqGFYNrKglVFOPm+9ivUw8lRoU13/AFM7XbINYsl1rQxCUMiv1AODgjtXF2/gvTLK6EV1DcFT82S/zfnjFdt4cnJhWJwVkA5Bqzqdut5GEkA3KcgkVxxqKjVdCpFcvfrqZ1MPSre9OKb80cle/DfTIXFxaG6khcZKiTp74xUH/CFaJLGQftLMP4fN4/lW+9regZW6c7BhQSQB/kVY0ueKa4NrqirI6plZm4LY65IrodGnON97djL6nh7/AMNfcjK02yitr2xs7RX8uMgcc8D1/wAfau7KJjJ6e9Q2dlaWuTawpHnPI9+TU7KmMnpWdaqqlrdDsiuXQrSKnmnFO2jHWkdV3nbTgor8/wAx/wB6n6lNjSMdDUFxn7TZ4GT5p/8AQGqyUFVpty3Vnxn96f8A0BqMu/3qHqItOHzkoDSbl/iQr9Kn3HHQ5pMN3xivuSuY+OLv/j7n/wB9v51DU15/x9z/APXRv51DXjM/So7IK+gvgME/4QyUsBn7U/8AIV8+19BfAYJ/whsu4c/an/kK6cJ8b9DxOIP93j/i/RnpQK9iBXE/FL/jxsPmz+8b+Vdt5SEcVw3xSjKWNjg/8tG/lXpR3PmcHb28Tzs5Pam8jqtPBPcUHJ6VofSFzQCo1zT85H+kR/8AoQr29iHHBP5V4joRI1zTyRn/AEiP/wBCFe2+cMfdP5VnI8PM1+9VuwhiO0/N29K+LlQM80R79Pb0r7RO+RSfurivjCf93MknbvWFToLA681/L9Qs5Dgxt95f5VZzVa5XZIsyfjVhGV1DDoaylrqjvpO3uPofR/wXlx4CtAASfMk/9CNd0PMbrgVw/wAFXQeArTkZ8yT/ANCNd0XUjhsV0rY8Kp8b06s8L/adBB8NZOf+Pn/2lXhEmdy4617r+04Bu8N/Nn/j5/8AaVeFrzIT6cUM7KPwIYdwmTPOc12nwjP/ABcjQeP+Wzf+i2rjX5lT2Fdl8Isf8LJ0HP8Az2b/ANFvR2CXwy/rofW+8Dk0m92PyDj3p20Zyxp25emRTODQvaEH+3ruIxtNdJXPaIc3y/7proa3p7HlYx/vAooorQ5QooooAKKKKACiiigArkL94xez5GT5jfzrr646/Lre3BAyPMbt71lV2O7A/EyITp3B/KneYh6c/hUfmMesRp6HP8BFYnpNWB4lk/hwfWmASRdORUjq/VG/A03fKOqCgE2NLbz1ZTSpFu5ZmP1p48w9QBTsZGG/SgG7bCFAB8pwaw/FjyJpLK3zK7heDjHfJPpxzWyYyG+X5h71zvjKVkhto9o2sWJLH5R0A3fXNbYdXqImT0Od1Bvs3hzW5hIBsspRGFGAjFNoA/E15bplssv2O2YZE8scYHruIX/2Y16H41ljg8Dal5O0G4nihyO5DhmH5JiuU8LW/wBo8U6HB2ScSn6Rqz/+yCvIzmfPilHtYdPSLPQtakee6mXDgtKwQI2N4x69v/rV3lmojtYYwfuIq8+wxXBwySzX9ttOyV2BaNzn5dwyeP8APNd2VyPlbn0zXvYv3YxguhEFcwbmIabrok2hYLgkk/7XHH6Vflx5hw2R2p2sRGawlE3RVLBhwQcVlaPN50A3Z3DoG64HrXLWh7SKq9Vox25XYvsPlwcVmanboysHAZTjJA56/X6VqMcCsK6nneeRYbZ5PLHzkLlgD6du3rRg1Jy0dhSNDwxNJcGeCaRmdDuBzkBckAZx7VvqAJADuJH5Vj+G7Ca1jlklTy3mYkgdh+PTNbblkHGPqavEcrqPlLi3azIJiPMOARTgSR0rM1SfU0lU2Fnb3CkfMZbgxYP/AHw2agW68Qlc/wBj2P8A4MD/APGq+PxuWYmrXlOEbpvuv8xS0NrJqtchzc2W04Pmn/0BqzjeeIR10ay/8GB/+NVPYPqdzeQm+sra2ijJfdHdGUk7SMYKL69c9qMFlmJpV4TnGyT7r/MVzYAkHcGlYsV4HzU7j1qNiScKxJ+lfVFbnx1ef8fc/wD10b+dQ1Nef8fc/wD10b+dQ14zP0uOyCvoX4CceC5uM/6U/wDIV89V9BfAbzP+ENl24x9qf+Qrpwnxv0PE4g/3aP8Ai/RnpBYg/KpriPikXNlY5GP3jfyrtyZB2riPihITY2O4YPmN/KvRjufNYP8AjRPOgGp2SOtLwaQ8d61Poi9oTga5p+f+fhP/AEIV7UJ1c4jHPrXiehDdrenjd1uE/wDQhXt4hUDms53PFzPlVRX7C4bacntXxpKnmRle/avsp2VFIXk49a+OBXPV6Cy/7Xy/Uq2xEkbRP1HGPaktz5UrQv8AUGi5BhlWVeh4NJeqSiTIeRjn2qI66HZO695dPyPpb4MtGvgO0ypz5kn/AKEa7tJozxn8xXDfBHMnw+snzwXkOMf7RrvGjTHK5roSsjxJyi5P1PCf2n5F/wCKbK/9PP8A7Srw1B8oFey/tKXKXN9occS/u4PPBPq37vP5cV4wZFAPf6UjspLlgriLzMx9Biuy+EilviRoIzj983/ot64yIkLkqeea7P4Qtu+JGg7T/wAtn/8ARb0+oSf7t/M+tzCv8TE/jSfZ17EilYMzcdu9SqCByc0zhcmupb0GIpqCncT8prpq53Rf+P8AX6H+VdFW9PY8rGO9TXsFFFFaHIFFFFABRRRQAUUUUAFclehxeT4Ix5jfzrra5G+jY3k/z4HmN/Osqux3YH4mMIJXGeajMb/3zTfLYdJDRkr99/yrE9JLsDechyCGFOSYHhuDSCZB60u2OTp1oB+aHPJt/hJHqKYJWb7qH8aVYtvRjS528DLGgWnQTft5ckVyviyUNqtpsI+WM8k9RnkAdzgV1ZLH7yZFcb4icHXWEahXEYUbwcNgE8enJ5rqwavUJnscd8TJx/YeiWw4FxcvcYIwflULyP8AtpVLwAgfxOW/ihtZplP4BP8A2emfE2Vn1/R7Xj9zZrIQOxdiT/6CKT4eAy6tq8m4qqWgiDA4x5kgP/tM14FT9/mC9f1LWkDu9FQza5aRTOGeP5soCMnBJz6dsV3Xlr6Vx/hZWfW3IZmWKMrnPGeOv+1z+RrsicDoTX0GMd52M43sUdZBGk3O0Fjs4Ga53w3JvgOxl8kZAHOc9P6V1U6tNG0ZX5GGDn0rjbm1k0S5x5QNuCCjAYXpzn04HU+tTTSq0pUluD0dzcu3Mds7KCXxgf41l6fqiafa393KwlZnVY1jHzSPyAnucj/OKq3F6946xRxjzS2xVXv2zz2GRkinavpzyXmhaZHMYZJZXnlkj4IKr29+Tg+tSqfsKTU/iZdNc0vIsy2viaSFbsaisN1nf9lEQMeP7hP9f/11s6RqH9qadBdbdrOMMn91hwR+eayNY8OWumadcajps09teW0bS+Z5hO8KMkMDwc4qb4emSXQmuJlAeWd3wBgcnnH45qnTXseZPqYe2/f8tuh0ccfdutOwy98ilJwclhio2aNu5rmN9WSeYvrUZkjz0pFWM96kVEHQCgNENVkI68VJxjio2ZA2CMGmvIig7W/CgLXPjy8/4+5/+ujfzqGprv8A4+5/99v51DXjM/S47IK+hPgKpPgyUhsf6U/8hXz3X0H8BmVfBcoY/wDL0/8AIV04T436HicQf7tH/F+jPSg2OGNcP8VHU2Nj3/eN/Kuz/dk8k1xfxRRBY2GP+erfyr0Y7nzODS9vE85yKcMGggAdKTK1qfRmhoaBtb08f9PCf+hCvamiwPmc4rxHQyTrdgFJz9oT/wBCFe1rHKDuc7vas5ni5l/EWvQkUKqEKO3WvjjB7V9j+Yu0hhtOK+Oc1z1egZfe8vl+pHKvmRlCOtV7Ql45IX6jIxVzNUpv3V8jjgPwf5f4Vkjvl3Pob4BXMh8Gi0J5ildh9CxB/UfrXY6pqs087afpB826/wCWjjpGOh59f89a8j+HN1cRWdjY6dNsmumdHk7RhmwfxyAfxFetQrbeHLdLa3JmuH6qoy8h9TXfKLk1ydUfPRapc3tN03b79Dxf9oLSm06Hw4JpTLI/2gsP4Qf3XSvGnYO+0Y2L1Ne0ftIHULj/AIR17xFgU/aNiA5b/ln1/SvGFgQdcn61Dioux1U5SqQTsKZM8RjJrsPg+PL+I2hZ5PnOf/IbVyYAAwBgV2HwhH/FytA/67P/AOi3qTSovdbfY+tfMkx8sf500yTA8pxUpYlsL+dP7UzgvboWtBkLagoKkfKf5V01c7ohBv1/3TXRVvT2PLxn8T5BRRRWhyBRRRQAUUUUAFFFFABXH6i8i3txhRjzG/nXYVyt6f8AS58/32/nWVXY7sC7SZnrIjH51wfWphHGeQBUUkidwPxFIpTqA34Vgeo12J2VQv3Rioi0Oe6mnCTH3VJpd399MUyVdCCcYwuTQC7H0FSAgLlR+VMM8ZyCfwxQHog8xU+81cRqbPPq96yny1JKhs5PGACB0A6/lXbCRD91ciuBjEc9+4kG7zZRguPmzuJAx2A6iu3BaOUjOojgPHkwl8fXajpbRRxD8EBP6sa0/hnDHJoup3MoUi4u0hUN32IW/nJ+lcv4hm83xN4iuev+kSqp+jkD9Frv/A0C2ngXSNy8zGa5ZuMDLnB/75Arwctjz4zmZc/hOt8HsGuLydzngIrDIBG5u3qOhNdK9xyAgyaw/CG2PT7qeVhzJlm6KQFHI9sVl2smu+JTJcxXY0zSixWDylzJIoONx7j8CPx617WJTc5SWyFT5bqLOwHnMecAUk9sLiJopsPGwwVI4NcufD2pxHdaeJb0Sek2WB/Mn+VJ9o8Vae3+kW8GqQjq0R2P+n/xNcqlbU39nfZr8vzOhsdLtrJy1vGqsSeTyeetZWu7YfFnh+VuEfzoyfcqMfrUumeIrDUJRBva2vM4NvONrZ9B2NZ/xBWWPSbe7iUiW0uEkDeg5H89tOU3LV6hTptT5Xpf9Sz49uxbaC0Ib5rpxFj/AGerfoCPxrU0SzFppFpA2VdYwXUdmPLfqTXKedH4l8UWBgcvawQiRh12k4Zh/wCgL+ddyo2LtBy3Xmumr7lKMO+v+Rw005VZT7af5/iKIU7jP1pxVFHQVGXl6bMU0RyMcscVzHTZ9WS/IfSl2gcg4qPyQOrGnKCPunIoF6MQshOHpypH/CBTiAw5FRGD0YigLo8/uPhD4dlmkkD3i72LbRLwM/hUR+D3h0felvh/20H+FeieU/8Az0NOEOerE1Hs4fyr7jp+t11/y9l97/zPOh8HfDp/5bX3/fwf4V13hTw1Y+GdOay0/wAxoi5kJkbJya1dhiP7sFs+ppG81xjBFNRjHZETrVaqtOba822SnYDjiuH+Km0WNgRj/Wt/Ku0WE/xN+VcT8UVVLGxGc/vG/lVx3NMHb28TzoEY4pRtNKCO1BXNan0hf0AAa5p2P+fiP/0IV7e28fdwa8O0FD/bengNj/SE/wDQhXtvlN3kNRI8PM7e1XoBZWUhhg+9fHGBX2NJArKdxJOK+OQPeuar0Hl9vet5fqBGOlU9S/1aHvnH6f8A1quYPrVbUF/cA+jCskehLY9i+Htilt8PbDVI+bxrlyz+g3Hb+oH516l4es91ut7IC91cDe0h7A9AK474XxJP8HkQjLBZHUY7q2R+ortfBd0LjQolLZaFmjP0zkfoRXqJt4fToz5Wdlim31/TT8jyL9ppHU+G9zZz9p/9pV4fmvdP2nyC3hrH/Tz/AO0q8LrlZ61F3ggzXXfCQZ+JOgj1mb/0W9cjXXfCTn4kaDzj983P/bNqRVT4GfXDMEAVeTSCJm5dvwFOTYvQ8+tL856EYqjzr22L+hRql+MddprpK5vQ1IvwSc/Ka6St6ex5eM/ifIKKKK0OQKKKKACiiigAooooAK5G+kIvLjCMcSN/Ouurk75tt5P8pI3t0+tZVdjuwPxMqmQEfPGR+FRYCndCeO4qfzCRlAGH603zV/iQj8KxPTVxwIePI4+nakEhXhxn3FR5jJyocZ9BUiDPR8/UUCtYUSR84OKQvFnnB/ClJjH3sE/SgMD91P0xQIgv5RHZTuhwVjY4HU8VxekFjLGd4Kxn5tw+bAXo3vmun8TSbNIlBAUyERg4LYz9K428uhY+H9TugCHit3CZOcM2AuD6ciuum/Z4ecyJatI8fuJjPb3k5PM8rSfmSf617FHF9g0nTbJHwbaxij2BdxJ2j5sfUmvGmT/R4II+dzAAV7XqZ3zTbSTh9qqOowPb2HQ8V5eRw5qsplVdrG/otl5/huSLYVNwsg5PTOR+VY+g6/8AYdLtNNjs5LjVFZo/s6nGMEnJJ6en1BrrdLhFvp1tGgHyxjjpjisXXvDhu7oX2nv9mvlO7IbAY+vsf59xXqwqQlKUamzdznrRqaTp7r8hn9qa/eF44dB+zuOBJPMCg/kT+FQSeFdRv8tq+s3JB6xWp8tB7e/4iovt3iuz+WazW4UfxeXuJ/FD/Sl/4SbXEH7zRXP/AGzlH/stTLCSk7xt8n/mVTx6pqzuvVDJPAWmbCsdxeQy9nJVgT7jH+FZ2vab4j0vRrrbqI1CwEZ8xHwWxjrhufybNap8Z3MYzd6OyKOpMpH6MgpNS8TaZqeh30Pz20zwtsEoGGOM4DAkfnipWCqJq608jT+1Itb3fZnJ/DDWYNLkmh1H5BO2POPHlsOoI7An8u/t66RkAjDrXDaPo1jr3hhYpE2XcEkiLOo+ZSWLAH1HzdP5VV8H63d6Rq50LVCTGH8mMk/6t+wB/unt+HrxjVThUcWdMOXEUlVgrO12v1R6GoXPUg+hp5JXoCRSZY9UH50m/b1Uj6c1JiChJB6/WmvCAMoSDSkRucg4PqDijDjpID9RQMjDyJweRT1kd+mKXc/pu+lNK56xke4NAyQKf4jmlOQPlxUYQHo7D2NO2KO5P40EiHJPzj8RTlAxwSfxpMkcIuR9aXJHVP1oARn5AcED1rkviJp13fWdotjbtMUkJYL15FdbvVhhhj2NKo2jCsMU07F06jpSU47o8Vbw7rIGf7On/wC+ab/YWsd9OuP++a9rLMOhH5U0lj1jzT5mdqzGt5Hk2i6Dq0er2MkljOkaTIzMRwAD1r14KB15qHYM8hl+hpwjB6uT+NJu5y160qz5piyF8HGK+Ns+1fZDBApz6V8cD2rCr0OzLvtfL9RM1Be82z8eh/WrGKgvMi2k+mKyR6Utj6P+Bu5/hxYjapXfKOf981oeCU+zajqWnueYzlf+AkqT/wCg1nfAssvw4seVA8yXr/vmtOFvsnj9wDxcpxgeq5/mhr08PrCcPK/3HymKvGrGa72+884/adUg+GsnP/Hz/wC0q8NzXuf7TxyfDXB/5ef/AGlXhlczPWofAgrrvhIP+LkaDxn983H/AGzauR/Guw+EWf8AhZOgYP8Ay2f/ANFvQiqnwP0PrddndcH3pxZVHUCjBxyajLKThF3GmeduaWhuG1ABRxtPNdJXOaCD9uG4AfKeldHW9PY8vGfxAooorQ5AooooAKKKKACiiigArndQiX7RKR3Y/nXRVztyR9ulDE/fJ/CvHzibhTjZ21OrC35nYzniAfKkqfUUq7gfmINW7rY+0R8c1UuI2UkH7y8g+tZYPHKp+7n8XfuelGXNuIzFT90ke1N3Mx+VQPc0qkyhQOM9as28Ct09cV04jFwoWUtW+hTaitSsI+7Hn2qQRlhjkj3qZkw5VBlganjaOJG8zAAHOe1eb/as5vlhFL8TOVR20OM8aEQ20Eakgli/XpgYHt1I68VwPxBuTbeGlt9w3XMyjAGPkUbj+oWus1m9XVNWaWAkwxALGQfvDrkH69vSvNviFeC512G0jYMlpHhgOzsckfkF/WvdxcpUMAo1Pie5ULyldnPaOobxHo8UnKm6iVvoWUf1r10g3FzHGNr+a+cYyMZAwQOv17V5JoC/8VZp27nFzHj8HWvZtFQS61ZqdpAJfGCMcNg7e3171lkr5aVSZVTdI7ZVCYyFH6UrKT2VhVyF41RlZQHzyD1qLytwJXjH6148c3adpxv6E8+upV2j+4R7g0ZI6MfxrQhSOReVANNmtgvQVtDNE9XHQPaq9mVUbPXr/OsvU9BstTRhPEqSnhZEADD/AB+hrSKGM5H3e49KlTJ5H5121cZ7Gi69N37BOMZKzV0cX4XM2ia7NpF3tAnIZHHQtjAP0IGPqMVW+KmkGM2uqwZDIwgmZfflG/A8fiK2PHtiI7a11KBitxBIFLd8HkH8GA/M1a8UH+1PAl5dKu0Pa/acehAD/wAxXDisVUrQp4lv4tGltdf8DUwwNR0a3s1svyZe8P3iavoNndup8x0+fHTeOG/UGr/kkLkLxXJ/Cy5aXw/LCCT5VywxjoCqn+prs5A5G0kfSuJY2tRk0ndeZ0Vk6dRw8yFLcyds/hSNEEzk49antiIASHJzkkH1qMOWlZ2U7e2R1qKmYV3ZqVmzPmd32BINw61C0CliGz7kGrjFCuVfB9KagQfMzc1KxmIjop/qJTaKxsQWAVs985pjWmG2ljn61NHN5UpGDt6k9hU8jrJyvU1azCtKOktfRf5Fuc0yg2YgU5yDgZ96ckf4n1NLdBt4ZxyMVNC4RskZwOK9Wti3Sw8altXYpv3boj8s5xipTbbV3EceuKkiQu7OzDJGMelOupm8ry0G5sdBXmSzGvKDk3btZf8ADmTm72RWWMFsZ5p0sGEznIqWIpja3HvQwBOA5IrFYzEL3ufX+ugczuVRao+eSD6Zo+xELuyR7ZqecoI/lOSOafFcBk2uCpI6EcitI5hWV4yl+RXPO10Uja/KSC31zXjsnwUXe3l6u2zPAaLnFe3DO4lBlcYqIBQhY10Ucz5V+/1NIV5w2Z4qvwUU/wDMXYf9sv8A69c94z+F8ejWcAGqmWaZ8BPL/hHJPX12j8a+jfLTyDK7qiBdxZjgAV53pKN4t8YtqBUjT7HHlZH3iDlf1+Y+20V1Sx9J03OKt6nTRxE5NylJ2W5ufD3w0/hrwpZ6dI3myoCznGMMeSPwNUtcUnxxpQT75Reg7Zf/AOvXeROI+HXpXE2zDU/iJLLGfltEIU/QbSPzdvyowGYVbTlKztFvb5I8nETcrJ9WjzH9p8MG8Nbv+nnt/wBcq8Lz617z+1M+5/DAIwR9pz/5Crwc104eu6tNTfU9zDu9NCGuw+EJx8StB/67N/6LeuP6V1/wiGfiRoI/6bN/6LauhF1fgfofXLAu2P4R1qxbxBsjGBTYUDHHc9KsNKYU5U/lXkZhjLS9nB2tv/keTKT2RasUSK/iCHlsg/lW3WFpSebdxzE8gEgfhW7XflE5TouUu+n3I83E/Egooor1TnCiiigAooooAKKKKACuav2X7dIW5IY/hzXS1zN2iPqE+/sx/wD114eefw4ep14T4mKUjKbg3I5FVpmy4z1/pUrWx2ko+BVQDMjZPQAV5eBoupWV9La+p3wS3uOtAdoI9avKUiTgYNRWijI7VLdxIflJB75FLF1nVqSqR6aEzkpSsyIRyR5duS3tXOeMtUcolhASkkgzIwUnAPQZBH1PtXVxjemWbIAzXmN6ftWrXbOud8rLyvUE45/Adc969PIsHGdV1ZbR/MSd3qYfijWRoWlK8C7r6clIEc5wepYg9h/UCvPbe2bc0tw7PK5LsxPLMepNN13Whf6zd6jOcxIxigX0QHj8+v1NVxqM8HlveWs8MMvMbSRlVcexI5qMyxM8VVfL8KOmCUUT6X+68V6WB/FeRD83Ar2K2la31K1l6BZAuT83BwM+ueSPSvHLNhJ4o0Nl/iu4j/4+teuzKHvUjVW3l19Tnlew5x+XvXqZHrTmmTV3PSUnDZXK7tx479amJfbgY5pkbKHJ4yDtJqe4ljZAFAzXyPRvmMJb6IqxxN8x83DH+H0p6PIQVYj0pjFmX5eSCMUSEu6YGwjris1JJaFWb3JLmBUhznJNQQtsIqUo4XJ+Zfaq6kM+3vXoYeHtaVSL92KSfzQ46qz1M3x8sf8AwjM5yNxaPbj13j+marXDbfhrKJCNrabtH4x4H8xWd8Qrne1npsbBGJ81ixAAHKrk+mS35VlfEDxJplp4bTSrC68/cUT5ATiNMH73QjhR+NdKozlhaaUXrJv0Wi19Tnw9p4rlv2X6m38KMR+HpJMDD3Tn64VR/Su0uZhJgKOe1eU6L4ludP0G0tLOzghdUy7ykuSWJY8DGOT6moLvXNUuCTLqE6j0iPlgf984P610RyTFVG+ZqKfzZGJx9J1ZSjd6nqk37qQM7KqdW3EADHvVa58R6LFHtlv7bcOySBj+Q5rxu4uYATLNKpx1ZzuOfrVU63ZDhHkc+iRk/wBK6IZFSpX9pV38kvzMFiatb+HC/wB7/I9WfxZpCSfJdyuvcLbufyJFLJ400tV+SK8c/wDXMD+bV5KdYBOUtLkj3XFIdXk7WUv/AH0KuOV5dBWcr/NfojRxx89qf4Hqn/Cc2Ayos73af9lP/i6dF4301X/497sDrkxr/Rq8n/tWfHFix+sgpv8AbF0D/wAg/wD8jD/Cn9Qy3+b8SlQzB/8ALs9cvvGWlToGEk6PxwYX9fYH3q1a+INJmIA1G3XP/PR9h/XFeLS6zcBTnTZfwlWpo9XyoL2VwntlTj9a6vq+DnQdL2n32f6GkaePirOl/X3nv8Jinh8y3mV16bkYMKdaEoAZBuJrwIapD1NtOD/uD+hq7a+JZbPHlX1/BjoMybR+HIrx5ZRRupUqy+f/AA4n9ZStOkz3C5VXOUyhpbSFm4d8t7DAryO3+IN6mA2oQT/9d4cf+g7a2tP+I0YCi4hhYgYLQzgk/wDATj+dcssqrRnzK0l5Nf8AAH7VqNpJr1TPQ5kCPjj2NR7vNUv8u5T0PrXPWnjDSLrDSXDwn0kjJ/Vcj9a14L+wuR/oV3b3B7+W4JH1xXFWw9aleU4NIuFSEtE7svQT4j+VcA+1RPsRTLKVCKCzFui+5rF1nxVpmkoy3E2+cDIgj+Z/x7D8SK5aKLXPGkqGfdp+ik7uP4x/Nz7nC1MKbqW53odMKDtzy0Xf/LuP8Q69P4rvhoegcWhP76c8Bhnr/uf+hfTr2uh6HFoumpBaBio5Zj1du7H3pdI0ay0y1S30+HainO48s59WPc1dmk8lWaU7UQFmycADvVVJ82ltOhNSqmlCnol+PqUda1U6dpNxcELuVdqbh1c8AfnWL4BspLfTpb6UEzXbbgzdSgzg/iST+VUDv8YeIUijyNItmyzHgMPX6t0HoOa7dgsL7IwNi8AAdBXdXUsHhlSb96dm/JdF+pwQaq1OZLRbf5ngP7UeTJ4aJ/6eeP8Av1XhVe9ftT4J8MFTnP2n/wBpV4JXZgVahH5/me/hnemhcV13wj4+JOgn0mb/ANFtXI113wj/AOSk6D/12f8A9FvXbDc0qfA/Q+wbbG7mpr6WNYXI4AXnNZE2raXaE/bdQtICBzvmVf0zWbJ438NxS86ks23osUbvz7YGK+exsant5xS3Z5Xs3KV0mdhpLo1zEU6Hpj6VvV5t4d8a6dqnimysrC2vCZS372RAijCMfXJ6elek17mUQlCi1Jdf0R5+MhKE1zK2gUUUV6pyBRRRQAUUUUAFFFFABXM30bPfS7RghzzXTV8y+PZLeTxnrKuzyMLlxtBZsc+leVm1FVYRTfU9LLKDrTkk7aHt86yRYBIOahyCzY696+dg0EJBDywHscslamna7qdsx+xaxdDB6NL5o/Js1wYXDxpRnKO7Vl5HtLL5W0kme+wRu25hjb1A9KCpfIPPfHqK8l034ga5ZgC5jtb6Lvx5T/mMj9K6zRviDot3Kq3jy6fKeMXC4X8GGR+eK8qWGkkrq5x1cLWp3bR2JmVQI1AyeMV57q9nNpururK2ySTfGRwGGScfhnnjJr0AS2t2I57SeOePBw8bBgfxFJd28F3bmO5VJYz1VhmvSy7HvA1JKesWcqaPlzR9KubHx5FbT2X2iOBpZ4wVyjhUYo3oRkL+PFdnrt5ZHwlqMl5FMHmsWaUzSmQTzlwsbqD0Ibd06BSK9L1mx0vRrGa/YOPIBdEL5BY9Bz71xnhnw/DrQNpehWhjs18xZEDqHaQumQfY/nXpUKmGkpunL3bPV9P6ua1JXpp/3l+rPN/hzYS3+sxX0q4trIZyQcM+PlGfbqfp717P4Zs2v9WWdlH2e3bcT1Bfngc9ec9OlaWn+Dbe1iEfnhLZRhYYUEYx6f8A1xitxY0tIo1gULEoxs/z3rOrmOHwOHdKhLmk+vQG+dmj9ljRdynk9RnrTTEoGcVCk0TdH69s1S1TxBpumoyXFwvm/wDPJfmf8h0/GvnoRVZ8tON35amMm4ayZoxyqmfk9qgf5n3bggHJJ6AVw+oeM7iRm/s+2WEEY8yb5m/75HA/M1zWp39zfNvv7p5R/dY4T/vkYH6V61DIMTVs6zUV97/D/M5p46nC/Jqz0HU/Fen2W6OGY3cg42wfMv8A310/WuWvvFl/O5+yLHaKQOR87/mRj9KoWujajcQmX7P9ntgMme5PlIB6884/CqdzeaHY5UTz6xcjgpbfuoR9X6n6g17WEw2X4Ryhfmdtev8AwPvJpLGYrSmrIZc3LSytNdzvLIfmLSNuOB/QVz0UDaxqxnuZre0s4wG33L7RsB4AHUlvTH8q1brXLq4t5beOG1sbKTh4bdOXH+255NZdpbm+u9tjayXlx6RIXx+PQVz4nMZNckI8qR7GCyd0FKpWlq9PTv8AM2JNT01HxC13fe8ai3T/AL6bcT/3yKpXN9POf3Udtax/7C+Y3/fT5wfpiuj0r4f6xfODfTQafH1Kj97J+nA/M109j4A0i0dTPHJfsOS1xIQAf90YBH4V5lbM5v45t+n/AALI0hQwGH+CPM/P/gnlUEQup9kMc99c+iq0rf1rct/CmvzBWGm+RGeAZ5VX9BkivZ7GOGytxFaQRQR44WJAq/pT9hkXHqc1wTxzlpBFvMJLSKSR5XD8P9edfnm05M/7bt/7KKs/8K31MIDJqdmv+7Ex/qK9GZJoMBG3KOxp0MpaTDkDArL67UejM3jK71UjzdPhnqL7v+JtbgA8Ytzz/wCPUz/hXF6r4fWYF9/sx/8Aiq9RkkcYEG3GOSSf5VD9mkmP7512+wrT29To/wAiVjaz1lLQ8sb4eXrlsaxCUXv9mPP/AI9Tm+Hl+pUf2rbnJxzbn/4qvUvJRHRVHCk49KguVKtlRyrZAruoV+ehKMdZpXNI42q3ZM82Pw91Zj+6vrFsf3ldf8ahuPAXiGMcLYS+mydh/NRXqcEyuxKnnqRViSQyYHOBXmxxs7O5LxteL3PEW8K+Ioyw/skyBeuydD+hIqpPoWqof3+g331W33/yzXurwMTvVip9hUXmypkPtOPrVrHzjpJGqx9SXZnz1cWsUDHz7OaAjrviZMfpTFNsGDJctx0BlIr6RhdCiliORniqt3YWl5xPa20o/wCmkSt/MVtHHWV7fiH19SdpwR8/xSMs6T21wquhyAUR1z64IIP410cHjLxJCgX7dBKAP+Wlsv8ATFelXngvw9cRnzdKtASefLTyz/47isOf4Y6RcHNlLdWzHoA5dfy6/rVqpSqtRnp6r/IJ46hPWULmDbfELxBAqgx6Y+O5icH/ANDqhrvjPWtYjEUyWkUP8Sxhhv8ATOT09q0dQ+G19bNi3kFyM4wkxRj+DcfrWHe+G7iyB+2R6jAB/E3K/wDfWCP1r0sPhIzkvYzjdba/ozkqYzA29+m9f67mnpnjbUdNsY7a1stPRVHLHflz3J561MfiFrmciDTQfdHP/s1c0NJiYZW7uSPUOD/Sp7bSoYjmUyXC+jyMp/Nf8K2nk1Wbc5JN+pCzLLoqyi7f15k2teJNR1koNQttKlCElQ1sW2564yxrGmXzhny7GMf9M7OMfzBrpoYNAAH2nR7n32X7t/PFaFvH4MjYE6DdnvmR9/P/AH8rn+p4ikrKm/lb/M2WZYDdRPO5tPtSP3zqP93an8gKqppmkRzLIkavMDwQSxr2KPUvCUQAh8PKpHf7LGT+ZNWP+Et02CPZZ6ZOgxjAWNB+jVdChiXUUfZu3cpZvho7RR5hZ6Vcz4NnpF5KD0ZbZsfmRW5Y+EPENwARpqwJ/emmVf0GTXUt40uAu2CwjX0Z5if0A/rVKfxTrE3CzxQr6RRD/wBmzW+IyzGSmuRK3m/8jKrn0VpD8ja8B+CNT03xJZaheXVpthLExRBmJyhH3jj19K9crxjwRe3F140043d1NMxL4EkhI+43QdB+Fez120MLLDR5Ju7ep41fGSxcueXoFFFFbGIUUUUAFFFFABRRRQAVwOp+ItHtdVuo3udsiSMrgRPwwPPb1rvq8S8Q6Hqkuv6nLFZF0e5kZT5qDILHB5aufEYOli0o1ZWt6fqXCpUg701c6e48U6NcoE+1RBe+9SP5is67Twrqj5nOlSsRg5ZA34HrXKSaLqy/e06X/gLo38mqvJpt+n39PvB9IWb+QNVhcpoUpOUal7+hvHGV6f2Lfebt54A0u5BfRtQltiei7vOj/InP61z154K8Q2pJFpFexdd1s4z+Ktg/lmq8sKxtmeAxMP8AnpGVI/MVZtb64iH+i31wntHOwH5A1lWySUZXpT07NfqdFPPa1PRo5x0awu9sn2nT7kc4+aBvr2rfsPF/iGywF1FLqEdBcxBz/wB9DBP51fbWNRli8q4uvPiPVJ4o5B/48prCvtMhuXLIFtnPU267Af8AgPT9K5ZZPVkves/69DrWeYappWpkmoa9e3959o1OM3SoMxRIQsat6lSeQPQnn1xwes8LeKND07T/AC57ueO6kYyzNPA3zsevIBrhv7NnTiO7DD0kT+opskF3EMtHC49Vkx/MVhVy6r7P2XJZeRu6+AryUue1tr6WPZE8VaJJbiRNUtmU/wAKyAt/3z1/Ss++8bWsYK6fbSXD9nk/dp/8V+gryZbC4uIzK2l3Txr1kSEuo/4EuarE28bbVnlhYdt7L+hrkw+Ew9GX76Lb7Xt/wfxCpgHWV6FVW/rzO51TW9Q1LIuLjZF/zzhGxfx7n8TVSw027vBmwtZJU/vKNqf99HiuS3qcE30pA5GZQalub97pRHdaldXK9Ajzs4+mM16/9oQpQ5cNTUf68t/vORZDVlK9WpodgYdLsWxrWqxiQf8ALrZ/vH+hIzj8h9ahl8WJZ5Tw7pMNn/09XX7yU/QZOPxJ+lY2leH9WvsDT9KmWM/8tZV8pPrk8n8M112mfDeWRg+r37le8Vqu0fi55P5CvLxGNlU/jTb8un3L9Ttp4LBYXV6s4fUb651O6X+0bu4vrlj8qMS3PoqDgfgK19L8Ia3qEgBt1sIcZ33B+bHsg5/PFeqaXo2maLFs02zihbGC4GXb6seTV6NDzn7x71tgmpxdWWiNnjmlakrI47SfAOl2zBrzzNRmHUzcRj6IOPzzXX20MMCrDAkcSqOEQBQB9BUqKFZVPQ9/WpgEOU2ZLc5rkxGZczcKSVvNbnDUqym/edxjRuoyrLk+lRkso+YEGrERWN9rg5Hb1pbjErZUYFc8MVBa1IRfy1M1LWzKe9M/eA/SpY7jYeCD9DQYd5wMZ96bs2vscbT3rvVLCYmnzQVrdt0V7rH+cXYE9KJikpwRlfenCDIyCMfSo3hZehOK5lhMJLRVH/XyEuW+hLA0UZJaMH6UNJuPy5Aqvkg8j8RUiuFPK5/GufE4GrQV1rHuv1Bx6jicSKACexx2pt0fmDNxninxOQ5bbx1oZ/tEhyNqg9KjA1PZT9rey6+f/BEtGVdibslQTTw20/LTnsf3m6OaVAedpII/UGp4bUuOtevJ4Gqm7K78tRuorXZC9w7KFzgelPidVjIYc0GEbtuQD05oa3IHB/KspvCVYKKlZLy/PQLx2IwibyxUFjVlpY9gCIQaqFXXvn2NKrH0P0rmqZdJQ58PLmX4jcbk+7PLHilt3ZVyAR+FRGTKbVTHvU/nbIiGXr3xXmfDKz0aIa0tYjk82d1MZxtOSSOvtS+cVIQhgT2HNTQEhiV5NQXRwd4HQim9I819RLV8tije6HaX7Brixt5B3O0B/wDvocj86yLnwRYvn7PNc2/sH3D/AMeBP611kM7KgCgEHvSsf3ZJ4NddHF1aMf3VRry6f5GM6cZv3oo4N/AU2CYdTiOOzwkfqG/pWfJ4O1JGws1mwzjJZh/7Ka9GjQuzccdjTSfKl+YcdPpXVHPMarXat6Iz+pUW9jzweD9W/iewA9fNf/4ilHg3UGzuubVR/s7m/oK9I3RMCX4PtVR3AO1eh5rswub4yrVjFNNddOgQwNJvZnFW/golsXGoEgf88oQv8ya3bDwVparmVJ7gjnMkpH6LgVqxnhn79R71cimKR91BHcU8zzSsqip8zS620NZYSlH4YkehabbWOpxraW8MSAE/IgXnB9OtdXXO6WJH1KOXOIyCMHqeDzXRVtk0nKjKUu/6I5cUkpJLsFFFFeucwUUUUAFFFFABRRRQAHpXL3sYN1L6lz/OuorAudn2uZW4JY814+cTnCEeSVtTrwjs2VDBsj3ZBoSNXOBwfrUjjnHmAimzbVQYbkd/SvnXVqKXPd/edqbZHLbFfmHNZt1Y2c5/0qyt5M93iVv5itiC4R48PwSO46Ux0DkgcivQp5hdctXVP70NPpNHPN4Z0eTIayVfQxOyfyIpq+D9HLcwzjPbz3/xrYI8tv8AZ9PSnBsnB4IrpqUcUkp4aq2u3MxSw9J68q+4zT4O0OMf8ezsf9qeQ/puqaDw/p1oVe3srVSDkMYxn8+tXh7kmnNLwAelefXjjpu1TmfzbQoUYw+FL7h0c7lceWy9ucUjwW8wxcQxyD0dQf50xpdxGAR9KQyZGCCfqKUcvrtc0rL1NOXtoQXGmaSy7RpliT6/Z0z/ACp9lbW1m2YLaGM/7EYH8qdubsoX6mlAc+/4VvTwPN79eol6MrlsrFiSZX5xg+1RF2wcscUzYSeRTXQD+EH2roo4PDOes+Z9roSiloKXGcLyamgGWG6oGYeXle/FTIDxjqK3zL3MPaO2g5bEk3zNhVzTjFnaS33Qe+OaRCS4x2qa5hxHk5BIyMGvnVHmvIxvZpFd2CjcOWIwPWrcSoEJkOFA71XXKKH27mwM4qSF1ulw+FU9jzVUdJa7insCplmKY4PFR3StKQSp3AYonVoW+TLD2PNEG+Xnaw9M1pSqyoz9zca094jikKR7ge/Iq3lZYuOTVWSL94ytnBGSO9G1VO6MkR/oKuvJKo3FaPp6jkk9UI4CuQ3T1pzRoUyjjNTII/Lbcfmqrs+b0HpWMqs4R5VLR+bGncVS6HI/MdKRX/ee/Xp1qTa3C4wDSvFjqOK5+V9Nh3XUJJGcAc1LEZI/mDcemKg2cDbgZ6U4yyYC4/I1cZOL5ne5LV1ZDtjSOWIx3p0U2HKuc4pdjhMnIHtUHlxliWyXI4Iq1eOwlZ7k1xHyWGMYqFBGxwTtNOjwDh2PHrTrpY2x5dWqko3nB28rjWmhC8eGO0gikaRtuGyQPanIhHQZP1p6xl8kjn2rB80231ZV11EhlKrleQe4o2mTd6mk8sZxgZ9aVS6HcmMfypK+iewtOhE8MkQ/dtx1wRRHKxkAkwAfrUhkZm5FLNiT5QuQRzSSW6Kv0ZLvUL8p+ao/LMhy7daSARxvjywQOlLIw3sQdo9K1vzWv9xFrPQW4WNFGzk96pMN0hGeAKkeQZ4OT2pqLgc9T1r6HLsM6cXUmrN9PI1iuVaiwklQR+FWmmyFQgA/zqnAcZjbgjp71NJITt3npxnFefm02qtrW037/wDDCnG7NPSiRPGo6ev4Vt1g6VIftca885/lW9XrZLK+Hfr+iPLxStMKKKK9c5wooooAKKKKACiiigArndSUNcSbCQ24544roqyLuwuJJJGQx4JJAJryM4o1K1KMacb6nRhpKMrtmfawux+dlz6KMU6eII21gD71ai066RV+aPdjB5P+FK2m3Ltl2jx9T/hXifUa3Lb2budbqx5r8xQP70FsLleMfSnw3CqhIHXuatnSZRkr5eTnJzinppsynny8emf/AK1CwWKTuosHVptbmVIu5d3Y1BIMAN3WtufTJWH7vyx68n/Cq39i3R3DdFgn+8f8K9nLqVWnTdOottjSFeHVmYDuck/dHGKmRWbohq9Ho1yv8UWc56n/AAqZ9NumA/1WR3yf8KzxU8ZGpalHT03HKvDozLC/OFPerIh2KGQbhj8aurpDAZyu/wBc01dMuhkbkC+zH/CvNqYbGVXzVYt/oZuvB7MpbDI2dvFIpEUoUnKjpWgumXAH3kH4mmHR5GbMhQ46cnrWSwGI3UHcPbQ6srzxq2GHTFVSwZMY+cHFaS6VcDI3oR7k099KcRgIU3ZzkmreBxLfMoNAq0I6XMJhhmHb71WI2KkkdxV06Ncls5i/76P+FPXSblT1jx/vH/CvTxlGvWw0bR97S6NJV6bW5RiLF/lUkY6+9PlaST92MgkdT2q9Bpt1F3i/M/4U8abPu3Fo8/WvIWAxFvgZm60L3ujMw9sgViWUDGT1x/WpIsCNcgHAxxWhLp08gAJQ/j/9aootLuVUBmjz3+Y/4U3gMQnpB2D20GtXqVmQhdxHHrT4ZGTkAemKvGznMJT93z71Cmm3CHOYz6jNafUa8JJxi/uI9rBrVlOZi0u48UwKyLtLHDc49K1Dp0hXBCZ+tRHS7gj7ycDA5pVMDiW78rZSrQ2uUIgu8Rr/AAip541SLcTzVqLTJI+gj/Omz6ZcTDBZFX2NJYHEKDTg22J1YOW5Si3Y3dV7VLcTLJGqgcirKafcoeDGR7mlOn3BbJ8r86awWIUXFQevkHtIXvcz0Pl8sOD+lSSbPlwPmq4dNndhv8vaOwJom02eR8gxgYxwaX1HEKNlB/cHtYN7ldpm8vYQKq7GcjacFTuyK000+ccMYyPXJofTZi2UKD8auWBxEtXFhGrCOzMx8E72OSoqxboHUZOARmp/7KlJBYxnHbNTGwmC/L5f5/8A1qilgMQnecGEq0GrJmbKNspVD83UVNDIIT84qUaVcBi29Cx9+lS/YLnbg+UfxP8AhRDBYmL5uRoJVINWuZz/ALyQ7e5zUsTKx2sMEcYq2NOuF6GLP1/+tUJ0m6MhcSRj2z1pLA4mLuoMftYPRsryx7HyBx1ohG9jx0q7/Z10y4do/wACaDpk64MbJkepqvqFe9+R2D2sbWuVLpBGAScg9agEZON3yj1rQm0u5lcEvGAOQM9aemn3CjBMZHuT/hQsFiVU54wa7Aq0UtzMaNB93n6U5Qq/K45PQ1ojTp85/dfmf8Kjn0u5kxho198nj9Kc8LjJ6yTY/bQejZQuLcbc44qBVK55zWwunXWMM0Rx7mm/2RKcncmfrXoYV4iC5KtNtfkUsRBKzZDoqbr1SBjaCev4f1roqzNNsJLadncrgrjg1p162EowowtBWT1scOJmpzugooorqOcKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the range of visible light and near infrared light (400 to 1200 nm), lasers that emit long wavelengths of light penetrate more deeply into the skin than lasers that emit shorter wavelengths of light.",
"    <br>",
"     Mid-infrared (eg, Er:YAG) and far-infrared (eg, CO",
"     <sub>",
"      2",
"     </sub>",
"     ) lasers do not follow this rule. Heavy absorption by water in the skin greatly limits the penetration of these lasers.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42871=[""].join("\n");
var outline_f41_55_42871=null;
var title_f41_55_42872="Enoxaparin: Pediatric drug information";
var content_f41_55_42872=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Enoxaparin: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"    see \"Enoxaparin: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?25/51/26421?source=see_link\">",
"    see \"Enoxaparin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708731\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F165076\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lovenox&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F165077\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Enoxaparin Injection;",
"     </li>",
"     <li>",
"      Lovenox&reg;;",
"     </li>",
"     <li>",
"      Lovenox&reg; HP",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1052533\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anticoagulant",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Low Molecular Weight Heparin (LMWH)",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11442390\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Initial therapy:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Chest",
"     </i>",
"     , 2008 recommendations (Monagle, 2008):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Prophylaxis: 0.75 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Treatment: 1.5 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Alternate dosing: Treatment:",
"     <b>",
"      Note:",
"     </b>",
"     Several recent studies suggest that doses higher than those recommended in the",
"     <i>",
"      Chest",
"     </i>",
"     guidelines are required in neonates (Malowany, 2007; Malowany, 2008; Sanchez de Toledo, 2010). Some centers are using the following; however, further studies are needed to validate these proposed higher initial doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Premature neonates: 2 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Full-term neonates: 1.7 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;\">",
"     <b>",
"      Maintenance therapy:",
"     </b>",
"     <i>",
"      Chest",
"     </i>",
"     , 2008 recommendations (Monagle, 2008): See",
"     <b>",
"      Dosage Titration",
"     </b>",
"     table:",
"     <b>",
"      Note:",
"     </b>",
"     In a prospective study of 177 courses of enoxaparin in pediatric patients (146 treatment courses; 31 prophylactic courses) considerable variation in maintenance dosage requirements was observed (Dix, 2000).",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Enoxaparin Dosage Titration",
"     </caption>",
"     <col align=\"left\" width=\"150\">",
"     </col>",
"     <col align=\"center\" width=\"180\">",
"     </col>",
"     <col align=\"center\" width=\"170\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Antifactor Xa",
"        </p>",
"       </th>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Dose Titration",
"        </p>",
"       </th>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Time to Repeat Antifactor Xa Level",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tfoot valign=\"top\">",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         Modified from Monagle P, Michelson AD, Bovill E, et al, &ldquo;Antithrombotic Therapy in Children,&rdquo;",
"         <i>",
"          Chest",
"         </i>",
"         , 2001, 119:344S-70S.",
"        </p>",
"       </td>",
"      </tr>",
"     </tfoot>",
"     <tbody valign=\"top\">",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         &lt;0.35 units/mL",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Increase dose by 25%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         4 h after next dose",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         0.35-0.49 units/mL",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Increase dose by 10%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         4 h after next dose",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         0.5-1 unit/mL",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Keep same dosage",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Next day, then 1 wk later, then monthly",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (4 h after dose)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         1.1-1.5 units/mL",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Decrease dose by 20%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Before next dose",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         1.6-2 units/mL",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Hold dose for 3 h",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         and decrease dose by 30%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Before next dose,",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         then 4 h after next dose",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         &gt;2 units/mL",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Hold all doses until",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         antifactor Xa is 0.5 units/mL,",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         then decrease dose by 40%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Before next dose and",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         every 12 h until",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         antifactor Xa &lt;0.5 units/mL",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1052526\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"      see \"Enoxaparin: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants and Children: SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Initial therapy:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Chest",
"     </i>",
"     , 2008 recommendations (Monagle, 2008):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants 1 to &lt;2 months:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Prophylaxis: 0.75 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Treatment: 1.5 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants &ge;2 months and Children &le;18 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Prophylaxis: 0.5 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Treatment: 1 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Alternate dosing: Treatment:",
"     <b>",
"      Note:",
"     </b>",
"     Several recent studies suggest that doses higher than those recommended in the",
"     <i>",
"      Chest",
"     </i>",
"     guidelines are required in pediatric patients (especially in young infants) (Bauman, 2009; Malowany, 2007; Malowany, 2008). Some centers are using the following; however, further studies are needed to validate these proposed higher initial doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     1 to &lt;3 months: 1.8 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     3-12 months: 1.5 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     1-5 years: 1.2 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     6-18 years: 1.1 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Maintenance therapy:",
"     </b>",
"     <i>",
"      Chest",
"     </i>",
"     , 2008 recommendations (Monagle, 2008): See",
"     <b>",
"      Dosage Titration",
"     </b>",
"     table:",
"     <b>",
"      Note:",
"     </b>",
"     In a prospective study of 177 courses of enoxaparin in pediatric patients (146 treatment courses; 31 prophylactic courses) considerable variation in maintenance dosage requirements was observed (Dix, 2000).",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Enoxaparin Dosage Titration",
"     </caption>",
"     <col align=\"left\" width=\"150\">",
"     </col>",
"     <col align=\"center\" width=\"180\">",
"     </col>",
"     <col align=\"center\" width=\"170\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Antifactor Xa",
"        </p>",
"       </th>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Dose Titration",
"        </p>",
"       </th>",
"       <th align=\"center\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         Time to Repeat Antifactor Xa Level",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tfoot valign=\"top\">",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         Modified from Monagle P, Michelson AD, Bovill E, et al, &ldquo;Antithrombotic Therapy in Children,&rdquo;",
"         <i>",
"          Chest",
"         </i>",
"         , 2001, 119:344S-70S.",
"        </p>",
"       </td>",
"      </tr>",
"     </tfoot>",
"     <tbody valign=\"top\">",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         &lt;0.35 units/mL",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Increase dose by 25%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         4 h after next dose",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         0.35-0.49 units/mL",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Increase dose by 10%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         4 h after next dose",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         0.5-1 unit/mL",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Keep same dosage",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Next day, then 1 wk later, then monthly",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (4 h after dose)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         1.1-1.5 units/mL",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Decrease dose by 20%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Before next dose",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         1.6-2 units/mL",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Hold dose for 3 h",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         and decrease dose by 30%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Before next dose,",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         then 4 h after next dose",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         &gt;2 units/mL",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Hold all doses until",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         antifactor Xa is 0.5 units/mL,",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         then decrease dose by 40%",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Before next dose and",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         every 12 h until",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         antifactor Xa &lt;0.5 units/mL",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Adults:",
"     <b>",
"      Note:",
"     </b>",
"     Consider lower doses for patients &lt;45 kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <span style=\"text-decoration: underline\">",
"       Prevention",
"      </span>",
"     </b>",
"     <b>",
"      of DVT:",
"     </b>",
"     SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Knee replacement surgery: 30 mg every 12 hours; give first dose 12-24 hours after surgery (provided hemostasis has been established); average duration 7-10 days, up to 14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Hip replacement surgery: Initial phase: 30 mg every 12 hours with first dose 12-24 hours after surgery (provided hemostasis has been established) or consider 40 mg once daily with first dose given 12 &plusmn; 3 hours prior to surgery; average duration of initial phase: 7-10 days, up to 14 days; after initial phase, give 40 mg once daily for 3 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Abdominal surgery in patients at risk: 40 mg once daily; give first dose 2 hours prior to surgery; average duration: 7-10 days, up to 12 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Medical patients at risk due to severely restricted mobility during acute illness: 40 mg once daily; average duration: 6-11 days, up to 14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <span style=\"text-decoration: underline\">",
"       Treatment",
"      </span>",
"     </b>",
"     <b>",
"      of acute DVT and pulmonary embolism:",
"     </b>",
"     SubQ:",
"     <b>",
"      Note:",
"     </b>",
"     Initiate warfarin therapy on the same day of starting enoxaparin; continue enoxaparin for a minimum of 5 days (average 7 days) until INR is therapeutic (between 2 and 3) for 24 hours (Kearon, 2008).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Inpatient treatment of acute DVT with or without pulmonary embolism: 1 mg/kg every 12 hours or 1.5 mg/kg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Outpatient treatment of acute DVT without pulmonary embolism: 1 mg/kg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <span style=\"text-decoration: underline\">",
"       Prevention",
"      </span>",
"     </b>",
"     <b>",
"      of ischemic complications of non-Q-wave MI or unstable angina:",
"     </b>",
"     SubQ: 1 mg/kg every 12 hours in conjunction with oral aspirin (100-325 mg once daily); continue treatment for a minimum of 2 days until patient is clinically stabilized (usually 2-8 days; up to 12.5 days)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <span style=\"text-decoration: underline\">",
"       Treatment",
"      </span>",
"      of acute ST-segment elevation myocardial infarction (STEMI):",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     Optimal duration is not defined; in the major clinical trial, therapy was continued for 8 days or until hospital discharge; optimal duration may be &gt;8 days.  All patients should receive aspirin (75-325 mg once daily) as soon as they are identified as having STEMI.  In patients with STEMI receiving thrombolytics, initiate enoxaparin dosing between 15 minutes before and 30 minutes after fibrinolytic therapy. In patients undergoing percutaneous coronary intervention (PCI), if balloon inflation occurs &le;8 hours after the last SubQ enoxaparin dose, no additional dosing is needed. If balloon inflation occurs 8-12 hours after last SubQ enoxaparin dose, a single I.V. dose of 0.3 mg/kg should be administered (Hirsh, 2008; King, 2007).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Adults &lt;75 years of age:",
"     </i>",
"     Initial: 30 mg single I.V. bolus",
"     <b>",
"      plus",
"     </b>",
"     1 mg/kg (maximum: 100 mg/dose for the first 2 doses only) SubQ every 12 hours. The first SubQ dose should be administered with the I.V. bolus. Maintenance: After first 2 doses, administer 1 mg/kg SubQ every 12 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Adults &ge;75 years of age:",
"     </i>",
"     Dosage adjustment required; see package insert",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &ge;30 mL/minute: No specific adjustment recommended; monitor patients closely for bleeding",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute:",
"     <b>",
"      Note:",
"     </b>",
"     Monitor antifactor Xa activity closely. Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     DVT prophylaxis in abdominal surgery, hip replacement, knee replacement, or in medical patients during acute illness: SubQ: 30 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     DVT treatment in conjunction with warfarin (in inpatients with or without pulmonary embolism and in outpatients without pulmonary embolism): SubQ: 1 mg/kg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Prevention of ischemic complications of non-Q-wave MI or unstable angina (with aspirin): SubQ: 1 mg/kg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Treatment of STEMI:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Adults &lt;75 years: Initial: 30 mg single I.V. bolus",
"     <b>",
"      plus",
"     </b>",
"     1 mg/kg SubQ (administered at the same time as the I.V. bolus); maintenance: SubQ: 1 mg/kg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Adults &ge;75 years: See package insert",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"     Dosage adjustment not established; use with caution in patients with hepatic impairment",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F165050\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as sodium: 100 mg/mL (3 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lovenox&reg;: 100 mg/mL (3 mL) [contains benzyl alcohol; vial]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as sodium [preservative free]: 30 mg/0.3 mL (0.3 mL); 40 mg/0.4 mL (0.4 mL); 60 mg/0.6 mL (0.6 mL); 80 mg/0.8 mL (0.8 mL); 100 mg/mL (1 mL); 120 mg/0.8 mL (0.8 mL); 150 mg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lovenox&reg;: 30 mg/0.3 mL (0.3 mL); 40 mg/0.4 mL (0.4 mL); 60 mg/0.6 mL (0.6 mL); 80 mg/0.8 mL (0.8 mL); 100 mg/mL (1 mL); 120 mg/0.8 mL (0.8 mL); 150 mg/mL (1 mL) [prefilled syringe]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F165035\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1052538\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: Do not administer I.M. For SubQ use, administer by deep SubQ injection; do not rub injection site after SubQ administration as bruising may occur. When administering 30 mg or 40 mg SubQ from a commercially prefilled syringe, do not expel the air bubble from the syringe prior to injection (in order to avoid loss of drug). I.V. administration is indicated as part of treatment of STEMI only; flush I.V. access with NS or D",
"     <sub>",
"      5",
"     </sub>",
"     W before and after enoxaparin I.V. bolus administration (to clear drug from port)",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F165124\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS; do not mix with other injections or infusions.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1052529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 25&deg;C (77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F). Prefilled syringes do not contain preservatives, discard unused portions; multidose vials should be discarded within 28 days after first use. For SubQ use, do not mix with other injections or infusions. For I.V. use (treatment of acute STEMI only), multidose vials may be mixed with NS or D",
"     <sub>",
"      5",
"     </sub>",
"     W; do not mix with other drugs.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1052537\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prophylaxis and treatment of thromboembolic disorders, specifically prevention of DVT following hip or knee replacement surgery, abdominal surgery in patients at thromboembolic risk (ie, &gt;40 years of age, obese, general anesthesia &gt;30 minutes, malignancy, history of DVT, or pulmonary embolism), and in medical patients at thromboembolic risk due to severely restricted mobility during acute illness (FDA approved in adults). Administered with warfarin: For inpatient treatment of acute DVT (with or without pulmonary embolism) and outpatient treatment of acute DVT (without pulmonary embolism) (FDA approved in adults). Administered with aspirin: For prevention of ischemic complications of non-Q-wave MI and unstable angina and for the treatment of acute ST-segment elevation myocardial infarction (STEMI) (FDA approved in adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F165126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Lovenox&reg; may be confused with Lasix&reg;, Levaquin&reg;, Lotronex&reg;, Protonix&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      National Patient Safety Goals:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Joint Commission (TJC) requires healthcare organizations that provide anticoagulant therapy to have a process in place to reduce the risk of anticoagulant-associated patient harm. Patients receiving anticoagulants should receive individualized care through a defined process that includes standardized ordering, dispensing, administration, monitoring and education. This does not apply to routine short-term use of anticoagulants for prevention of venous thromboembolism when the expectation is that the patient&rsquo;s laboratory values will remain within or close to normal values (NPSG.03.05.01).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F165123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As with all anticoagulants, bleeding is the major adverse effect of enoxaparin. Hemorrhage may occur at virtually any site. Risk is dependent on multiple variables. At the recommended doses, single injections of enoxaparin do not significantly influence platelet aggregation or affect global clotting time (ie, PT or aPTT).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Central nervous system: Confusion, fever, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Bruising",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Hemorrhage (major; includes cases of intracranial, retroperitoneal, or intraocular hemorrhage; incidence varies with indication/population), thrombocytopenia (see \"",
"     <b>",
"      Note",
"     </b>",
"     \" below),  anemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: ALT increased, AST increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site hematoma, local reactions (irritation, pain, ecchymosis, erythema)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Hematuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Allergic reaction, anaphylactic reaction, anaphylactoid reaction, cutaneous vasculitis (hypersensitive), eczematous plaques, hematoma (see note on \"Spinal or epidural hematomas\" below), hyperkalemia, hyperlipidemia (very rare), hypertriglyceridemia, intracranial hemorrhage (up to 0.8%), erythematous pruritic patches, pruritus, purpura, retroperitoneal bleeding, skin necrosis, thrombocytopenia with thrombosis, thrombocytosis, urticaria, vesicobullous rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Spinal or epidural hematomas: Can occur following neuraxial anesthesia or spinal puncture, resulting in paralysis. Risk is increased in patients with indwelling epidural catheters or concomitant use of other drugs affecting hemostasis. Prosthetic valve thrombosis, including fatal cases, has been reported in pregnant women receiving enoxaparin as thromboprophylaxis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Thrombocytopenia with thrombosis: Cases of heparin-induced thrombocytopenia (some complicated by organ infarction, limb ischemia, or death) have been reported.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1052542\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to enoxaparin, heparin, any component, or pork products (enoxaparin is derived from porcine intestinal mucosa); active major bleeding; acute heparin-induced or low molecular weight heparin-induced thrombocytopenia",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1052525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with uncontrolled arterial hypertension, bleeding diathesis, pregnancy, history of recent GI ulceration, diabetic retinopathy, and hemorrhage. Use with caution in patients with renal impairment; decrease dose in patients with severe renal dysfunction (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute). Use with caution and monitor carefully in low-weight patients (ie, women &lt;45 kg and men &lt;57 kg) receiving nonweight-adjusted doses (an increase in enoxaparin AUC has been reported). Institute appropriate therapy if thromboembolism occurs despite enoxaparin prophylaxis",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1052524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Bleeding or thrombocytopenia may occur; major hemorrhages (eg, intracranial and retroperitoneal bleeding) may be fatal; thrombocytopenia with thrombosis may occur and may be complicated by limb ischemia, organ infarction, or death; discontinue therapy and consider alternative treatment if platelets are &lt;100,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     and/or thrombosis develops. Use with extreme caution in patients with an increased risk of hemorrhage (eg, active GI ulceration or bleeding, angiodysplastic GI disease, bacterial endocarditis, bleeding disorders, hemorrhagic stroke); recent brain, spinal, or ophthalmic surgery; concomitant platelet inhibitor therapy; or a history of heparin-induced thrombocytopenia. Do not use unit-for-unit in place of heparin or other low molecular weight heparins (units are not equivalent). Enoxaparin is",
"     <b>",
"      not",
"     </b>",
"     recommended for prophylaxis of thromboembolic disorders in patients with prosthetic heart valves, especially pregnant women (prosthetic heart valve thrombosis may occur; several cases occurred in pregnant women and resulted in maternal and fetal deaths; pregnant women with prosthetic heart valves may be at a higher risk for thromboembolism; use with extreme caution and monitor peak and trough anti-Factor Xa levels frequently in these patients; adjust dosage accordingly)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Epidural or spinal hematoma resulting in long-term or permanent paralysis may occur in patients receiving low molecular weight heparins or heparinoids during epidural/spinal anesthesia or spinal puncture",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; these patients must be monitored frequently for neurological impairment and treated immediately if compromised. The risk of epidural/spinal hematoma is increased with the following: The use of indwelling epidural catheters for analgesia; concomitant use of platelet inhibitors, NSAIDs, or other anticoagulants; history of spinal deformity or spinal surgery; and repeated or traumatic epidural/spinal puncture. Potential benefits must be weighed against the risks. Enoxaparin should be withheld (at least 2 doses) and antifactor Xa activity should be determined (if possible), prior to lumbar or epidural procedures.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     To minimize the risk of bleeding following percutaneous coronary revascularization procedures (eg, vascular instrumentation during treatment of unstable angina, non-Q-wave MI and acute STEMI), strictly adhere to the recommended dosing intervals. Hemostasis must be achieved at the puncture site after percutaneous coronary interventions (PCI). See product labeling for further information. Cases of hyperkalemia have been reported, usually in patients with risk factors for the development of hyperkalemia (eg, renal dysfunction, concomitant use of potassium-sparing diuretics or potassium supplements, hematoma in body tissues); monitor serum potassium.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Enoxaparin multidose vial contains benzyl alcohol which may cause allergic reactions in susceptible individuals; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse; avoid use of enoxaparin products containing benzyl alcohol in neonates; use the preservative free injection;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate, a metabolite of benzyl alcohol, displaces bilirubin from protein binding sites. Use multidose vial with caution in pregnant women and only if clearly needed (benzyl alcohol may cross the placenta).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299264\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F165044\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     5-ASA Derivatives: May enhance the adverse/toxic effect of Heparin (Low Molecular Weight). Specifically, the risk for bleeding/bruising may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: May enhance the anticoagulant effect of other Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Apixaban: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Collagenase (Systemic): Anticoagulants may enhance the adverse/toxic effect of Collagenase (Systemic). Specifically, the risk of injection site bruising and/or bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Anticoagulants may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Drotrecogin Alfa (Activated): Heparin (Low Molecular Weight) may enhance the adverse/toxic effect of Drotrecogin Alfa (Activated). Bleeding may occur.  Management: Potential benefits of therapeutic doses of LMW heparins should be weighed against an increased risk of bleeding in patients who receive drotrecogin alfa.  In patients receiving prophylactic LMW heparin doses consider continuing this during drotrecogin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Anticoagulants. Bleeding may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ibritumomab: Anticoagulants may enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to an increased risk of bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omacetaxine: Anticoagulants may enhance the adverse/toxic effect of Omacetaxine. Specifically, the risk for bleeding-related events may be increased.  Management: Avoid concurrent use of anticoagulants with omacetaxine in patients with a platelet count of less than 50,000/uL.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omega-3 Fatty Acids: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Palifermin: Heparin (Low Molecular Weight) may increase the serum concentration of Palifermin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentosan Polysulfate Sodium: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the anticoagulant effect of Heparin (Low Molecular Weight).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the adverse/toxic effect of Anticoagulants. Specifically, the antiplatelet effects of these agents may lead to an increased risk of bleeding with the combination.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Anticoagulants may enhance the anticoagulant effect of Rivaroxaban.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: May enhance the anticoagulant effect of Anticoagulants. Management: See full drug monograph for guidelines for the use of alteplase for acute ischemic stroke during treatment with oral anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tositumomab and Iodine I 131 Tositumomab: Anticoagulants may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse effects may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin E: May enhance the anticoagulant effect of Anticoagulants. Vitamin E may also increase the overall risk for bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F165046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F165060\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. Low molecular weight heparin (LMWH) does not cross the placenta; increased risks of fetal bleeding or teratogenic effects have not been reported.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     LMWH is recommended over unfractionated heparin for the treatment of acute venous thromboembolism (VTE) in pregnant women. LMWH is also recommended over unfractionated heparin for VTE prophylaxis in pregnant women with certain risk factors (eg, homozygous factor V Leiden, antiphospholipid antibody syndrome with &ge;3 previous pregnancy losses). Prophylaxis is not routinely recommended for women undergoing assisted reproduction therapy; however, LMWH therapy is recommended for women who develop severe ovarian hyperstimulation syndrome. LMWH should be discontinued at least 24 hours prior to induction of labor or a planned cesarean delivery. For women undergoing cesarean section and who have additional risk factors for developing VTE, the prophylactic use of LMWH may be considered.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     LMWH may also be used in women with mechanical heart valves (consult current ACCP guidelines for details). Women who require long-term anticoagulation with warfarin and who are considering pregnancy, LMWH substitution should be done prior to conception when possible. When choosing therapy, fetal outcomes (ie, pregnancy loss, malformations), maternal outcomes (ie, VTE, hemorrhage), burden of therapy, and maternal preference should be considered (Guyatt, 2012). Monitoring antifactor Xa levels is recommended.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Multiple-dose vials contain benzyl alcohol (avoid in pregnant women due to association with gasping syndrome in premature infants); use of preservative-free formulations is recommended.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1052532\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC with platelets, stool occult blood tests, serum creatinine and potassium; antifactor Xa activity in select patients (eg, neonates, infants, children, obese patients, and patients with significant renal impairment, active bleeding, or abnormal coagulation parameters);",
"     <b>",
"      Note",
"     </b>",
"     : Routine monitoring of PT and APTT is not warranted since PT and APTT are relatively insensitive measures of low molecular weight heparin activity; consider monitoring bone density in infants and children with long-term use",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1052536\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antifactor Xa:",
"     <b>",
"      Note:",
"     </b>",
"     The following are suggested peak values of antifactor Xa. Once daily dosing in pediatric patients is not feasible due to faster enoxaparin clearance and lower drug exposure in pediatric patients compared to adults (O&rsquo;Brien, 2007).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Therapeutic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neonates and Children: 0.5-1.0 units/mL, measured 4-6 hours after SubQ administration",
"     <b>",
"      or",
"     </b>",
"     0.5-0.8 units/mL, measured 2-6 hours after SubQ administration (Monagle, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Once-daily dosing: &gt;1 anti-Xa units/mL (Garcia, 2012); the manufacturer recommends a range of 1-2 anti-Xa units/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Twice-daily dosing: 0.6-1 anti-Xa units/mL (Garcia, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prophylactic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children: Prevention of central venous access device related DVT: 0.1-0.3 units/mL (Monagle, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults: 0.2-0.4 units/mL (Nutescu, 2009)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1052523\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Potentiates the action of antithrombin III and inactivates coagulation factor Xa; also inactivates factor IIa (thrombin), but to a much lesser degree; ratio of antifactor Xa to antifactor IIa activity is &sim;4:1 (ratio for unfractionated heparin is 1:1)",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1052540\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antifactor Xa and antithrombin (antifactor IIa) activities:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect: SubQ: 3-5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: &sim;12 hours following a 40 mg daily dose given SubQ",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1052541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Based on antifactor Xa activity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Does not cross the placental barrier",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mean V",
"     <sub>",
"      d",
"     </sub>",
"     : Adults: 4.3 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Does not bind to most heparin binding proteins",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Primarily in the liver via desulfation and depolymerization to lower molecular weight molecules with very low biological activity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Adults: SubQ: &sim;100%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: SubQ: Adults: Single dose: 4.5 hours; repeat dosing: 7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: 40% of I.V. dose is excreted in urine as active and inactive fragments; 10% of dose is excreted by kidneys as active enoxaparin fragments; 8% to 20% of antifactor Xa activity is recovered within 24 hours in the urine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Clearance: Decreased by 30% in patients with Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F5629883\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?25/51/26421?source=see_link\">",
"      see \"Enoxaparin: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enoxaparin may increase the time it takes to stop bleeding; report any unusual bleeding or bruising to prescriber. Inform physicians and dentists you are taking enoxaparin, especially before any surgery is scheduled. Report the use of other medication, nonprescription medications, and herbal or natural products to your physician and pharmacist; do not take any new medications or products without consulting prescriber.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     If you had an epidural or spinal anesthesia or spinal puncture (lumbar puncture), contact physician immediately if you develop tingling or numbness (especially in the lower limbs) or muscular weakness.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1052543\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Each 10 mg of enoxaparin sodium equals &sim;1000 international units of antifactor Xa activity.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Enoxaparin contains fragments of unfractionated heparin produced by alkaline degradation (depolymerization) of heparin benzyl ester; enoxaparin has mean molecular weights of 3500-5600 daltons, which are much lower than mean molecular weights of unfractionated heparin (12,000-15,000 daltons). Low molecular weight heparins (LMWH) have several advantages over unfractionated heparin: Better SubQ bioavailability, more convenient administration (SubQ versus I.V.), longer half-life (longer dosing interval), more predictable pharmacokinetics and pharmacodynamic (anticoagulant) effect, less intensive laboratory monitoring, reduced risk of heparin-induced thrombocytopenia, potential for outpatient use, and probable reduced risk of osteoporosis (further studies are needed).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Accidental overdosage of enoxaparin may be treated with protamine sulfate; 1 mg protamine sulfate neutralizes 1 mg enoxaparin; first dose of protamine sulfate should equal the dose of enoxaparin injected, if enoxaparin was given in the previous 8 hours; use 0.5 mg protamine sulfate per 1 mg enoxaparin if enoxaparin was given &gt;8 hours prior to protamine or if a second dose of protamine is needed; a second dose of protamine sulfate (0.5 mg per 1 mg enoxaparin) may be given if APTT remains prolonged 2-4 hours after first dose; protamine may not be required &ge;12 hours after enoxaparin administration; avoid overdosage with protamine",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Some centers dispense pediatric doses in an insulin syringe for greater delivery accuracy and to avoid errors associated with dilutions. Each 1 unit on a 30, 50, or 100 unit graduated insulin syringe is 0.01 mL; using a",
"     <b>",
"      100 mg/mL",
"     </b>",
"     enoxaparin injection, each \"1 unit\" on the insulin syringe would provide 1 mg of enoxaparin (Bauman, 2009a).",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bauman ME, Belletrutti MJ, Bajzar L, et al, \"Evaluation of Enoxaparin Dosing Requirements in Infants and Children. Better Dosing to Achieve Therapeutic Levels,\"",
"      <i>",
"       Thromb Haemost",
"      </i>",
"      , 2009, 101(1):86-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/19132193/pubmed\" id=\"19132193\" target=\"_blank\">",
"        19132193",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bauman ME, Black KL, Bauman ML, \"Novel Uses of Insulin Syringes to Reduce Dosing Errors: A Retrospective Chart Review of Enoxaparin Whole Milligram Dosing,\"",
"      <i>",
"       Thromb Res",
"      </i>",
"      , 2009a, 123(6):845-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/19038418/pubmed\" id=\"19038418\" target=\"_blank\">",
"        19038418",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bontadelli J, Moeller A, Schmugge M, et al, \"Enoxaparin Therapy for Arterial Thrombosis in Infants With Congenital Heart Disease,\"",
"      <i>",
"       Intensive Care Med",
"      </i>",
"      , 2007, 33(11):1978-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/17554520/pubmed\" id=\"17554520\" target=\"_blank\">",
"        17554520",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      deVeber G, Chan A, Monagle P, et al, &ldquo;Anticoagulation Therapy in Pediatric Patients With Sinovenous Thrombosis: A Cohort Study,&rdquo;",
"      <i>",
"       Arch Neurol",
"      </i>",
"      , 1998, 55(12):1533-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/9865797 /pubmed\" id=\"9865797 \" target=\"_blank\">",
"        9865797",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dix D, Andrew M, Marzinotto V, et al, &ldquo;The Use of Low Molecular Weight Heparin in Pediatric Patients: A Prospective Cohort Study,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2000, 136(4):439-45.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/10753240/pubmed\" id=\"10753240\" target=\"_blank\">",
"        10753240",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dunaway KK, Gal P, and Ransom JL, \"Use of Enoxaparin in a Preterm Infant,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2000, 34(12):1410-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/11144698/pubmed\" id=\"11144698\" target=\"_blank\">",
"        11144698",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hirsh J, Guyatt G, Albers GW, et al, &ldquo;Executive Summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition),&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2008, 133(6 Suppl):71-109.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/18574259/pubmed\" id=\"18574259\" target=\"_blank\">",
"        18574259",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hirsh J, Warkentin TE, Shaughnessy SG, et al, &ldquo;Heparin and Low-Molecular-Weight Heparin: Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2001, 119:64S-94S.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/11157643/pubmed\" id=\"11157643\" target=\"_blank\">",
"        11157643",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kearon C, Kahn SR, Agnelli G, et al, \"Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition),\"",
"      <i>",
"       Chest",
"      </i>",
"      , 2008, 33(6 Suppl):454-545.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/18574272/pubmed\" id=\"18574272\" target=\"_blank\">",
"        18574272",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      King SB 3rd, Smith SC Jr, Hirshfeld JW JR, et al, &ldquo;2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2008, 117(2):261-95.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/18079354/pubmed\" id=\"18079354\" target=\"_blank\">",
"        18079354",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Malowany JI, Knoppert DC, Chan AK, et al, \"Enoxaparin Use in the Neonatal Intensive Care Unit: Experience Over 8 Years,\"",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2007, 27(9):1263-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/17723080/pubmed\" id=\"17723080\" target=\"_blank\">",
"        17723080",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Malowany JI, Monagle P, Knoppert DC, et al, \"Enoxaparin for Neonatal Thrombosis: A Call for a Higher Dose for Neonates,\"",
"      <i>",
"       Thromb Res",
"      </i>",
"      , 2008, 122(6):826-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/18207492/pubmed\" id=\"18207492\" target=\"_blank\">",
"        18207492",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Martineau P and Tawil N, &ldquo;Low-Molecular-Weight Heparins in the Treatment of Deep-Vein Thrombosis,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1998, 32(5):588-98, 601.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/9606481/pubmed\" id=\"9606481\" target=\"_blank\">",
"        9606481",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Massicotte P, Adams M, Marzinotto V, et al, &ldquo;Low-Molecular-Weight Heparin in Pediatric Patients With Thrombotic Disease: A Dose Finding Study,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1996, 128(3):313-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/8774496 /pubmed\" id=\"8774496 \" target=\"_blank\">",
"        8774496",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Michaels LA, Gurian M, Hegyi T, et al, \"Low Molecular Weight Heparin in the Treatment of Venous and Arterial Thromboses in the Premature Infant,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2004, 114(3):703-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/15342842/pubmed\" id=\"15342842\" target=\"_blank\">",
"        15342842",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Monagle P, Chalmers E, Chan A, et al, \"Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition),\"",
"      <i>",
"       Chest",
"      </i>",
"      , 2008, 133(6 Suppl):887S-968S.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/18574281/pubmed\" id=\"18574281\" target=\"_blank\">",
"        18574281",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Monagle P, Michelson AD, Bovill E, et al, &ldquo;Antithrombotic Therapy in Children,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2001, 119:344S-70S.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/11157659/pubmed\" id=\"11157659\" target=\"_blank\">",
"        11157659",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nutescu EA, Spinler SA, Wittkowsky A, et al, \"Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2009, 43(6):1064-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/19458109/pubmed\" id=\"19458109\" target=\"_blank\">",
"        19458109",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      O'Brien SH, Lee H, and Ritchey AK, \"Once-Daily Enoxaparin in Pediatric Thromboembolism: A Dose Finding and Pharmacodynamics/Pharmacokinetics Study,\"",
"      <i>",
"       J Thromb Haemost",
"      </i>",
"      , 2007, 5(9):1985-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/17596139/pubmed\" id=\"17596139\" target=\"_blank\">",
"        17596139",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sanchez de Toledo J, Gunawardena S, Munoz R, et al, \"Do Neonates, Infants and Young Children Need a Higher Dose of Enoxaparin in the Cardiac Intensive Care Unit?\"",
"      <i>",
"       Cardiol Young",
"      </i>",
"      , 2010, 20(2):138-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/55/42872/abstract-text/20199704/pubmed\" id=\"20199704\" target=\"_blank\">",
"        20199704",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13270 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-62E4DD783C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42872=[""].join("\n");
var outline_f41_55_42872=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708731\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F165076\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F165077\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052533\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11442390\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052526\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F165050\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F165035\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052538\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F165124\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052529\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052537\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F165126\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F165123\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052542\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052525\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052524\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299264\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F165044\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F165046\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F165060\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052532\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052536\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052523\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052540\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052541\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5629883\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1052543\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13270\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13270|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=related_link\">",
"      Enoxaparin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?25/51/26421?source=related_link\">",
"      Enoxaparin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_55_42873="Radiation techniques for locally advanced breast cancer";
var content_f41_55_42873=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Radiation techniques for locally advanced breast cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/55/42873/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/55/42873/contributors\">",
"     Moataz N El-Ghamry, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/55/42873/contributors\">",
"     Alphonse Taghian, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/55/42873/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/55/42873/contributors\">",
"     Lori J Pierce, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/55/42873/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/55/42873/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/55/42873/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 14, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Locally advanced breast cancer (LABC) constitutes a wide variety of clinical presentations including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Large tumors (&gt;5 cm)",
"     </li>",
"     <li>",
"      Extensive regional lymph node involvement",
"     </li>",
"     <li>",
"      Direct involvement of the skin or underlying chest wall",
"     </li>",
"     <li>",
"      Tumors considered inoperable but without distant metastasis (including supraclavicular lymph nodes)",
"     </li>",
"     <li>",
"      Inflammatory breast cancer (IBC)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the TNM staging classification (",
"    <a class=\"graphic graphic_table graphicRef65393 \" href=\"mobipreview.htm?29/14/29920\">",
"     table 1",
"    </a>",
"    ), LABC is represented by stage IIIA (T0 N2;",
"    <span class=\"nowrap\">",
"     T1/2",
"    </span>",
"    N2; T3",
"    <span class=\"nowrap\">",
"     N1/2),",
"    </span>",
"    stage IIIB (T4 N0-2) and stage IIIC (any T N3) disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/1\">",
"     1",
"    </a>",
"    ]. IBC constitutes T4d primary tumor designation, and therefore, stage IIIB disease.",
"   </p>",
"   <p>",
"    Although a combined modality regimen employing combinations of systemic and locoregional therapy has become the treatment of choice for LABC, the optimal sequencing of the individual components remains unproven. However, at most institutions, neoadjuvant chemotherapy followed by surgery and radiation therapy (RT) has become the standard of care. Here we will discuss the techniques and complications of radiation therapy for LABC, including IBC. The epidemiology, clinical presentation, and benefits of combined modality therapy, particularly neoadjuvant chemotherapy, are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/46/19177?source=see_link&amp;anchor=H528513711#H528513711\">",
"     \"Overview of the treatment of newly diagnosed, non-metastatic breast cancer\", section on 'Locally advanced breast cancer'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/20/31048?source=see_link\">",
"     \"Inflammatory breast cancer: Clinical features and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RATIONALE FOR POSTMASTECTOMY RADIATION THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of adjuvant RT following mastectomy is the sterilization of subclinical disease within the chest wall and peripheral lymphatics in high-risk patients. This topic is discussed in greater detail elsewhere; here we will summarize the available data with particular attention to LABC. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/3/41017?source=see_link\">",
"     \"Postmastectomy chest wall irradiation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Risk factors for locoregional recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The size of the primary tumor, invasion of the pectoral fascia, the number of involved lymph nodes, and number of lymph nodes examined are independent predictors for locoregional recurrence (LRR) following mastectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/3/41017?source=see_link&amp;anchor=H4#H4\">",
"     \"Postmastectomy chest wall irradiation\", section on 'Risk factors for locoregional recurrence'",
"    </a>",
"    .) As an example, one report from the Eastern Cooperative Oncology Group (ECOG) included 2016 patients undergoing mastectomy and adjuvant chemotherapy but without RT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/2\">",
"     2",
"    </a>",
"    ]. The 10-year risk of LRR with T3 versus T1-2 lesions was significantly higher for women with both one to three positive nodes (31 versus 12 percent) and four to seven positive nodes (45 versus 20 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/2\">",
"     2",
"    </a>",
"    ]. In multivariate analysis, larger tumor size, higher number of involved nodes, negative estrogen receptors and fewer nodes examined predicted for a higher LRR rate, with or without simultaneous distant failure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Sites of locoregional recurrence following mastectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common sites of LRR following mastectomy are the chest wall and the",
"    <span class=\"nowrap\">",
"     supraclavicular/infraclavicular",
"    </span>",
"    regions. Recurrence in the axilla following an adequate axillary dissection (ie, &ge;10 nodes removed) or within the internal mammary (IM) nodal chain is uncommon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/2-7\">",
"     2-7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/52/42825?source=see_link&amp;anchor=H11#H11\">",
"     \"Management of the regional lymph nodes in breast cancer\", section on 'Axillary dissection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These general principles are illustrated by the following data:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Over one-half of LRRs occur within the chest wall; the mastectomy scar and the surrounding skin are at greatest risk [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/2-4\">",
"       2-4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Following a level",
"      <span class=\"nowrap\">",
"       I/II",
"      </span>",
"      axillary dissection, 20 to 40 percent of LRRs occur in the supraclavicular",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      infraclavicular region [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/2-8\">",
"       2-8",
"      </a>",
"      ]. The rate of axillary failure is dependent upon the extent of axillary nodal dissection. Following a level",
"      <span class=\"nowrap\">",
"       I/II",
"      </span>",
"      dissection, the ten-year risk of axillary failure is only 2 to 4 percent in contemporary series [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/2-4\">",
"       2-4",
"      </a>",
"      ]. As a result, full axillary radiation is usually not offered to such women. In contrast, less extensive axillary surgery is associated with a higher risk of axillary failure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/9,10\">",
"       9,10",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/52/42825?source=see_link&amp;anchor=H10450984#H10450984\">",
"       \"Management of the regional lymph nodes in breast cancer\", section on 'Extent of dissection'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Although pathologic involvement of the internal mammary nodes has been reported in up to 37 percent of axillary node-positive breast cancers that are located in the inner or central breast [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/11\">",
"       11",
"      </a>",
"      ], clinical evidence of recurrence at this site is uncommon [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/2-6\">",
"       2-6",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/52/42825?source=see_link&amp;anchor=H2#H2\">",
"       \"Management of the regional lymph nodes in breast cancer\", section on 'Risk factors for lymph node involvement in breast cancer'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H13\">",
"       'The role of regional lymph node irradiation'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CONTROLLED TRIALS OF POSTMASTECTOMY RADIATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;For women with LABC who are treated with neoadjuvant chemotherapy followed by mastectomy, we recommend adjuvant radiation therapy (RT). In addition, for women with at least four positive lymph nodes, we recommend postmastectomy chest wall RT because it has been shown to improve locoregional control, relapse-free and overall survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/9,10,12-15\">",
"     9,10,12-15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Older series and meta-analyses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several prospective randomized trials of postmastectomy RT were conducted prior to 1980, the majority of which did not include adjuvant chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. In some of these trials, orthovoltage machines were used, and doses were less than the usual 45 to 50 Gy considered adequate for the control of microscopic disease. Furthermore, some trials included large proportions of patients at low risk for residual subclinical disease (eg, node-negative",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    small tumors), who are unlikely to benefit from adjuvant RT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Nevertheless, in all of these trials, adjuvant RT was associated with a significant reduction in the LRR rates, from 30 to 45 percent without RT, to 10 to 15 percent with RT. A subsequent meta-analysis of these and other trials found that adjuvant RT was associated with improved breast cancer-specific survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/19\">",
"     19",
"    </a>",
"    ]. It became clear that an excess of late cardiac deaths was responsible for a detrimental impact on OS that may have masked a potential cause-specific survival benefit from RT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. In support of this theory, with the use of modern radiation techniques, no evidence of worsened cardiovascular mortality was noted in patients who received RT following conservative surgery at the Princess Margaret Hospital after 1982 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/20\">",
"     20",
"    </a>",
"    ]; others have confirmed this finding, both in patients undergoing conservative surgery or mastectomy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/21/34137?source=see_link&amp;anchor=H6#H6\">",
"     \"Cardiotoxicity of radiation therapy for malignancy\", section on 'Randomized trials'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Modern clinical trials",
"    </span>",
"    &nbsp;&mdash;&nbsp;A survival benefit for postmastectomy RT in women with operable breast cancer has been shown in several trials using modern RT techniques and systemic adjuvant chemotherapy. Two of the three largest randomized trials, although predominantly enrolling women with node-positive disease, included a small subset of women with T3N0 breast cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/9,10\">",
"     9,10",
"    </a>",
"    ], while two other trials enrolled only patients with T3N0 disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Premenopausal Danish Breast Cancer Cooperative Group Trial - This trial included 1708 premenopausal women with \"adverse features\"; 92 percent had positive axillary lymph nodes and 14 percent T3N0 disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/9\">",
"       9",
"      </a>",
"      ]. All patients underwent mastectomy, axillary sampling, and postoperative adjuvant chemotherapy with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      , and 5-fluorouracil (CMF). Patients were then randomly assigned to chest wall and regional nodal irradiation (supraclavicular, axillary, and IM nodes) between cycles one and two of CMF, or no adjuvant irradiation (RT). With a median follow-up of just under ten years, postmastectomy RT was associated with the following outcomes compared to no adjuvant RT:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A significant reduction in locoregional recurrence (LRR, 32 versus 9 percent)",
"     </li>",
"     <li>",
"      A significantly improvement in both disease free (DFS, 48 versus 34 percent) and overall survival (OS, 54 versus 45 percent).",
"     </li>",
"     <li>",
"      The benefit of RT was noted in all groups, including those with large tumors.",
"     </li>",
"     <li>",
"      In the subset of patients with T3N0 disease, there was an improvement in OS (40 versus 33 percent) and DFS (37 versus 22 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Postmenopausal Danish Breast Cancer Cooperative Group trial - A second trial sponsored by the Danish Breast Cancer Cooperative Group evaluated adjuvant RT in 1375 postmenopausal women with stage II or III breast cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/10\">",
"       10",
"      </a>",
"      ]. Following mastectomy, women were randomly assigned to adjuvant",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"       tamoxifen",
"      </a>",
"      alone (30",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      for one year), or chest wall and regional nodal irradiation as described above with tamoxifen. Features of locally advanced disease (tumors size greater than 5 cm or with fascia and skin involvement) were present in 444 patients at the time of enrollment. Compared to tamoxifen alone, the use of postmastectomy RT was associated with:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A significantly lower LRR (8 versus 35 percent)",
"     </li>",
"     <li>",
"      A significant improvement in 10-year DFS (36 versus 24 percent) and OS (45 versus 36 percent).",
"     </li>",
"     <li>",
"      Although the Cox multivariate analysis suggested no difference in outcome between women with small versus large tumors, adjuvant RT did not significantly improve the five-year (49 versus 47 percent) or ten-year (30 versus 29 percent) OS rates in the subset of women with T3 tumors, compared to mastectomy alone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      British Columbia trial &ndash; In this trial, 318 premenopausal women with node-positive breast cancer undergoing mastectomy and axillary dissection were randomly assigned to CMF with or without chest wall RT (chest wall and regional lymph nodes, including the IM nodes) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/12\">",
"       12",
"      </a>",
"      ]. No patients in this trial had T3N0 disease. As in the Danish trial, postmastectomy RT was associated with significant reduction in LRR and significantly improved 15-year DFS (50 versus 33 percent). In a later report with longer follow-up, a significant improvement in OS (52 versus 43 percent) became evident in favor of adjuvant RT [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At least two trials have evaluated adjuvant RT in women with stage III disease.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Eastern Cooperative Group Trial (ECOG): In an ECOG sponsored trial, 426 patients with operable LABC undergoing mastectomy, axillary dissection, and six courses of chemohormonal therapy were then randomly assigned to adjuvant RT or deferral of RT until local disease recurrence [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/22\">",
"       22",
"      </a>",
"      ]. With a median follow-up of over nine years, the LRR was significantly less in the immediate RT arm (15 versus 24 percent), but there were no significant differences in either relapse rate or survival.",
"     </li>",
"     <li>",
"      In the second study, 120 women with operable stage III breast cancer were randomly assigned to postmastectomy RT, chemotherapy, or both, with or without levamisole [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/21\">",
"       21",
"      </a>",
"      ]. LRR as the site of first failure was significantly more common in women who did not receive adjuvant RT (38 versus 7 percent), and survival was significantly worse.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     THE ROLE OF REGIONAL LYMPH NODE IRRADIATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of regional lymph node irradiation in patients with early stage breast cancer is incompletely defined. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39657?source=see_link\">",
"     \"Techniques of breast and chest wall irradiation for early stage breast cancer\"",
"    </a>",
"    .) The strongest argument in its favor is that all three trials described above that demonstrate a survival benefit from postmastectomy adjuvant RT included radiation of regional lymph nodal basins (axilla, supraclavicular and IM nodes) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/9,10,12\">",
"     9,10,12",
"    </a>",
"    ]. Nevertheless, other data fail to support a benefit either for survival or LRR:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In two separate prospective randomized trials comparing conservative surgery and radiation to mastectomy for early stage breast cancer, there was no significant survival advantage from the addition of regional nodal irradiation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/23,24\">",
"       23,24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In other series of patients with either histologically negative, or one to three positive axillary nodes, the addition of regional nodal irradiation has had no significant impact on the risk of a LRR [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/25-27\">",
"       25-27",
"      </a>",
"      ]. As an example, in the NSABP-B06 trial, which compared mastectomy with lumpectomy with or without breast irradiation in women with early stage breast cancer, the LRR was low despite the lack of regional nodal irradiation (5.1 percent overall) and was not significantly higher in node-positive compared to node-negative patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These data suggest that regional lymph node irradiation can be safely omitted in some patients with positive axillary nodes. However, for women with at least four positive lymph nodes with or without extracapsular extension, we recommend regional node RT (in addition to postmastectomy chest wall RT) to improve locoregional control and to improve relapse-free and overall survival. The techniques and doses are described below (see",
"    <a class=\"local\" href=\"#H19\">",
"     'Regional lymph node irradiation'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Axillary radiation and the role of extracapsular extension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extranodal soft tissue extension of axillary lymph node metastases (also termed extracapsular extension, or ECE) has been considered an indication for postmastectomy RT of both the chest wall and axilla. However, it is unclear whether patients with ECE are at an increased risk of axillary recurrence. Although higher LRR rates are observed in women with microscopic ECE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/28,29\">",
"     28,29",
"    </a>",
"    ], these women also have a higher number of involved axillary nodes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. As an example, in one series, ECE was detected in 39, 78, and 92 percent of cases with one to three, four to seven, and greater than or equal to eight positive nodes, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/29\">",
"     29",
"    </a>",
"    ]. Thus, the extent of nodal positivity rather than ECE appears to predict for increased rates of LRR, and failure patterns demonstrate predominantly chest wall rather than axillary recurrences [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Treatment of the internal mammary nodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefit of elective treatment of the IM nodes in women with operable breast cancer is controversial. Previous randomized trials have not shown a benefit to the extended radical mastectomy, which includes resection of the IM nodes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/32\">",
"     32",
"    </a>",
"    ], but a survival benefit for RT has been suggested by some in patients with medial tumors and positive axillary lymph nodes. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one series of 1195 patients with node-positive operable breast cancer from the Institute Gustave-Roussy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/33,34\">",
"       33,34",
"      </a>",
"      ], patients with medially located tumors who did not receive IM irradiation had a significantly higher risk of metastasis and contralateral breast cancer.",
"     </li>",
"     <li>",
"      In a nonrandomized phase II study of 100 women with high-risk stage II or III breast cancer were treated similarly with doxorubicin-based adjuvant chemotherapy, followed by high dose chemotherapy, stem cell support, and locoregional radiotherapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/35\">",
"       35",
"      </a>",
"      ]. The radiotherapy was planned to include electron beam irradiation of the IM nodes, but only 67 patients received it since electron therapy was unavailable for 20 months, during which time 33 patients underwent the same treatment but without IM irradiation. At a median follow-up of 77 months, disease-free survival was significantly better for women who received IM irradiation (73 versus 52 percent), while the improvement in overall survival (78 versus 64 percent) did not reach the level of statistical significance (p = 0.08).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    On the other hand, at least two contemporary retrospective reports and several randomized trials have failed to show a benefit for IM nodal irradiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Furthermore, as discussed above, two trials comparing conservative surgery and radiation to mastectomy for early stage breast cancer reported no significant survival advantage to regional nodal irradiation that included the IM nodal chain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. A comprehensive review on this subject concluded that elective IM nodal irradiation was not indicated as a component of routine breast cancer treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two ongoing or recently completed trials may provide further clarification regarding the benefit of IM nodal irradiation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A French trial, which accrued between 1992 and 1997, randomly assigned 1391 patients to receive chest wall and supraclavicular radiation or chest wall, supraclavicular, and IM irradiation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/39\">",
"       39",
"      </a>",
"      ]. Approximately one-half of the patients had central or inner quadrant tumors and the others had node-positive tumors located anywhere in the breast. Preliminary results have not been published.",
"     </li>",
"     <li>",
"      In 1996, the EORTC (Trial",
"      <span class=\"nowrap\">",
"       22922/10925)",
"      </span>",
"      also began a trial evaluating the role of IM chain irradiation in patients undergoing either breast conserving therapy or mastectomy. This trial completed accrual with approximately 4000 patients, and final analysis is awaited.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite the paucity of available data, it is our policy to treat the IM nodal basin in patients with four or more positive axillary lymph nodes, ECE, or medially located T3 tumors, independent of the number of positive lymph nodes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     RADIATION THERAPY TECHNIQUES AND DOSES FOR LABC",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Breast and/or chest wall irradiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients undergoing neoadjuvant chemotherapy, adjuvant RT is begun approximately three weeks following either local excision of the primary tumor (if breast conservation is intended), or mastectomy and axillary node dissection. If adjuvant chemotherapy is planned, radiation is usually deferred until after its completion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Technique and dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation is delivered to the entire breast",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chest wall to a total of 50 to 50.4 Gy, using daily 1. to 2 Gy fractions over a 5 to 5.5 week period. Typically this dose is followed by a supplemental boost of 10 to 18 Gy to the tumor bed. The benefit of this boost is controversial, although at least one study suggests it leads to improved locoregional control. In a trial sponsored by the EORTC, 5316 women undergoing breast conserving treatment were randomly assigned to boost (16 Gy) or no boost [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/40\">",
"     40",
"    </a>",
"    ]. In an early report, the five-year actuarial risk of local failure was significantly reduced in women receiving a boost to the tumor bed (4.3 versus 6.8 percent). Although this study included only patients with early breast cancer treated by conservative surgery, we believe that extrapolation to those undergoing BCT after downstaging by neoadjuvant chemotherapy is justifiable.",
"   </p>",
"   <p>",
"    We routinely administer a boost of 10 Gy for patients with negative margins and 18 Gy for those with a focus of close or positive surgical margins, if reexcision has not been accomplished. The same boost dose is directed to the chest wall in women who have undergone mastectomy. Tangential fields are used to treat the breast or the chest wall; an isocentric technique and megavoltage machines are used to decrease the volume of lung and heart in the field [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39657?source=see_link\">",
"     \"Techniques of breast and chest wall irradiation for early stage breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Roughly, the medial field usually enters at the midline of the patient, and the lateral field enters around 2 cm below the lateral extent of the breast tissue. The inferior border extends around 2 cm below the breast, and the superior border extends up beyond all palpable tissue or matching with the supraclavicular field. However, adjustments are made based upon the patient's anatomy and the tumor location. When CT-based three-dimensional (3-D) conformal techniques are used for treatment planning, the borders can be individualized to the individual patient's anatomy.",
"   </p>",
"   <p>",
"    The patient set up should be accurately reproduced on a daily basis. The dose distribution should be calculated at least at the central axis, with correction for lung density, and dose inhomogeneity should not exceed 10 percent. This will usually require the use of wedges or compensators or even intensity-modulated RT. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/55/32630?source=see_link\">",
"     \"Intensity-modulated radiation therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CT scanning is starting to be used in conjunction with simulation to allow an isodose distribution planning in complex cases (tangents and IM chain fields). 3-D or conformal treatment planning is now being used more frequently in most centers, and using the dose calculation algorithm, doses received by volumes of lung and heart can be estimated from dose-volume histograms (DVH) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Regional lymph node irradiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, we recommend radiation of the axillary apex, supraclavicular region, and IM chain for women undergoing a level",
"    <span class=\"nowrap\">",
"     I/II",
"    </span>",
"    node dissection who are found to have four or more positive lymph nodes. In addition, we recommend IM chain irradiation in patients with ECE or medially located T3 tumors, regardless of axillary nodal status. Radiation to the full axilla should be considered in patients with invasive cancers in whom axillary dissection was inadequate or omitted, although the level I nodes are usually included within the tangential fields used to treat the breast or chest wall.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Technique and dose for axillary irradiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a decision is made to treat the regional nodes, recommended doses are usually between 45 and 50 Gy, delivered in daily 1.8 to 2 Gy fractions. The supraclavicular area receives the dose at a depth (usually 3 cm) which could be determined from CT-planning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. The dose is delivered through an anterior field (with 10 to 15 degree gantry angle to avoid the spinal cord). The axillary apex receives the dose at the midplane through two opposed anterior and posterior fields. A posterior axillary boost field is usually used to compensate for underdosing of the deeper tissues in the axilla by the anterior fields [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/44\">",
"     44",
"    </a>",
"    ], unless there is a CT-planning. In this situation, the exact depth of the axilla is determined, and doses from the",
"    <span class=\"nowrap\">",
"     supraclavicular/axillary",
"    </span>",
"    field adequately cover the axilla. In many instances, based on the information from the CT-planning, there will be no need to perform a posterior axillary boost [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/43,44\">",
"     43,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The full axilla requires treatment when an inadequate or no lymph node dissection have been performed. The doses and techniques will be the same. If grossly palpable axillary lymph nodes are present, and axillary resection has not been accomplished, radiation doses should be higher.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Technique and dose for IM chain irradiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best technique for IM chain irradiation is uncertain. In one report, four different techniques were evaluated using CT planning systems and calculated DVH to the target volumes and normal structures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/45\">",
"     45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Standard tangential fields",
"     </li>",
"     <li>",
"      Extended tangential fields",
"     </li>",
"     <li>",
"      Five-field technique (two tangential, anterior IM chain photon, angled IM chain electrons and supraclavicular)",
"     </li>",
"     <li>",
"      Partly wide tangent fields",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Compared to the alternative techniques, the partly wide tangent field offered many advantages, including optimal coverage of the target volumes, reduced coverage of the normal tissue to an acceptable level, and easy reproducibility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a second Dutch study, 3-D treatment planning was utilized in 30 patients with left sided breast cancers and a variety of breast sizes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/46\">",
"     46",
"    </a>",
"    ]. Two techniques were compared: technique A (two tangents and anterior IM chain mixed photons and electrons) and technique B (two tangents and oblique IM chain mixed photons and electrons), and both DVH and normal tissue complication probability (NTCP) for the heart and the lungs were compared. Compared to technique B, technique A was associated with occasional treatment volume underdosage and significantly higher NTCP, while technique B showed good coverage of the target volumes (breast and locoregional LN) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ideal dose to the IM chain is 45 Gy over five weeks using daily 1.8 Gy fractions. The use of electrons, or a combination of electrons and photons minimizes the dose to the lung, heart, and thoracic spine, reducing the incidence of complications when compared to photons alone. It is our policy to use electrons for an \"en face\" field (to avoid the use of \"en face\" photons as much as possible) to 45 Gy in 25 fractions, with the dose calculated mostly on the 90 percent isodose line. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'Late complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     POTENTIAL COMPLICATIONS OF RADIATION THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Potential complications of postmastectomy radiation (RT) include both short-term side effects and long-term complications, of which arm edema is the most common.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Acute side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation therapy to the breast or chest wall is usually well tolerated with few side effects. Early side effects that can occur during treatment include fatigue and skin changes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Fatigue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fatigue is common during treatment, particularly in women undergoing both chemotherapy and radiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. In one report of 76 patients undergoing adjuvant RT, fatigue gradually increased during the course of treatment, was at its peak during the last week, and gradually dissipated within three months of treatment discontinuation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/49\">",
"     49",
"    </a>",
"    ]. Exercise may reduce symptoms and improve physical functioning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Skin changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin changes accumulate gradually within the radiated field over the course of treatment. Initial erythema and tenderness may progress to dry then moist desquamation. The magnitude of the side effects is variable, but virtually all patients recover satisfactorily. Both the incidence and severity of skin changes are higher in women with large breasts.",
"   </p>",
"   <p>",
"    The development of breast edema and skin thickening following breast conserving treatment has not been well studied or quantitated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/51\">",
"     51",
"    </a>",
"    ]. Although the contributory factors have not been precisely determined, both surgery (particularly axillary nodal dissection) and radiation have been implicated. Breast edema and skin thickening can cause some discomfort and may compromise the cosmetic result of breast conserving therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Late complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Late complications following radiation therapy to the breast or chest wall include arm edema, brachial plexopathy, rib fractures, cardiac morbidity, radiation pneumonitis, telangiectasia or atrophic ulceration of the skin, and secondary malignancies. Overall, the incidence of late complications is usually low, and is dependent upon the radiation dose and schedule of administration, the technique used, and the field of treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Lymphedema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphedema results from interruption of the axillary lymphatic system by surgery",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    RT. The reported incidence of arm edema following treatment for breast cancer varies widely, depending upon the definition of lymphedema, the type of therapy, and the time elapsed since treatment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/52/1866?source=see_link\">",
"     \"Clinical manifestations and diagnosis of lymphedema\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Brachial plexopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A brachial plexopathy may result when the supraclavicular and axillary regions are treated by RT. The classic symptoms include shoulder discomfort, and progressive paresthesias",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    weakness in the ipsilateral arm and hand. In such cases, the differential diagnosis should include recurrent nodal disease in the axilla.",
"   </p>",
"   <p>",
"    An early transient brachial plexopathy has been described in 14 percent of patients receiving an average of 50 Gy axillary radiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/52\">",
"     52",
"    </a>",
"    ]. The latent period was short (median 4.5 months), and paresthesias and weakness were transient, resolving spontaneously within weeks or months.",
"   </p>",
"   <p>",
"    Paresthesias and weakness that develop within weeks following RT may portend a late-delayed plexopathy, which is more often permanent. The overall incidence of late-delayed brachial plexopathy following radiation therapy for breast cancer is low. Permanent brachial plexopathy occurs in less than 1 percent of women receiving &le;50 Gy in 2 Gy fractions administered to a supraclavicular and axillary apex field. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/34/38437?source=see_link\">",
"     \"Complications of peripheral nerve irradiation\"",
"    </a>",
"    .) In one report from the Joint Center for Radiation Therapy (JCRT), the incidence was 1.2 percent with a median time to appearance of 10.5 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/53\">",
"     53",
"    </a>",
"    ]. In 80 percent of cases, the symptoms were mild and resolved within a year.",
"   </p>",
"   <p>",
"    The incidence of late-delayed plexopathy is significantly higher with axillary doses greater than 50 Gy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/53\">",
"     53",
"    </a>",
"    ], with daily radiotherapy fractions in excess of 2 Gy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/54,55\">",
"     54,55",
"    </a>",
"    ], with concomitant chemotherapy administration, and with a three-field RT technique [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/53\">",
"     53",
"    </a>",
"    ]. The most important factors are the dose per fraction and the technique used. In one report, the risk of treatment-related brachial plexopathy at six years was significantly higher in patients who received 51 Gy in 15 fractions to the axilla compared to those treated with 54 Gy in 30 fractions (5.9 versus 1 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/55\">",
"     55",
"    </a>",
"    ]. This suggests that the risk of brachial plexopathy is more dependent on the dose per fraction if the total dose remains within the 45 to 50 Gy range. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/34/38437?source=see_link\">",
"     \"Complications of peripheral nerve irradiation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Rib fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of treatment-related rib fractures is extremely low following adjuvant RT for breast cancer. In the JCRT series described above, 29 of 1624 treated patients (1.8 percent) developed rib fractures at a median of 12 months post-treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/53\">",
"     53",
"    </a>",
"    ]. This risk increased when 4 MV photons were used, compared to 6 or 8 MV. The incidence of rib fractures appears to be higher with radiation doses that exceed 50 Gy, and with the use of concomitant chemotherapy, even when the radiation dose is &lt;50 Gy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Radiation pneumonitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of RT to treat the supraclavicular and axillary areas is usually associated with subsequent radiographic changes in the irradiated lungs without significant clinical symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/56\">",
"     56",
"    </a>",
"    ]. These changes can be confused with lymphangitic lung metastases, if the radiologist is not familiar with their appearance.",
"   </p>",
"   <p>",
"    Between 1 and 5 percent of patients will develop symptomatic radiation pneumonitis following thoracic irradiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. Typically, patients present two to six months after completion of therapy with shortness of breath, and dry cough with or without a low-grade fever. Symptoms are usually transient. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/33/24090?source=see_link\">",
"     \"Radiation-induced lung injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk is greater with higher doses, increasing lung volume in the treatment field, treatment to the supraclavicular, axillary apex, and internal mammary (IM) regions, and the use of concurrent rather than sequential chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/57-60\">",
"     57-60",
"    </a>",
"    ]. In one report of patients undergoing tangential beam RT following breast conserving surgery, radiation pneumonitis only developed in those patients in whom the volume of irradiated lung exceeded 10 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chemotherapy may contribute to the risk of radiation pneumonitis. In one report, patients treated by a three-field method with concomitant adjuvant chemotherapy had a significantly higher risk of radiation pneumonitis than those receiving sequential chemotherapy (8.8 and 1.3 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/57\">",
"     57",
"    </a>",
"    ]. However, in another report, treatment regimens incorporating either concomitant or sequential",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    with radiation were associated with a significantly higher rate of radiation pneumonitis than occurred in women receiving non-paclitaxel containing adjuvant chemotherapy with radiation (15 versus 1.1 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Cardiac injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;The adverse cardiac effects of RT in women treated for breast cancer are related to both the volume of heart irradiated and the radiation dose delivered to that volume. Contemporary techniques deliver less radiation to the heart and reduce the associated cardiotoxicity. However, there is no minimum radiation dose that is entirely free of increased risk, the frequency of cardiac events is increased in women with other cardiac risk factors, and risk appears to persist for at least 20 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/61\">",
"     61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/21/34137?source=see_link&amp;anchor=H3#H3\">",
"     \"Cardiotoxicity of radiation therapy for malignancy\", section on 'Breast cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, the absolute increase in risk of having a major coronary event or dying of ischemic heart disease is small, particularly compared with the benefit potentially derived from such treatment in appropriately selected patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Radiation-induced sarcoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation-induced sarcoma of the soft tissue or bone, and angiosarcomas involving the skin of the intact breast have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/53,62\">",
"     53,62",
"    </a>",
"    ]. In one series from the Institute Gustave-Roussy in France, nine of 7620 patients treated for breast cancer developed a secondary sarcoma within the irradiated fields [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/62\">",
"     62",
"    </a>",
"    ]. The mean latency period was approximately 10 years, and the cumulative frequency at 10, 20, and 30 years was 0.2, 0.43, and 0.78 percent, respectively.",
"   </p>",
"   <p>",
"    Angiosarcoma, a relatively rare tumor, has occasionally been reported to occur in the breast following irradiation. These tumors usually present as multiple reddish, bluish and purple nodules or areas of skin discoloration. The topic of radiation-induced sarcomas following treatment for breast cancer is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/3/28729?source=see_link\">",
"     \"Breast sarcoma: Epidemiology, risk factors, clinical presentation, diagnosis, and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Other secondary malignancies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Modest increases in the absolute rate of lung cancers have been observed following radiotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/63-65\">",
"     63-65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12298?source=see_link\">",
"     \"Cigarette smoking and other risk factors for lung cancer\"",
"    </a>",
"    .) In two separate studies, the relative risk among women treated with radiation who survived 10 or more years from diagnosis was 2.0 and 2.8, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. The absolute number of women potentially affected with radiation-induced lung cancer is very low; nine cases would be expected in 10,000 women surviving their breast cancers for at least 10 years. Not surprisingly, smoking appears to play a significant role and, even though the risk is small, smoking cessation interventions should be encouraged.",
"   </p>",
"   <p>",
"    In women undergoing chest wall radiation, the risk of acute nonlymphocytic leukemias (ANLL) appears to be related to the volume of bone marrow in the field, the total radiation dose, and the concomitant use of chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/66-68\">",
"     66-68",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/58/20393?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia\"",
"    </a>",
"    .) The absolute risk is very low, especially with limited bone marrow in the radiation port.",
"   </p>",
"   <p>",
"    The relative risk of treatment-related ANLL in one review varied from 0.86 to 3.7 following radiation compared to 1.3 to 11.5 after chemotherapy alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/68\">",
"     68",
"    </a>",
"    ]. A higher relative risk after radiation (RR = 10) was noted in the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-04 and B-06 trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/69\">",
"     69",
"    </a>",
"    ]. However, there were still only four cases of ANLL compared to the expected 0.39, indicating that ANLL is a rare complication.",
"   </p>",
"   <p>",
"    Limited data suggest a slight excess of contralateral breast cancers following radiotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/70\">",
"     70",
"    </a>",
"    ]. The risk may be higher with younger age at treatment. In one report, an increase in relative risk (1.59) was seen only in women under age 45 at the time of treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the risk of radiation-associated contralateral breast cancer, if it exists, is extremely low, measures to reduce scatter to the opposite breast, such as omission of a medial wedge from tangent fields should be used to reduce the contralateral breast dose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/55/42873/abstract/72\">",
"     72",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39657?source=see_link\">",
"     \"Techniques of breast and chest wall irradiation for early stage breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11432762\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Locally advanced breast cancer (LABC) constitutes a wide variety of clinical presentations including: large tumors (&gt;5 cm); tumors with extensive regional lymph node involvement; tumors that directly involve the skin or underlying chest wall; inoperable tumors without distant metastasis (including supraclavicular lymph nodes); and inflammatory breast cancer (IBC). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The size of the primary tumor, invasion of the pectoral fascia, the number of involved lymph nodes, and number of lymph nodes examined are independent predictors for locoregional recurrence (LRR) following mastectomy. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Risk factors for locoregional recurrence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women with LABC who are treated with neoadjuvant chemotherapy followed by mastectomy, we recommend adjuvant radiation therapy (RT). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Controlled trials of postmastectomy radiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women with at least four positive lymph nodes with or without extracapsular extension, we recommend postmastectomy chest wall and regional node radiation therapy to improve locoregional control and to improve relapse-free and overall survival. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Controlled trials of postmastectomy radiation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'The role of regional lymph node irradiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients undergoing neoadjuvant chemotherapy, adjuvant RT is begun approximately three to four weeks following either local excision of the primary tumor (if breast conservation is intended) or mastectomy and axillary node dissection. If adjuvant chemotherapy is planned, RT is usually deferred until after its completion. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Radiation therapy techniques and doses for LABC'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      RT is associated with both acute side effects (eg, fatigue and skin changes) and late complications (eg, lymphedema, brachial plexopathy, pneumonitis). Careful posttreatment surveillance is recommended for all patients who receive RT for locally advanced breast cancer. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Potential complications of radiation therapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/12/5322?source=see_link\">",
"       \"Approach to the long-term survivor of breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     American Joint Committee on Cancer Staging Manual, Greene FL, Page DL, Fleming ID, et al (Eds), Springer Verlag, New York 2002. p.224.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/2\">",
"      Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999; 17:1689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/3\">",
"      Taghian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 2004; 22:4247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/4\">",
"      Katz A, Strom EA, Buchholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 2000; 18:2817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/5\">",
"      Halverson KJ, Perez CA, Kuske RR, et al. Isolated local-regional recurrence of breast cancer following mastectomy: radiotherapeutic management. Int J Radiat Oncol Biol Phys 1990; 19:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/6\">",
"      Schwaibold F, Fowble BL, Solin LJ, et al. The results of radiation therapy for isolated local regional recurrence after mastectomy. Int J Radiat Oncol Biol Phys 1991; 21:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/7\">",
"      Toonkel LM, Fix I, Jacobson LH, Wallach CB. The significance of local recurrence of carcinoma of the breast. Int J Radiat Oncol Biol Phys 1983; 9:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/8\">",
"      Vicini FA, Horwitz EM, Lacerna MD, et al. The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 1997; 39:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/9\">",
"      Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997; 337:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/10\">",
"      Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999; 353:1641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/11\">",
"      Lacour J, Le M, Caceres E, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. Cancer 1983; 51:1941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/12\">",
"      Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/13\">",
"      Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005; 97:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/14\">",
"      Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 2001; 93:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/15\">",
"      Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366:2087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/16\">",
"      Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/17\">",
"      H&oslash;st H, Brennhovd IO, Loeb M. Postoperative radiotherapy in breast cancer--long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 1986; 12:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/18\">",
"      Rutqvist LE, Pettersson D, Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer: long-term follow-up of a randomized clinical trial. Radiother Oncol 1993; 26:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/19\">",
"      Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994; 12:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/20\">",
"      Vallis KA, Pintilie M, Chong N, et al. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol 2002; 20:1036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/21\">",
"      Klefstr&ouml;m P, Gr&ouml;hn P, Heinonen E, et al. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. II. 5-year results and influence of levamisole. Cancer 1987; 60:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/22\">",
"      Olson JE, Neuberg D, Pandya KJ, et al. The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer 1997; 79:1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/23\">",
"      Arriagada R, L&ecirc; MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 1996; 14:1558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/24\">",
"      Veronesi U, Zucali R, Luini A. Local control and survival in early breast cancer: the Milan trial. Int J Radiat Oncol Biol Phys 1986; 12:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/25\">",
"      Halverson KJ, Taylor ME, Perez CA, et al. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 1993; 26:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/26\">",
"      Recht A, Pierce SM, Abner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1991; 9:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/27\">",
"      Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995; 333:1456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/28\">",
"      Mignano JE, Zahurak ML, Chakravarthy A, et al. Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation. Cancer 1999; 86:1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/29\">",
"      Donegan WL, Stine SB, Samter TG. Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer. Cancer 1993; 72:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/30\">",
"      Leonard C, Corkill M, Tompkin J, et al. Are axillary recurrence and overall survival affected by axillary extranodal tumor extension in breast cancer? Implications for radiation therapy. J Clin Oncol 1995; 13:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/31\">",
"      Hetelekidis S, Schnitt SJ, Silver B, et al. The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer. Int J Radiat Oncol Biol Phys 2000; 46:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/32\">",
"      Veronesi U, Marubini E, Mariani L, et al. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer 1999; 35:1320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/33\">",
"      Arriagada R, L&ecirc; MG, Mouriesse H, et al. Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol 1988; 11:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/34\">",
"      L&ecirc; MG, Arriagada R, de Vathaire F, et al. Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary lymph nodes? Cancer 1990; 66:2313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/35\">",
"      Stemmer SM, Rizel S, Hardan I, et al. The role of irradiation of the internal mammary lymph nodes in high-risk stage II to IIIA breast cancer patients after high-dose chemotherapy: a prospective sequential nonrandomized study. J Clin Oncol 2003; 21:2713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/36\">",
"      Obedian E, Haffty BG. Internal mammary nodal irradiation in conservatively-managed breast cancer patients: is there a benefit? Int J Radiat Oncol Biol Phys 1999; 44:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/37\">",
"      Fowble B, Hanlon A, Freedman G, et al. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys 2000; 47:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/38\">",
"      Freedman GM, Fowble BL, Nicolaou N, et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys 2000; 46:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/39\">",
"      Romestaing P, Ecochard, R, Hennequin, C, et al. Role of irradiation of internal mammary chain after mastectomy: A French S.F.R.O. phase III randomized trial (abstract). Radiother Oncol 1998; 48:s119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/40\">",
"      Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345:1378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/41\">",
"      Lichter AS, Fraass BA, Yanke B. Treatment Techniques in the Conservative Management of Breast Cancer. Semin Radiat Oncol 1992; 2:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/42\">",
"      Krasin M, McCall A, King S, et al. Evaluation of a standard breast tangent technique: a dose-volume analysis of tangential irradiation using three-dimensional tools. Int J Radiat Oncol Biol Phys 2000; 47:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/43\">",
"      Goodman RL, Grann A, Saracco P, Needham MF. The relationship between radiation fields and regional lymph nodes in carcinoma of the breast. Int J Radiat Oncol Biol Phys 2001; 50:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/44\">",
"      Bentel GC, Marks LB, Hardenbergh PH, Prosnitz LR. Variability of the depth of supraclavicular and axillary lymph nodes in patients with breast cancer: is a posterior axillary boost field necessary? Int J Radiat Oncol Biol Phys 2000; 47:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/45\">",
"      Arthur, DW, Arnfield, MR, Warwicke, LA, et al. Internal mammary node coverage: an investigation of presently accepted techniques. Int J Radiat Oncol Biol Phys 2000; 48:139-46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/46\">",
"      Hurkmans CW, Borger JH, Bos LJ, et al. Cardiac and lung complication probabilities after breast cancer irradiation. Radiother Oncol 2000; 55:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/47\">",
"      Gallagher EM, Buchsel PC. Breast cancer and fatigue. Am J Nurs 1998; Suppl:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/48\">",
"      Woo B, Dibble SL, Piper BF, et al. Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum 1998; 25:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/49\">",
"      Irvine DM, Vincent L, Graydon JE, Bubela N. Fatigue in women with breast cancer receiving radiation therapy. Cancer Nurs 1998; 21:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/50\">",
"      Wratten C, Kilmurray J, Wright S, et al. Pilot study of high-frequency ultrasound to assess cutaneous oedema in the conservatively managed breast. Int J Cancer 2000; 90:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/51\">",
"      Mock V, Dow KH, Meares CJ, et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997; 24:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/52\">",
"      Salner AL, Botnick LE, Herzog AG, et al. Reversible brachial plexopathy following primary radiation therapy for breast cancer. Cancer Treat Rep 1981; 65:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/53\">",
"      Pierce SM, Recht A, Lingos TI, et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 1992; 23:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/54\">",
"      Olsen NK, Pfeiffer P, Johannsen L, et al. Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys 1993; 26:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/55\">",
"      Powell S, Cooke J, Parsons C. Radiation-induced brachial plexus injury: follow-up of two different fractionation schedules. Radiother Oncol 1990; 18:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/56\">",
"      Rothwell RI, Kelly SA, Joslin CA. Radiation pneumonitis in patients treated for breast cancer. Radiother Oncol 1985; 4:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/57\">",
"      Lingos TI, Recht A, Vicini F, et al. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1991; 21:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/58\">",
"      Marks LB, Clough R, Fan M, et al. Radiation-induced pneumonitis following tangential breast/chest wall irradiation (abstract). Int J Radio Oncol Biol Phys 2000; 48(suppl):294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/59\">",
"      Taghian AG, Assaad SI, Niemierko A, et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 2001; 93:1806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/60\">",
"      Kimsey FC, Mendenhall NP, Ewald LM, et al. Is radiation treatment volume a predictor for acute or late effect on pulmonary function? A prospective study of patients treated with breast-conserving surgery and postoperative irradiation. Cancer 1994; 73:2549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/61\">",
"      Moslehi J. The cardiovascular perils of cancer survivorship. N Engl J Med 2013; 368:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/62\">",
"      Taghian A, de Vathaire F, Terrier P, et al. Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 1991; 21:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/63\">",
"      Neugut AI, Weinberg MD, Ahsan H, Rescigno J. Carcinogenic effects of radiotherapy for breast cancer. Oncology (Williston Park) 1999; 13:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/64\">",
"      Inskip PD, Stovall M, Flannery JT. Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 1994; 86:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/65\">",
"      Neugut AI, Robinson E, Lee WC, et al. Lung cancer after radiation therapy for breast cancer. Cancer 1993; 71:3054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/66\">",
"      Pagana L, Pulsoni A, Tosti ME, et al. Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia. Br J Haematol 2001; 112:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/67\">",
"      Chaplain G, Milan C, Sgro C, et al. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol 2000; 18:2836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/68\">",
"      Shapiro CL, Recht A. Late effects of adjuvant therapy for breast cancer. J Natl Cancer Inst Monogr 1994; :101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/69\">",
"      Fisher B, Rockette H, Fisher ER, et al. Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J Clin Oncol 1985; 3:1640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/70\">",
"      Vallis K, Pintilie M, Chong N, et al. Assessment of coronary heart disease morbidity and mortality following radiation therapy for early breast cancer (abstract). Proc Int J Radiat Oncol Biol Phys 2000; 66:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/71\">",
"      Boice JD Jr, Harvey EB, Blettner M, et al. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 1992; 326:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/55/42873/abstract/72\">",
"      Fraass BA, Roberson PL, Lichter AS. Dose to the contralateral breast due to primary breast irradiation. Int J Radiat Oncol Biol Phys 1985; 11:485.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 748 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-519069B3B6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42873=[""].join("\n");
var outline_f41_55_42873=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11432762\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RATIONALE FOR POSTMASTECTOMY RADIATION THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Risk factors for locoregional recurrence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Sites of locoregional recurrence following mastectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CONTROLLED TRIALS OF POSTMASTECTOMY RADIATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Older series and meta-analyses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Modern clinical trials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      THE ROLE OF REGIONAL LYMPH NODE IRRADIATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Axillary radiation and the role of extracapsular extension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Treatment of the internal mammary nodes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      RADIATION THERAPY TECHNIQUES AND DOSES FOR LABC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Breast and/or chest wall irradiation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Technique and dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Regional lymph node irradiation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Technique and dose for axillary irradiation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Technique and dose for IM chain irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      POTENTIAL COMPLICATIONS OF RADIATION THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Acute side effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Fatigue",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Skin changes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Late complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Lymphedema",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Brachial plexopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Rib fracture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Radiation pneumonitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Cardiac injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Radiation-induced sarcoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Other secondary malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11432762\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/748\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/748|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/14/29920\" title=\"table 1\">",
"      TNM stage breast cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/12/5322?source=related_link\">",
"      Approach to the long-term survivor of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/3/28729?source=related_link\">",
"      Breast sarcoma: Epidemiology, risk factors, clinical presentation, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/21/34137?source=related_link\">",
"      Cardiotoxicity of radiation therapy for malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12298?source=related_link\">",
"      Cigarette smoking and other risk factors for lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/52/1866?source=related_link\">",
"      Clinical manifestations and diagnosis of lymphedema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/58/20393?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/34/38437?source=related_link\">",
"      Complications of peripheral nerve irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/20/31048?source=related_link\">",
"      Inflammatory breast cancer: Clinical features and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/55/32630?source=related_link\">",
"      Intensity-modulated radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/52/42825?source=related_link\">",
"      Management of the regional lymph nodes in breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/46/19177?source=related_link\">",
"      Overview of the treatment of newly diagnosed, non-metastatic breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/3/41017?source=related_link\">",
"      Postmastectomy chest wall irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/33/24090?source=related_link\">",
"      Radiation-induced lung injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39657?source=related_link\">",
"      Techniques of breast and chest wall irradiation for early stage breast cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_55_42874="Psoriasis palmar";
var content_f41_55_42874=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F81295%7EDERM%2F61113%7EPC%2F55722%7EPC%2F57816%7EDERM%2F69623&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F81295%7EDERM%2F61113%7EPC%2F55722%7EPC%2F57816%7EDERM%2F69623&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Palmar psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Hand psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dyshidrotic eczema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 279px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Small vesicles are visible on the lateral fingers.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP. Goodheart's photoguide to common skin disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tinea pedis and tinea manuum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This image shows concomitant tinea pedis and tinea manuum, also known as the \"two feet, one hand\" presentation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Chronic allergic contact dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The skin is dry, scaly, and thick, as a result of hyperkeratosis, acanthosis, and lymphomononuclear cell infiltration.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42874=[""].join("\n");
var outline_f41_55_42874=null;
var title_f41_55_42875="Diagnostic laboratory evaluation for neutropenia";
var content_f41_55_42875=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F51687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F51687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic laboratory evaluation for neutropenia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Test",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serial blood counts",
"       </td>",
"       <td>",
"        Observation over time of the complete blood count is often the best approach.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sedimentation rate (ESR), C-reactive protein (CRP)",
"       </td>",
"       <td>",
"        Elevations of the ESR and/or CRP in the absence of any overt infection suggests underlying infection due to neutropenia or presence of autoimmune disease.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ANA*, C3, C4, anti-DNA",
"       </td>",
"       <td>",
"        Screening tests for the presence of collagen vascular disease.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methylmalonic acid, homocysteine, copper, ceruloplasmin, pyridoxine",
"       </td>",
"       <td>",
"        Indicate abnormality in micronutrients that can be associated with marrow failure. High methylmalonic acid and/or homocysteine suggest B12 or folate deficiency even if serum levels are normal. Low ceruloplasmin is associated with neutropenia or pancytopenia and corrects with copper replacement.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone marrow aspirate and biopsy with cytogenetics",
"       </td>",
"       <td>",
"        Testing to address possibility of underlying hematologic malignancy, myelodysplastic syndrome, maturation arrest.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD3/CD16,56,57, immunoglobulins, tetanus titers",
"       </td>",
"       <td>",
"        Natural killer cells/cytotoxic T cell subsets. A clone of &gt;20 percent suggests large granular lymphocyte disease; immunodeficiency can present with neutropenia.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Genetic testing",
"       </td>",
"       <td>",
"        Specific gene tests are available for several of the congenital neutropenias.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * ANA would include both antineutrophil as well as antinuclear antibodies",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42875=[""].join("\n");
var outline_f41_55_42875=null;
var title_f41_55_42876="Common herbal therapies";
var content_f41_55_42876=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60567&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60567&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Commonly used herbal therapies",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Herb",
"       </td>",
"       <td class=\"subtitle1\">",
"        Common uses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aloe",
"       </td>",
"       <td>",
"        Burns, minor wounds, skin irritations, aphthous stomatitis, constipation, gastric and duodenal ulcers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calendula",
"       </td>",
"       <td>",
"        Skin soother",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cascara",
"       </td>",
"       <td>",
"        Constipation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cayenne",
"       </td>",
"       <td>",
"        Topical treatment for pain, post-herpetic neuralgia, nasal spray for migraines and cluster headaches",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chamomile",
"       </td>",
"       <td>",
"        Sedative, colic, antiinflammatory, antispasmodic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clove oil",
"       </td>",
"       <td>",
"        Teething pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coffee",
"       </td>",
"       <td>",
"        Stimulant, ADHD, bronchodilator",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dandelion",
"       </td>",
"       <td>",
"        Mild diuretic, liver tonic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dill",
"       </td>",
"       <td>",
"        Antispasmodic, colic, decrease flatulence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Echinacea",
"       </td>",
"       <td>",
"        Immune stimulation, antiinflammatory",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Feverfew",
"       </td>",
"       <td>",
"        Migraine headaches, rheumatoid arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Garlic",
"       </td>",
"       <td>",
"        Antimicrobial, cholesterol lowering",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ginger",
"       </td>",
"       <td>",
"        Antiemetic, antinausea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ginseng",
"       </td>",
"       <td>",
"        Stimulant, enhance endurance and performance, adaptogen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hops",
"       </td>",
"       <td>",
"        Sedative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lavender",
"       </td>",
"       <td>",
"        Sedative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Licorice",
"       </td>",
"       <td>",
"        Antiinflammatory, demulcent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Milk thistle",
"       </td>",
"       <td>",
"        Hepatoprotection; cirrhosis, hepatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oats",
"       </td>",
"       <td>",
"        Antipruritic; eczema, varicella",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pine bark extract",
"       </td>",
"       <td>",
"        Antioxidant promoted to treat ADHD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rhubarb root",
"       </td>",
"       <td>",
"        Constipation, chronic renal failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Saint John's wort",
"       </td>",
"       <td>",
"        Depression, antiviral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Slippery elm bark",
"       </td>",
"       <td>",
"        Demulcent; pharyngitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tea tree oil",
"       </td>",
"       <td>",
"        Antimicrobial; acne; minor skin infections, including fungal and yeast infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thyme",
"       </td>",
"       <td>",
"        Antimicrobial; colds, sore throats; cough; expectorant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Valerian",
"       </td>",
"       <td>",
"        Sedative",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     &nbsp;",
"    </p>",
"    <div class=\"footnotes\">",
"     ADHD: attention deficit hyperactivity disorder.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42876=[""].join("\n");
var outline_f41_55_42876=null;
var title_f41_55_42877="Exercise training in HF";
var content_f41_55_42877=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F82041&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F82041&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Efficacy of exercise training in HF",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 263px; height: 245px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plot of individual values for the ventilatory anaerobic threshold (VO2) before and after exercise training in 12 patients with chronic heart failure. All but one patient improved and the rise in mean VO2 (shown in bold lines with 95 percent confidence intervals) was highly significant (p = 0.01).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Sullivan, MJ, Cobb, FR, Chest 1992; 101:340S.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42877=[""].join("\n");
var outline_f41_55_42877=null;
var title_f41_55_42878="Plasmapheresis in myeloma";
var content_f41_55_42878=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F59043&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F59043&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Figure showing reduction in circulating light chains after plasmapheresis in a patient with multiple myeloma and acute kidney injury",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Serum protein electrophoresis before (left panel) and after (right panel) four consecutive daily plasma exchanges in a patient with multiple myeloma and acute renal failure. The monoclonal peak representing the circulating light chains (arrow) has essentially disappeared.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Andre Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42878=[""].join("\n");
var outline_f41_55_42878=null;
var title_f41_55_42879="Adrenal steroid inhibitors";
var content_f41_55_42879=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F56781&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F56781&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 495px\">",
"   <div class=\"ttl\">",
"    Inhibitors of adrenal steroid biosynthesis or action",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 475px; height: 527px; background-image: url(data:image/gif;base64,R0lGODlh2wEPAtUAAJmZZszMmczMsn9mM5l/TIx/TJWSX3JMGWYzAJkmGZlMM5lyTGk5Bol5Rmw8CcXCj3VSH6ycaW9GE4VyP4+FUpKMWYViL3xfLJJ1QpmPX3lZJmw/DJkAALKlcpmFWZl8Un9ZJpkcE5k5JplfP7+4hZkvH5kTDHJGE5lpRoJsOXlPHJlCLJlWObivfJ+JVoxsOZkJBuXl2LKyjKWSXwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAADbAQ8CAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uru8vb6VMgLCw8TFxsfIycrLzM3Oz9DPMlHB0dbX2Nna29zd3t/gydNWAjHh5+jp3+ZR5erv8PHy8/Te7OQCv/jt+fr+VMKuBPwnZeATgwQTMkE4haHCJQ4h9ntI8UhEKBcrFsmIhKNGgh4XTvzYcWSTkCR/oVSykmJLIS9T6opphCZIkyJlarRJhKe//5g+dc4KCoCoL6A4hf5MipFpFwoDBjQQcuALVKlUByFV+pCoUSYDDjQooGEAAARewo4te1ar05JcFXp9m4XCBiIG2nKxi1dvoK1xbwqki2XABSNouRhG7JZfYMH7xERlrNhskcR/CW/U/LjW3DETIFDeEno0IMC6rk41UmBIhQo7OSf5qsQAg9YAKkzFrMU2bt1+T8uGOXyVWrKWiWCeXPHzGAoQJBw40Jq3FujSqQf/g/oW3yF5Lw9h7rJ4TfN3JkxQ1N3WYiUIooZN3hV9T/tbGqyuMgHB+kTt1UIeEggUYCBbzeFH3BsNMPDfFP09iEiAtJRWxHRV+TXZANkl5P+cGxQwoAGE/jFC4Sy+CQFcXhdUN55ZA+DmoYJF0dibBBCE50SEjZw4C3bTyZijhjDiKONSg8lhQHQ6LsFjj8XRlooGEhYBWwUSzJjkHBowQAETT0LpmD9U1iZElpBVIaUWEzCw3xFhitmUPwUwMF2VQ1wggQR4HkXjmlrop4R6kfgoUwHyJapookeq8mFchpJkwAYYEGDppZhiigEDTabyqB2qCSHja49EGouBV1wAQgCsturqqwFYIBorn9JxHFvL0beIqaMIqsSAUlDgAAmwFtvqAw68iUqtcnwnRF65lhqljZUYcIEDDgyJBLBRHEAAqxFEYGyr4QYQAaerMBv/x3vKyXeAruxNywoFEoBAwgMWuLktvE+kcEKrJ8wwLrgOPBDrrJ7+Se0X3BZ4IL8TyqtKCgx8S262nQLArRO2dcAqAasOzCoIGASArLKlqAuHhcq9KO2Ypyx5gsev4qsvERs3ocELrCJLs8gkOODxuRmPovIbKea2m8uO8LpJARtYYLCxEWDMdBQFFMwqBhaI7CoBKrAqa8Jb3gGkdtE2LXEpAzjggtc2r5bzEhu8HQAJCBDrdasqfHuyFQXAltuVggPQqHBlQ7q2KBUcoEILexOc49xJDBByrCVHzmoHw5qLLhUIoLlhctYhHllgTltSJwZTa27zu1FUwADkAXDe/7rmGIQ8NugDrDf6EKVzp3BnqVcyQOaau4oBAu8u6rx8EiAPgsXJm+yAuMhe8Pz2MZ5lQJYbNj9A8H4cLQeqlhRPyQDUVx8AAeJzn+gBJ0w9w7/ugytuACeUJf+iLurdhjRgoAKQrw/mWxfEXjanURxgf/kjwAKR0ACtmQuC+WOVC9A0BbR873dCSAyGTKemhUlmgnI6iAkTcYCfuU+CUoBA1zIIK2Qd7gmJGcAGYES6ZwGgRcJLHB4ol0InAOoQLaQhDKNgGwzS8H0ZAt2zGMBD4BFBWwgcHuD+x6gpEDEJiOJiVG6oBvVNIokZXGIUKni7DNrQDGUK4ummMKlKZf/qjpbaVNGW8MUj1BGPeNQjHMwoCQboLYIoTIIMn8iqF4yoDHGUYwmtoKrk7Q4KfTRCJTV3yTYQMhIIeKIamcgAJ1YPb4UTQ53uJEmA4EdYh9zb3zCZSCPAMnmz9OTiQBFKJdaSghbMnyMdpcUpeEt/AyuX5/a4Lykc84LJ3B/R3PBJSPQyjb9EwiJb1QFAWsqFHfjcsooZBX8BTGDjqpreOgmWbArBnKwKWDI7dzBq7tITFXCAKN1phCZy05sEcCEI+KmJBPqRATQDmdcwEDbroaxy7uzYxy43Lob2LFm6hBkoCkDRFxK0CGysXjiZKQqDGmFnF3XhuFSQuWk2AX3/TkCp9VRqLJaCS5xPCBUAothAFY6Co/vEwjY1p4IU0IqcTsja1LgWuaDtj51J0OkSlLq1GXrNqWJDmBNuZZYDsuSenQCqL7FgGzsC9FIvuMtRhdiEurEKb7EUmTodChaxIIcJbr1b3jQ311wywVkAgFZDwMqJBnS0eqOsQgPEKB8ypgypYLmcBZAXOYsuUwmAJanGJEvZvVnWpWA5jHgKQthMqId9+/QV8SCrBNnRznbus2k9KyfaJrh2c8Ekauag2szRavQkKyREhI6XWgYYdbVsVcIBpNc+zWE1AgjQXmNxBq8wLip6rZpe/rCaPe7hhmVWJO1vNcEjDSBAahnE/8Bh7PJI1LGWgvVj1f1oWC7oSneMRACvqJxHP/vhL3/lesAJ7us83CQNOF6dTWkrwaP+pAAC16teC0CwAeMGdk+aTVBygTk1ZT4RAzzt521U9FAhhBSajARxTqMTpO0YccGTaHCJANAg9MJtUwMwAHuFoIENfIkrJhXCUBkZgBYwIJVHOJtjATBkRhoZyWWo5iFkLKElRbhVLaDdAyDngmwV7nsSyAvFShybDSPBn0QOwEC5gGYir7mMMI4EoeI0hBpPDQSd68AJVCCBG/b4S6rVSZBNnNsMukCtXDjxEw/NBikT4ioVoDNeICyu6b2ABPk6LhLGXARIf2TQQraqG/8dsOQqNNl9b1yDowWhAQgUoAHS6RNIGWABFUTgBA6YDhMC3epX86nMc+RYKZ84zC+0WZjthfN4JeEs2XEMAghwgAQIGOK/ItrZGg62ExQtUpx2gdvJG2lGe2q82gKgz084gFEPMIFq89Hc6C6PmZcw5G5604Un0DQY6g1QfOtb2eReH3204wTtQM3dvxp4qXsBavAMe3P9bhX8yNBmewPyZxO357LlnOwjp7uAuobCBDoO5X80vM6FBpoDfjwGcKuc5Y2OMyNs8+MUIDzhdPTSO2+uj5MP4dQDA4G5xwD0cQl9kDJnBHQOMO0MGyGTtoQA0zXgdF74fIpmPevyZG3/bAZkHaAY2EDVxbDqTED9MVc3MWMNo3MzLJaxC49y0kdxdvfO+wttGntB5w4KChggKjruTE60TQYNhHmcGz8FdcbIc8HX6O771iopym6Jxceo8YJPexW+l2yj8f0TB9DAdETv+K9CHgy24XonKF8JdWtAAzYvvYJPD4YQ7UenmGegT11BHZDLHi6EP4OvuOriSrCeEgQvQO7R/t40ZLb4lDj+GXGj/N9bpPloYFd4MyF963tC81po2Ca6731OgD8L+oX+JMhf/r3TfgwHXpr7A97+oWAfDUpWvyTYX/9LnN/qn9d/j/V+9ZF4ArhWwScT/HeA63d/nxaADBgK/7cL/wsYgZAwgTMBgRb4fQ4IbLu3ga6AgblQgSBoIh2YbR9YgulygvJGfyp4CiKICyT4ghFDgHKhgTTofyxYgC6Yg55ng1rSgz4ogTt4gwY4hBwIhGnyYkgIg0UYhCnYhCX1hETwAR8wBFYIABlwhWXwASWQAVAwAiNQBBmwAGYIhkLgAWa4AFVohlwIAF6Ihlkwg3hQhk3gAR5ABQlQBR+wAkXwAXJ4BFtYhX44hUo4BAkAA2CYATCwh30IAAqgAEgQiVmQAG/oBJRIBAtgApEYAoWoAAmgACsQAmMIAAkgAgogAiHAhSwgiVpAh3fAAhzAhksghlTAAUiAi7koBAuwh/9EsAKXaASPOAS9+IMJ2ASnKIkjIAJ76AFjmACh6AEZAIoKAIbQqABqWAKnCIYLgALMSIsokAAlEIwLIAJDMAKnmIea6I2WCABmWATFKASoCImumAEhwIYJQIsfYAJoGAKBeIzX1wmcaI4A4IygOAJeWAJ5+I4jgAIloJBCgI4ioI4S6Yq4+I6Q6I4coABj6IUJgAIayZG9CIosEJF5qADhuAIZ8I0FOYbTKI6+CIoi8I+YkHb5aAIAcI97WIwiIAILsJKSmIoA0JM/+QF5yALmCIoesI8A4JAZ4AH8+Iu0OAJfuIlFAIpbCANIEI8FqZWZCABUaYq0OJQlCYkgOYf/OHgIH+CPWumOJvCTnJgBSEmPpqiSc0mVZYiTTukBuoiLmYiLfLkARhkC0piPgfkBmwiXeZiPAMABY/iQS4mTxbgCyriHlNmUvjh+VIiIC0CNxViMmdiWAOCV9cgCJRACe/iXAFACqKgAb0kEmVkCtNiOQ5CJjCkE0LiTmdmYdMmLe3ibvdmZr5iWhrACJVkCIBmPjAmakriceyibuOmFZ9mXvUmdAMACoUiNvOmOvsiYjKmLqlmMisidoxmJCqCLmnmIuAmXZaib1TkEfumKIcAC7fmeCcACaxiImXmbwNmb/UmMmekBIdCbYOmHwCkCZymcaHmEkWACqGkC5qic/2zInGJJnvzZi7RInaq5nam4hnmoixJaoeBpkeQJons4i2u4epu5ngBKnqIoBMjpjiUAiYXIAWCIju+pADOqheooj+rIAn6YATgJlldIiYy4lb5ojyCZifu4mFM5oBFZilgAi3SwlkJwpCFKoc55nUGKk5eZAdQJpAXZl9wYlXDYmNzYnfjIhiMqBBe5h/eImaZYlsFYkytaob5JngJqiR+Qm1e4px8wAiZwiqlJogAwiglAmEQwAvWoiiFwljBwkoP6qFvZiIl6lq6ZqOOIm6gZAjOJiD1qg0fUB8Y5BMiZpYVaocW4kiFAqRkAjStAnUKaALEqBArgiWDZqUvqif8h+p22SqLFuJasuYcZcJohsKPpCZB74I9H4IW/OgbluAVUOgloCJWZd6dwgALMWgQoQItf+QVNKq3ESQr7mKh1qhQxeAvTKoV84BXmUA/wGq/dcA8H8a7yeq/4mq/6uq/DQK9UUA38GrABOw5PALACe7AIm7AKywwEy64OSxIGu7ASqw4N+7Ak4Q4Tm7Hn4K9NELEa+7EgG7LhULGDxXztYK8im7Iqu7LNwLEla3dCaLF2OqXBpa7jKrM1qJ4qcbM4awhGMaqewbM9Swg/W7O2sK5DOwdFqwc6NSoldwhIm7RxsLRDZFe4cjW7IrRSS0KTZDaIFlhEojYMurViq7P/kjF0Z+EuH7UHUUu246asbNAwBYQgJji2bpu1NIsH6Rct7SYBaNsYMXu3ReRKeBB/YRseHOSzWiu4ekC1ZsNiaMM0BXABqtdKwMW4xmcjQIsGurF8bLu4mHsHjksIiAsgoBu6dTC6g6Anv5azUYi6g/uyimO3sAu4cPsGMNWAtFu7mZG3e1B3hdC2vEt2mmu0XQC8RHu6w/sGqnsHyEsF1sVFcRe451F60fs/05uEZnu98pO91GUGf3RWeSR2XCC8qRC+4itIibZ23dO4xWsF6Kt13tYEzysFmxQ5Ryeuu0sR97s3vLV5Xie+l6K+eNC8UNC/XvO/OEcGt+RcK6e//9T7EQ0cOX51BUU3Lgo8te9LBRMsSxhFS2XwTF6jTBm3oBGsEc/kYcWiTKBlBS4nMhVMBwZccBajwrDCwvO7wGIATyhGNfSUb8O5vwnBw/KUThaUwcJmSnvTwjK8wVJAxOjkw+skeXy0tk8gUdajxMrTUOLmu6+rE1isUCJDMhdFZk5wwQlMxXIww0sQxocFK5YVwxA1BjIVALmzN7JVbKJqvLQgUz5zVUJzU3oHUim3N+3qxFDgx4HsNbLFxGDkvVJAVbVDTyqHPaTmxUwoCJ62CJLMVHsDNq2CxElwbMlzyJicVBbkyYD8VGocVVFhxkMgVUqQVwHQN3zVOYy2x/+s5mqwhifqMcgA0LSu8bSYFRXEXAR5BVdEZTFyPFWLRAJxZciGIzikEiyvHMvGTARv9yWBJwR+V71AmMx7FTl99cF1tRYoRHy/cjmgnDyW9WZd+8VMe20M4BoDwAAqAAIikr3ElzZP0Gu9HFmh3Fkiwzl648hLgAAIYDCW4j4hJDoERXwA3bqh92q9F0UEdx+nLNBiQ9Ai81k53GlfS1LPlwS3dTeLnDw29WS3OwSbCwbaxydkgQAvQDMkQAAnsEPHHMwjHbY5Rc9LcNKw5c6S1cpnhgAgIDANXT0h1Dsaw0+Z1Wz1nALJZgDVRxWHw8ZHINSFLDKyJcra927pJj3/Hr3Kduy5AXnCVcC93VvFRHAADOAABBDNtfMCubY9GoO28REVsHME2wNvbA09zIVqV9ZdYnQACx02S13K3gM+a9caYR3TyqcsUCMfG5DViMwEy5VdzdVUEWbYz/PURYDXwPLX8WUuXT3C2HMCsGx6ak0FG/ACAjy+JDVyRMAAPAPDLxA/iSLalzG3EMM9bx3YYXHa8wVg+yNgBMY9B+AAoUQAM7DYmhNCGjMBfC1GkK0rA0IdGS0qfWYg8abR79cAxv1f7hNgAybc+oXX6/08F3DaNpw/Atbas/faT9xQmgPPB1VzCNDZxZJY+UXFfMt0sGzbQ+BxHIZMKea55B1K/w/QN/4tMtT9QVjxBPpl4EJwZLBXBFe9U61xAUy3HlpNyB2mxe6MeYY7yiOmNMpV1umF1uAsz1mAxZrD0lElddN2ARH+KgDucL8hf6KdFwbQeDS3c/Qmak6G4AXXSzi94+NC3RqzQ6T040UOALEHNYJTABTQ4doh5FUx4kWAxhKm5JgFuaWWfyY9O2lWZGQuXvaNSW9MNfuDAUb9dE4ucROUf/6MKH+F41TXxg/nZlC9V8hy58UC5bZBUPm3dE1nYtkBARXA5d+lAV8C5ngR6Iyk33Eb5+6j6W4u41eAxfH9KlVjMKkGFob+PlZMBBRwAMC8a6mtObkcBReA5ExtNv8pcBiWrs2xHjmz/ga0TEO/TrhvHlO5jSwmnl2Zs0Fbleo9HgWt/upNIOZwc8lSQOMObQde/nhASO0wbO1MkLtT1RriDka9/u2QnNagXgUVMM53DMg0U1T06+yrThUd4gWkXD16fN9EhtBqIB0SUOmZ3QT5njz77tZbVUXGTmydR+zrTgUyZdCR085d/Cv0zgcvvDcVPwUSYDejRt8A19K83kaas/EIT78KT/AIlUEm7/CZzOrXvFNYY0G2vMxi87ejffF8wG/35ipADDjnjsF1rnGHyPMX5/P/dvLt5NtOwMO1E3G1QwL5Vs0iz+3jYbVd1S0W084l3zlBA3N+rfP/e1BxUA9FWQABLi5XIY10G53E/9TzHwPjUAdC6UY9FodHNBNtVVG/Lr04z5dgHK41QUNTCxUyJbwtYr8HGW8sX58FJ41L5mwHu34Ei18sjQ/CCc/0TtDBXhNtRsX3C0JuYa1/RtDxI5P244LsJsPaFv/JA7DJeeDt2YXzXsTpQu++bR/usCFDdG0s+Yv5KK/5ToDAIoMAhif8svvyyI8WxI1fE4A/pZ5BytQ/zD09HXD9tAMrBMAAvNy6hRvAAhx20u5HlDLbebT2Gpz7CZ0ltjE94U++UTD3KX/F5R/+CPB31l3vVq/8ewsEgMKAWDQOCoCG4xGIRAJR6ZRalbok/8Oj8XC4dA8bxPgEMmNAG8C6wli/4XH5nF63xxtbfTF598e19vb6/goNDQUEDukSF9cQBiYABg4EtwgPiQw1NR3zLI8QAAwkOh3hGg9T1wwY+ioaAEQNISysbnGjHhww50zjKAqEKS/gsk6Rk5WXmZudURWXVw8RSCcHnul+7zixs+dmBza8laf/zCkgJLqSZgtboXLlpQgO/La1yQEOer/9/wEGZGbuFME/oiLh+yZsEzaF32a10ofMoJ2KypY0mZdrVz85D+NM0ACHQQWBJ1GmVAltYLRFokiBXAmHIcOZzS4ycpmt1sZcL0bem0inFYU1KezdVLqUaaGcTncaCv83rmlVgE/lYD0Fz6cVEghMCi2U7oAEDQasplV7U+udtnEiMhi6lq6qqH7eLsrYlQrQQjLrBhaMMq/OwcsoEAl72LDdgD2ldCAwmTLlDlM6MED7BzBjz58p3nVUWGXiAbGEvKmweI4GCAUaSJAEmqVjgFyjSK5c+bIUEHPz0RY+vKDoRaRRUmpQQAM2dyApqGHjhnhh5Ib2ds28mTNw4t/Br7lem250OGifex9Q7M2x4daNP4PsU0WKTN7D56c9/g3/f+vlgISISur4hZ/q4mssoFYw2M1Byl6QriH9KATPPwAu/AYfBIRhzjuRSGINNPhQ+gSUAfHzJcUKWaTrwgz/s5kAggDf0GSCsthjhQGjAEDqOxLp6iwOIVsssqkXE1yqlVdiSW+UNSQABoKyzvoxyayunInIN2wy0su6kBQsnXUOdFKIC2YrEsi1tvzSTcHCzA+WpNTMkjy12nxTT7XiBG+zKI1cE88V9yyUTzstQjSwCySQzUtB08rTNNQIWc3QS7PpE9MRFcWw05PaVM5DWWokdNNT69AU1cMgtWpL895Ar9RVabWtnE9rXanVqrYEEK4iCMxV2FRxjQPGYTPt9NhkJh3wr6E4FKY5ZKm9M7RqXVS22GdE1YAfd+6QkcY1bCwLNWxpVRVdpnZdCVZWSP1jSTaanBUtA+hc91R1//VlS1tec3wD3DtS2IDMdmZdY4h+UeWXYZXaVWnDCf2g4ADuHjbU4YxPijglceGi2A6LMeZ4z41NvurfpuYFAJZ4u/OjrC5SLhTlmr/xOKUx2YFZLJyRvRloZ3T+bFqXRRwaU6GVlmbl/BCQLs+mK2Sa6mttDQ8BBiSZ+ur8rP76uKe1ZvQasS8NG22oxqZQwAm8Xvu9bfujW25jyQYPgQNSKMXUuy2021PAccqbuAkQOEGFqP8mfO6WHHe6bfAm2OAEBHJzgAENko4cbMGXXbvowCo/YYYqSHjBgdc8rxp0wQkffa3ST8flAQJOcK/1wCHffTTDByvA8to3eqFx3//XUhv5wbNmbIAX+AqAgICX57T36s8BXrALCOigN3m87yBf7D1THnnZrTpAt40mE5/8/V5/Hy/tA1N/Mva7H19+OOPfn9jJP2M/AuCvA4Dy32DM5zv0VWUDLbjfPO43sANm63oTtNb8aIO5B8ojghbkXwU9yDxEwA4lGhwgBAcowRBWJYG7W2BTTIi/AFRjhcnrXw1fuBQKnEB6J+TgAEHgkRoqpYWty6FSCgCCHsowiENMSxE9d8SbJHGJ83gBECfQOSfq6oYrlOJMqOi9jSBABQEAQSm2eKQuhvCLKxkABviCAALMgACQSCO71ujBNkoMBA/yYx0xUAY73pGIebT/4B5TEogTEQESUwoWIWcCxcghUjAw8Rsk/QVCPdJPP1M5nhwW8IYFeIAuIxjB0CSJjFGKkpTVomRg4vLJOHBgDSMIQQbkoAAFLEWXqDQkSjiQgDUsgAO7zKUx98XJatHSlrgEgAISIAJcJiABCvBABqCpAGdCUwQfAMAIoklKD4wAmiyoJTV36QFd9tIDIkjAKZ+5ywy4E5kPS+UpOCCCUIpABMbk5jSriQJ4esCcI/gACxYAzmrWEgUlKAEusVlNXC4ABe4MJQA+UIIEoOCJyqQWBz4AA2euYJcoECY/FzDPXSpABABYQUs/INCHLsAEAKBpSk1AypQCoAQjyMAC/xawghAAwAQp7Wk8ARCCUJKUY/d0BEhL4IES9JKpJgUASj0g0meuAAAJMIECgIrLoyaAqywowVVX2lJoeuADNfVACK6ZgIuqEYAP44AJzroGGKyTlr0EAAzeAFitrqEEF03ABxYgzK6GUp1eNWZbM/ABxS7grLpsqy7d2dRfnoSW1FxAL/eqy74aUwSnzOli19DYr6IWALQErF6R2loAsKCa2bTKK/fEgXa2tLVABWpsabkGWgZ3DXItLlAVK1cPmICjvcyAUm06WWHqcgFKBao3M+bURdAysUjlgG9D6de2NvS4AFhuc3dpXNkSd7TCfaY+gdpKujavX7R87ikTYP9OjG6VsBylbFfheVCuZqCm3V1sddfQz6vq96+4VIA5dZkBGGAXu/bcrECIi9T8rsGbCuBqcYtaXgSjFbXkLYF/K2tM7prAmRXGY10ZFtz7ZqAEIQjBWd96WMlS05s73ug8bezf5O4zBAmYKjGpKUwU2FiaSP1AkUNQz35p9xAZdm6Nb2zeInvTlm9QrwiKPNWuFvmwGE1yh1VcSyhzlIUexaQvNXmY0v5BveHB7ZupReWALLcQdeYdffF8NT2jzToxSMShEZ1oRS+a0Y129KMhHWlJT5rSlbb0pTGdaU1v+tCGHoihOR1qUY+a1JX29CFkUGpVr5rVrXb1q2GNaRn/MCPVsbb1rV8960Dveg61xvWvgR1qXRvC18E29rGRnWxlI3rYyRAAqJcd7WSfGhHQlva1sZ1tbTua2s4m4d3uzOtaDVps4Rb3qsj9NXOfO5lxrpZpwmIAHgGAAiUjmpvZzbB0V8g1sHFUAeh0IH+sO99pu3Cu3tUGIQRciJIDdMFNtm/9+ApKwhgHETbQ8FvBGOIpk3h+DCSMLIhc497meMc16+5hgegNJQH4GwSeM3yj3JUHr1VRjmKPl68h5sk6Oc31bfNakcUsaNn5PkqOtRECvWYfT8ukFKYaLc536UyPuNAnfoDlTMtMFHy41dHl9Ka860ldt+HPwY4tsTOF/+ICAxZ+ugSxmac9XVgPz4Y6dLTgRHLudG+Y3Sk3o5CRCxs3kgD14mbyr/t9WGtXkivoBTNN/GlIstz44hmfK8frUB09M1MB0FT5TGI+83VXOarmJHq+o73jn1iOMKa+qc0fhvJwSLwcKqVFglvQABtokBnM4IAxbA0MlUCCwU+/KUY5yvaWB0fCsMT6gl9AibggQfgiQAAMaEZjgF/V7Qd/tjns/oAUcAAJomcBwZ/M+16KuxwuQD1lCIgSwCG//w7gw3k8IQC7ONebZm8lGuD/VKQOLsABHKA5ji8QkoABHZAI+iBaRmX8+u7NUoCHpID/cGEGMDACuE9PAhAlDP/gAFfH3qAPDipAAlSABEhgcTSgAflACPjgAY9P8uyvAiGpFb6nBRwgHnChj6JA/dgv+cCDAiQABEjgASyAAQjwBNegARgAjqRg+5rwJZywbqQPXaAuNdgg9lZCA6BHFxyAeHChA5ig/xygClskBAMiBRhA/yKgBD9iIg7QBzPQAeSPGq5QPHCQVrrFOfZwEbYw9/ygAM6w/1QgDOfBAqTQA02QRdjQHwwAAk7ge6RACZlQ9VxGBdHPK1RAArzQ4aqOY8hOVghvGf7QBv1gA1xACizAFnziKzpRCN0kErNBeCxAI6wgDiGAOzoBCqUwF6gwIO6vRdruEd5OGUpRFe3/YACqLwBeQAV0cSMwABb9rxbbTzAGwAFaUR4wETU0oQ59Ig7zsHCykFrwTlqcbxLkj/4eaQ7aoAWiYAYOsSt2oTcc8UtskRkq4ABUQB7HsQQHQAM4kS9aEBQHrg9RBWTgwEkMrxwLBFryDj8OoBEdACCjhwCekRYDJRvXogCicBo3AhMPAAGCMXq2L+nO8YL6pWVexkn+RJFAAQAYUmBKRRAu4AQ0QgOjJwpMRwzV8HOI0HlOEiVNsienAAPWkQJXEll4pkwSBvQmQCYtYRQgz2XqhfBwUieRsgo08Bo7cihRYhClThv0LyPlqCujgACWMvpIb2hSTxA7DypPsQ7y/08tb4Ej60QsBSIVzQ4ODsAO0fIsM7It8aYpU6b23OX88JIK8vFRPPIZlvEvYc4SBxMv2VLmENNkli9NVuICYLEx0TAo9WMfj1EWknEO1Ect64gw+SIzfe4t8UwHRTMA9DIsRZHtJFId6WA1u7I1MdMwWTJRmC4FyqgxH1MfI9MZavIRZuUhW64TkRI4WVM4sVA2fef9kEECurErwRIb+fI2rvIl7QVKBAYz07I6NRM7dwf8FKYee/I2ITM8AeIpEaYupfI8WTM9f9M6+XAzPcc91wACTlI3/uh7khM8c/Mz4lIW0NM1uwI2n6EYU0ZAXYYBMNJA/ag3vhMAl3Mmav+vAhzgQYNzPUdxgix0Ep6xK+RTOemzKTpTYVa0J6mzP02UbTwoRXuvQf7IQbbvEXHz8sCDivYTQn1CQu8NQCMnRWVwkYxAJV3nRT9yRi9TPWPzRA+ISS2sdwogLCxFJqHUGbQTDhqASl+TP6fTP0UIRy1IS4OudxAAUDQBTOFgC/1BJgbASNkHTWlUTSnUZNx0yvoHEromRVLRE0hTJi6gKI2yj3r0UX/jRrMnhMbUceKkGqJkTo+gD5bxECYRAXtx7+RgBBEQBDCyK1ogDZwUFMKUTV219PJsUCcBbrCBTtnxDQbwEKAwF7+xAOXACJFQCU1SJG1n+wYASNtMSWH/FQRlNSZqdVPrUgkYIFTv4FPtkBdLBh/cEA4RsDtxwQVWJxSp7lVBgyy7cA4MAG5SwCQsJergMQVqcA3grU6JgDTZSFYngSpstSYnMRPrYFeJtVdPcBIrsQqEVQUsMzI+sVWX4k+dwS+vMAWRoHLEz2feYAIkYDkgICj6LTZm41AXoUvPNYrwVSLswCVjAQqp9TwgoAdzAVujFReJ9Q4RwAKkMwBIYAntw3rY0yom8wohIE3QwhRUqCTeYAMoIOHcoFNfYgMK1Yiy0T5ZAQL89QkZIBfnoVc7YRu99RaE1QEI4AFuBw+RFUwUUilO0x2hJVuNbwAkqAAMCAAugAgC/yYLTrMAJqBsLxYBENBg1DTsPlQOVNYArJUveHFu+/EfuyIOE+cEDmDe4EdZlyIdJ7AhP+IFheFt88UIAFMLcO8ANkfjSgcBHgBhVWBzxFVpBq1fr3ZmvdEC9iYko0dYIZIxHJYZmlMVoRNpNXEWwMBlJAQAgpbl1qAkcpcNxGEcRIR2Zkh66OgFVId1ACfdFhUvMeAou1Ip/wxLPQNlVZHyBoBa7YNo4eUCkoBv5FUzcK5H7MF7AUEDGOBAmDcKMKd07+d2codhsytwzZJEbdRKJJfzDoYZ83MSyGQkyPcNQtUAvKULeIToqoTe5lKI0lUcfnIKMEd6TkD/jAfc+P9XNQUTLUM4Qv+WMM6WMRq0EDTAM+9UETFYDPVvejxYSv/AN38TARKWhLeXXFlEMf9ghU+Ce8RoHsJHfwTtg+XAhqcTh60UQQL4MGK0EECyC1g4GwSIgIyYatJNiWmUif/XiXtWbK4YhdxHbtKNAW62i9P4NUu4Y054aMb4h1ogeMsNieGiMeuoRAE4jL8GjTcoFzrIjO24IfE4g7/4cfj4amIIhWZohhf0GQz5hvUYjLl3dxb5hxpZkGn4DkQUj0e0iRG5kj3HAC4ZkAfoBCBX3QZZRvHYTHV4j0U5cqjoj3HhfppIdFZZCFw5QneZfdpYIG53WGZZT+kBiPT3TR//uRmIlDV7GYJ+mRjfGGeGuXiwKHVTLpmZoUxbeZJDmYc9JwWgZ4jlgYwC4HqfWfZyOU/xmJg56Jz/IZiFxRkfdTfI6AVAYJDqeJPrAGMZNSP7+ZUp2ZtleVUZaQDk4h2PWJ8/dxw2AAnV8gVq1nXnQXthWaA9CCFoFZcVWjXg91hH4QDZuQpSFQEuoGVHOBdSNeN2eFLvyJICFd0C1wAMmnOeMBYspmBH0ljnVlqxNmuNVW8RKJo9x5M0GpuxYwMErl/PxQ1fQKKjAFwhwCQ6oXBzAaqt+YMSeXliqaiF9BDgrQHSZHDjgIG58RY6YGG5BBMA1grOWneEMquX1UWN/7oOOpb5lLoOhMdUpyBnGWBn03qsTXqvdXYNhTquo3Su50BppXVlCyQkx/YC7E0hAPaxgTpy4dqw9xKxP6JuYcNeUfAATsBxUzkQP1W05/OyMRsSvS/kTgFxqjgQa1pBYzm1l8b7iBcAjLa1EeC1heCYD3u2abv76HN9fSQZJoC3K9VmCju4K1rpDAGCK9sOjnsOTQ+1mdvOcnkRXFsT2826r7u5i0MttvuvYfqJv3ulw1u8DyBNknsIvfu8hWMf4WC8X7p8lhu+P0O+53u3K7a7gRu/g1Tx6GK625tZzRvALbur62Je/duiETyzFXwt6pq3PfTAH9y+N9ofFBudLf/8wlklu5Wh7dxauTvcw7E6wiNFH3qOxN/bxANDv0MiKIr3qikEnl08JWD8PHYk5xqcpW/8tFH86aak6Hocg34cyAXci+77yG8LxLV4yZl8XJ37Xks8ypNVs9/Hxq08ITP8JH6rtqt8T8DLxRZhroqLfPZxBRIgBGCAx0RpuqRsDkxJtcNcT4pJl/DLzPtsluggwxw5yG/CwDxg0D8gsmKLnFpJnazpqvQpAwhKAQZqnBbdvB7Mmbzuv7Elw5ZLwdrpnRjKoSJKv4wJnEQguNR8o2yqmE4po1A9n7EcJQxMAWxsBbqrlwJKqc5rBLgKnTxAoBZAwWR9BGjLzARqqMz/ts7f5M4h/bkQiqiMCr9WIANYQKkIjJRoqaEcPbg4qto94Ls+4K3iSs9V18kNIdZ5q9atydgrqq0qzK8wigUyy69oqZ+ACrou3cHR5buuC7Uka5jOyrgMzLho6cTcy6bUHAZCKbhoS5cWSpW7fBli3ZjQ3cC6C5yKKbZE4MSGXd67qp90Sb4OBdndxM8BXrpQK+ATnrWuPQS8SeDXgKV8C+SbRr8jfpjgXMJqKdrXIAPaS7aiC7hIbOePvcULheTZTKse7OSHTLaYiuf567kSfqJYjMNcHdBnouZ/vpegSajY6qtKoKVoSgE+IONPHeifq59YfugxfZmSjKuWTMmY/2yaQgnlZSsD0Mm+wgy6ZJ2rbGnN2SyhX/0kDN28WsnQBz215uqnKswDLmoBCt2bDt+m3gCxLP3siH7LG5bcx13kMV/uHl6TL7/zVy/wq0fLRd8cpcHatm31V63bzkH1WT/2ZX/2X831T6HYaD/3M63Z/gD3df/3gT/4I433T7/4W8T3hT/5F4347wD5lf/5oV/2mf84YD/6k9/23aL6rX/7uR/ZsJ/zZx7Kjd+NP5+r8X38X1zz4Sz00R+ay5/QxL/931n9gcb05d+8Qwf+wf/+kxQIAMIhsWgUCgTHJbPpfEKj0il1mqReq9ott+v9gsPi8TfbNZPT6rUXDXWz4//yOb1u58Kr+Tu/r1daAfoNEhYaHg7tBSIyIiouPTZKTlJWJgriYVpuqkUaeXKGio6OgTqZkqYyoSJpqr7Cxp66/snazmLR3u7ycrJC6vbG/v4KGx/PFX8GI5MSMzdHS3dCv1VPVz5jb3OTKRd9Y1MMDDQIFQxVVMRpj6ILqRtVvAPQd9+XXePiQw0cNBTQMAAAgiHk2Om7RKqgkINFBjCYIIQhv4pawim0yITCBiIGCBocyKadKIoOiQy4IGGixpZSMLZyeSSlEQTk/IlcQzKUTXIHcoYcIJGizKLL8hlFCXRigaYCEeZa2DTgUgDkDKwkmjQpTABdj02AUDMkgAn/ByRc8JYw5iiTA81KMHdQqNatRbt+NWaAwbsK5twC+AhgZam1Xg0TAvzRwAGrA7HW1dLAnN1deBFvowBBwoED6ADXuyCxcNS2ZM8NdDiA6GQqBiA4cABBcOVhmMHdNuq3MelFtigcoL2kAYPZUYhbePDAAgPKtV9dfg5FMGExO18BF87kdXMnrx1ECCA+QATZ2qX7yp0RfT17QlRKGG3dcF4/ZzsfL35eCPIH48cv1x17oUQ34EnJ0KceLNw5J8R34Y0XAYTilWccIuMMsE5gFAxBwX4uFcjegXJc1w1xFvb3H3kOJAcgcw0OogEEBTQQXz28AeBZZSGiNyJUvlXE/11Y4KnoIpERmkcIR+kwcOMQOtrFo3Q+jpSgSxcg0GKR/5WnZQABumcHTUNI0NQGN20QpkxSPkelTla2NAAGW2653JHiYVBVHQd6VkCZTZW5o4KHDeiYHSXiMwABdNLZpX8BEKAnHRNoQAQD8+AI5VZs1uYmNaVppCijdNoZXqSD7MUhACk0VkCmaoI4aH2xNOWEp2kgeo+oHXQwapESQiopHZqdpcFHrj4Ja0ucJipsQ86qBapFohKwqK9bnlpoI8wK0xoTtwJwQVp15NoNtdZeq2K22joi66CWfJfkTMJWcMAJ8pIIZ6iLVptukesWUmuh3N7SX4AwPrsERBgo9/8igtJWdK6/6kK7Z8VGERzLg1zim3ARBWwAQgscW/gmxPxIPPF4ABMCLlfuHpOiigcr5ZEGDrhQp8MmAzktv+iqzPIgLmMMcy8bM1qhYCelwMALjzbasRMYamiAqgB4uF4Us76SssrBIkL0XUbvIvOoNB8E3Am9XkvzEzLSaCOyQmhaLjdeB33xHGKvSbYsSPtbobgXOAB0uko3sSQ8Tc6dIz12b4P3xEL7wXesSNlSAANeTrwcAgiAQMLX4oH57bhC/HkmOWlqbY1Lu7L9NeV98I2hOQXcdBM9tkPBez3paFhIxqHIOfp/GMxp/HgY/JQ7OejwCehUgbL10ruyiKr/PNhzCKyw3v4AJBDuzr8DPlW2/nM+aML7DUv2yverPaTNk19WpUNc2njd+vo8OrDby+FWF2heU55XD90pzkEb6cgQPiSEBAYGJB5jH+awZzjZXVB2wkqVEFjlJLo9jn8RS56/HoCBI2HgdFzw1rckZYCbOYABAyjgDA/4vDENYXy5g54Kn6U7g/SQIDf5ySGGx4n3GS9+2pvdAyFQrGO9qnVP4JoqGhCykV2rBSoAgX9aAIIN6GcL8SqZEagEsuSQQAUSCN68Pua8GvqofhMcAgKm8hRDGHETSBydEuGnN9f1zCIGWBjUtuQCBOTMhDI0gAEuwIAUVMFgOytjVQiX/7PlCegIYXFj/TYZBU8SATBwCSId8miJPWJQfgCs4Naud4sKwOaSMwOBCkbmAtmwEWQHYGMTALciMs6RAhII3a8cQMrA8AUeAHkjOvbSF4R5JJkA8IsEDUUdP5iyEqgMWgbzNp+TtcRPKojdihjWATWqaZAyfILZXJTJCa6mmwFI4xqPoBnOaMqem+mMspqIz8+cpgCiwWb7uibPdPUxiX+cogiL0jQLiI48ESABcyCZOAlI4GpF8GUxS3aQetXyWhh4JyN2Q1BWuu+g10ooHxe6D+vVppGFUw4BjOnAhyyyCO0k1c7I0TQSXqs8x0QV6k7aBldWTqW+YqkGvxnIrf+o7QQH0CgU6sW6wMBmQoczD0TW9jV68pIQ8JHPHbJJiW1OTqlLdWkTICcTFlahaRfYaboCtLlCqmyk/byHWSeBVn8x1ZthcCu7lvAaBLxAfhgAATlHl6eiodSg8gvs5Ni6ioYWVgoXUCujKAtYyyKjr5L4K0I521nQHoGwmZ2JabHVWmyh1hiitUP3WDvZ1/4rtrgB52qfQNqV4pZikD1qDjUUDx0a8IHkgKYYbvXbpQb3P0ysxVN769voisezCNVtL0KEAMIcBLk1tEr67igZ5s7RCBcAKh9BUK33wje+8n0vCLgrxZdaNwrPHZV2V2pfy5DNJhLxFARvuh3YSO3/NEaIF+fySr83QjjCe61uW5E6JexCCsOrXFaAsWIo8fLQC5IkaXr5c9dSfc2LV2WEavPbEAz3d63DPYMgCiKU8NZvRA0gay+zSjLtjMiXjqrrSAdg4D602MX77ayGp8vXAAdGAjjeYVnEQgQr5vMIdHXbHLdsgTvR6ZYQCGu7eOti2y6xyf+9hXcbciYb/tCZymxIccjMURUhzlBYBXMxGyyec1IvG5g9M5rhp+YZZ4KODlrnRvapqUYi4ALCoWuR0DYQSs/sy1ql6CMJNGhCPwTGhx5bZL8Ay3XeeVSCu4CPJ+aoB9RU0qJIcn6XTKcY83fNtpjtE1wFRj+3zQKf/wO2r+wkVapugtbWtbVrVenkbvAaChpg79eQp9ihCtrMoDaIqJ2ta1lE+7q3ney386XtbVul2+RG9BaoiBJ1+1EVysYHXCVzAGrn1b3z3fd868vui1g41ONeYrl/BNPnyDTB00Ew6LCoMhVHOOIS/jd118Dsf8G44FU6t0aEGTou5yc5nkMAw0pY5CMXNty2grdC5f3pljQNaHn2Tqsp5AAE4OxaYibzmVXehIurK+Mu5zg+XuPVTJNYp3ettLARME46AXrC1vX5t1je0qFT2CJnxOuPjwC4/yFp2BEVD6ctiu7dEpcNQJeu0FMx72YMIOfFnqSJtWRCPn9J2BuYKf+sbXr21BZ0DGtfWdud8fJugNThQU0S4LTIxaQ5YAMSOMGx/w6MUjfX6k11++G3obmSqyxAEPHSIWXJqADN1fKXxXwYBp/dwo/i7cIonvIwQHIA0VLxvnqs6i+fdotrXrCGJ/o0XE8ABFirPKD/bO99T+M4uD7D6+Y88aVxAK3KDvkUwv52mw941oMh+ri+tcZ5dvCWHKCxQdM+wb1/lN+rQfywn3XnsZH+JbI/3u4nAtWLMAG54NvkBCDzUV/WdcP9wU/+tdz+3Vf1fdIGbIA5YJpIZQnX+QvvDZ8BcgMDjB0fKeDVMWD1JFoYTAAEklWqjYqKNUDN+YuKSd221N//NCDAZH3g5oWgz1nRBsgHC03gfyiSkdWdBVbayUFHDErDDOLf/Lkfr1HNjqXDAUSgR7CgIeHSRk1hkeycbThgMyBhAiqh980W3NTIaAySTewHpUUdE6AhOu2aETZDBTgADX5h84lWAlVAk2AZzzkIC5bdE/hSH7KZGyJDAYCAHE7fDQaeb6lQmdSbGp5YrKFcEPadrAHYFh4DIRpi+4UgocCfFESPa8BG5YGiA4giL8geL2BiEh4iA4oWpViKHjLBBDAAAvDYFDRiIFqiMTRAIaqiJiIi+G0HA6iKB1GBI1HABNDipghitzQA0P3P8c1h780WsUiAsVCBBmSUECBj/y1qxCnKQtM04wCG2ZEcnziKVPnVRv9FAVZIgHBsI8VVWEVowAZwSA/+xwucgMMxzxWNjgtuIic+nx1UQDWexzv2TS7+DUbRBgoCiAqowKO4oDotX7ER4T+q49QwwP1oUjIqVzmcA/BEgzemAkdopLdgWgucQGJ9SUVOUyzpXBX+owi2m4LQQzws2ARABLRMwGiYz1OszzGI5CgQh0U1UibdWXlcUhYagTip35+xYUw2oAY+wU/Cg5SlwAUw0BMUWDVZTgGe3zFQDX9QhjAFhxG0E7CkYRM8VAcCIlRG5VdqAVUCAATIRyTiEB0NEToSQlBOghjayBCkAAKY3YLxYf9FrSPhEABN+Z1b8l8iSkFP4ERNRGLNFEEdOYVeDgJfNoIdNklgnAWymeUjLqYURNVUMeb7BSQXWOb5VKYWgJKiJcwoCYNmMsJdMiIDUKIfhqJpbsEtnma4idJZpAU9VoGcTdNfkMU1ddcyEg9QeIZvNgF0nmYnApwXKEZRDYCFDObUOBpAeYxAcaMWSuUruCL+wOJ0GlVqbgFogGdD4JNGioFJLSdCbgIHrQqOoCeLOWYXyGccKKcpMmcoUKM15icMAqMW/CcbjNVsBmiB5tdFhgtGheeA0KaDUuh+MmaFWih6QCihaeiGPkeH9lyDgmjKYahbfmiJRsmJQmWKquj/yxxoi5Loi15ojMaki9LoQVJnfuJojnKYjYoBCiiAAnxAGCQAUM6oKCyABwzBkgKABzBpBohAAhSpFHxABrDBCKzAky7AAlQpAFxpkzJBmALAAijACGCpEHgACygAAGRACXzpNojoEiSACCwACiTAAoABBzTBAhypV7bSNnDAny4AB7TpCIwAAIgAC7jpFKxAnAoBn35BBoQAlipAAiiACISAEOTpEEiqEYwAB+ipApSAmf4pnqIACgjBB/wpN8ypEbCACBBBBrAAkwLACHzAApRAnWLpnU6pnpZpCZRqpAoBC6gqnsIpACiACSiAno5AnTKpB4zApTIqmO6qqmZm/5KGAgfYqaKKQJt2qQeYwLcCALIWqbReaqIqqwcogLQy6aXCaaGeabAOq7LiqawKwaWKQJoOwbwqa5sCQAjoaacSqxF8QAh0agJgq6SagK0OQbe6KosaKbYOwQq0aQbAQAZ8AJPGqrImgAd8gAk8acOKK5Py6QpUKgqUQAaIawaMgMBK68ougMjO7AJkAMmGgAdkAMEimbZyAgd8QAl4QAkM6b9SKgvc6cq27MxeqQkU6aC2a56yQAmAKQp4gKhuLMk2LABwQKKWQKJabLm2qhBsar5e7Nby7KcOAavurJ6iALMWbchOqQKk6QJsacQC6RfwrJqK7AjIKq2WAML+K/+xsmm+MmrXVioAlMC3LmuX/mm9UqmfcuoCsACmXirA9ix9kgKfJkCeFm3RduriDqkJOK7Zcu0Q5OnL4mrBFq6yHq7pwsCQKoDaAkCrLmsCwAC2pu2tdi6aUmntOusKPOuWLkDOKirmju00vGoRLKoRfG0IFGkIsEAGSG7Rnq71Fi0HjCunIm2XUu+fEmyeSi7wZmqXOml6Bio28Gn1tinoDmz32uz4Zi/q6qndMuvpDu7gSmr2mi+wom6/tmkCVOvuEsHMdi4MQG/Gkm2uEmqrJq80LG8Bb22ZFqkBRyqWPmv+8unBcurTKq6skqoQsGzxFuuW3myZgm+XmkCaQur/ofjsJqjt5wbwqFKtm3rA+EIv/gJvmOIp12IpB9euBw+uAK9qEdju2Y4qwPYwneop6brp1sLAu96tB+CrnEpsGKAAwiaA0AqBCWDrCJhAnR6p9e5vCIQAwPIppcoqyiaA8faulJqxqo5vp75sG1MsH/ToIcRw+86wELBxzi4ADLQxGtNvFrdxkSpACGxpIp9xwRbtm5pxDT8ssFpvyF6ppnZuC9MvmGqxuh7sFqepv1px3qqBuK6o5k7D+PKBBzxwHFDqk5FyGoiAusLoeFqEKvPBClSxHFDqHWNDBK9WHvtoReBFDCTBMSNzMivzMjNzMzvzM0NzNEvzNFNzNBszexYYczVr8zZzczd78zeDcziL8ziT8zJfsxfIQDmr8zqzMznLABWkczvL8zzTcz3b8z2P8zsP8z7zcz/78z8DdEAL9EATdEEb9EEjdEIr9EIzdEM79ENDdERL9ERTdEVb9EVjdEZr9EZzdEd79EeDdEiL9EiTdEmbtEEHAQA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chemical structure of eight inhibitors of adrenal steroid biosynthesis or action. Mitotane is an adrenocorticolytic agent; aminoglutethimide, metyrapone, ketoconazole, trilostane, etomidate, and cyanoketone inhibit one or more of the enzymes in the steroid biosynthetic pathways; and mifepristone is a competitive antagonist of glucocorticoid binding to its cytosol receptor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_55_42879=[""].join("\n");
var outline_f41_55_42879=null;
